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Tissue Engineering Strategies for Fibrocartilage Interface Regeneration 
Dovina Qu 
 
 Ligament and tendon injuries remain a persistent clinical challenge, accounting for up to 45% of 
the 32 million musculoskeletal injuries reported in the U.S. each year. However, current soft tissue repair 
and reconstruction techniques are limited by insufficient integration with subchondral bone, potentially 
leading to graft failure and suboptimal functional outcomes. Therefore, there is a pressing clinical need for 
functional solutions that can enable integrative soft tissue reconstruction via regeneration of the 
fibrocartilaginous insertion present at the junction between bone and major ligaments and tendons. This 
fibrocartilaginous enthesis consists of compositionally distinct but structurally continuous tissue regions 
(non-calcified and calcified fibrocartilage), and it plays a critical role in mediating complex load transfer 
between soft tissue and bone while minimizing the formation of stress concentrations at the insertion. Given 
the functional significance of the insertion site and using the anterior cruciate ligament (ACL) as a model 
tissue, the objective of this thesis is identify and optimize tissue engineering strategies for regeneration of 
the fibrocartilaginous interface. Thus, the studies detailed in this thesis consist of elucidation of key interface 
characteristics that can inform interface scaffold design, identification of an optimal cell source, and 
optimization of chemical and physical stimuli for fibrocartilage formation.  
 To guide biomimetic scaffold design, this thesis began with quantitative mapping of the 
compositional and structural properties of the native ligament-to-bone interface. As both the aligned 
collagen matrix structure and distinctive mineral distribution pattern across the insertion were shown to be 
highly conserved over time, an ideal scaffold for fibrocartilage interface regeneration should therefore 
consist of aligned fibers and must be able to support the formation of both non-mineralized and mineralized 
fibrocartilage tissues. Additionally, evaluation of ex vivo behavior of insertion fibrochondrocytes cultured on 
aligned nanofiber scaffolds indicated that an ideal system for fibrocartilage regeneration should also support 
cell-mediated deposition of both types I and II collagen as well as proteoglycans. Comparison of potential 
cell sources for fibrocartilage tissue engineering showed that synovium-derived mesenchymal stem cells 
(SDSCs) exhibited higher proliferative and fibrochondrogenic differentiation potential compared to bone 
 
 
marrow-derived mesenchymal stem cells. Thus, subsequent studies focused on optimization of culture 
parameters for SDSC-mediated fibrocartilage formation. Nanofiber scaffolds that provided controlled 
release of transforming growth factor (TGF)-β3, which is known to play a critical role in development of the 
insertion as well as in scarless healing, were developed to guide SDSC differentiation. Scaffold-mediated 
TGF-β3 delivery enhanced cell proliferation and matrix synthesis in a dose-dependent manner, resulting in 
synthesis of fibrocartilaginous matrix consisting of both type I and II collagen as well as proteoglycans. As 
mechanical loading is known to also play a critical role in insertion development, a custom bioreactor that 
mimics the complex loads sustained at the interface was also developed. It was shown that the bioreactor 
simultaneously generated both tensile and compressive stresses and modulated SDSC matrix synthesis, 
where deposition of fibrocartilaginous matrix was observed on mechanically loaded scaffolds without any 
additional chemical co-stimulation. Finally, as a functional scaffold for integrative ACL repair must support 
the establishment of both non-mineralized and mineralized tissue regions, the combined effects of TGF-β3 
and hydroxyapatite (HA) on MSC-mediated formation of mineralized fibrocartilage were also explored. The 
addition of HA nanoparticles to the scaffold was shown to enhance cell proliferation and matrix synthesis 
and represents a promising strategy for formation of mineralized fibrocartilage. 
 Collectively, these observations delineate the importance of bioinspired chemical and physical 
stimuli in fibrochondrogenic differentiation, and how they can be optimized for stem cell-mediated interface 
regeneration. These studies yield valuable scaffold design criteria and establish in vitro culture parameters 
that can be applied to functional integration of soft connective tissue with bone at various critical 
attachments throughout the musculoskeletal system, including the ligament and tendon-to-bone entheses, 
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1.1. Specific Aims 
 Ligament and tendon injuries remain a persistent clinical challenge, accounting for up to 45% of 
the 32 million musculoskeletal injuries reported in the U.S. each year1. Among these, anterior cruciate 
ligament (ACL) rupture is the leading ligament injury, with over 250,000 injuries diagnosed and 125,000 
reconstruction surgeries performed annually in the U.S.2,3. Connecting the femur and tibia, the ACL plays 
a critical role in joint stabilization, and injury to the ligament is associated with progressive articular cartilage 
degeneration and osteoarthritis4,5. However, due to limited vascularization, the ACL exhibits poor self-
healing, necessitating surgical reconstruction following injury6. The current standard treatment involves 
replacing the ruptured ligament with an autologous tendon graft. Although bone-patellar tendon-bone 
(BPTB) grafts exhibit favorable mechanical properties and facilitate superior graft integration via bone-to-
bone healing, concerns regarding donor site morbidity and persistent anterior knee pain following BPTB 
reconstruction have led to increased use of hamstring tendon grafts7-9. However, soft tissue-to-bone 
integration is much slower than bone-to-bone healing, delaying recovery and return to function10-12. 
Moreover, hamstring tendon graft-to-bone integration occurs through the formation of disorganized scar 
tissue that is mechanically inferior to the well-organized native ligament-to-bone insertion13. Therefore, 
there is a pressing clinical need for functional grafting solutions that can enable integrative ACL repair via 
regeneration of the native ligament-to-bone interface. 
 To this end, tissue engineering has emerged as a promising approach for integrative ACL 
reconstruction. In particular, fibrous scaffolds can mimic the well-organized structure of the ligament, exhibit 
mechanical properties on par with those of the native ACL, and support cell attachment and matrix 
production14-20. However, these systems do not facilitate biological graft-to-bone fixation via an organized 
interface, which is essential for long-term functionality of the ACL graft. The native ACL-to-bone enthesis 
consists of four compositionally distinct but structurally continuous regions: ligament, non-mineralized 
fibrocartilage, mineralized fibrocartilage, and bone21-23. In particular, the fibrocartilage regions serve to 
mediate load transfer between soft tissue and bone while minimizing the formation of stress concentrations 
at the insertion22,24-27. Given its functional significance, the goal of this thesis project is to facilitate 
regeneration of the fibrocartilaginous enthesis following ACL reconstruction. Previous work, both from our 
group28 and others17,19,29,30, have demonstrated a variety of design strategies for achieving spatially-
3 
 
controlled differentiation of mesenchymal stem cells (MSCs) into fibroblast- and osteoblast-like cells. 
However, lacking the formation of an intermediary fibrocartilaginous region, these ligament-bone scaffold 
designs do not fully recapitulate the organization or composition of the native interface. To address this 
gap, this thesis focuses on developing a tissue engineering strategy for regeneration of the 
fibrocartilaginous enthesis. 
 Inspired by the native development and maturation process of the ligament-to-bone insertion, the 
working hypothesis of this thesis is that controlled chemical and/or mechanical stimuli can guide MSC-
mediated regeneration of insertion fibrocartilage (Figure 1.1). Thus, the studies detailed in this thesis consist 
of: 1) biomimetic scaffold design, 2) identification of an optimal cell source for fibrocartilage tissue 
engineering, and 3) optimization of chemical and mechanical stimuli for fibrocartilage formation.  
Benchmarks for evaluation of fibrochondrogenesis are derived from characterization studies of the native 
ACL-to-bone insertion. These characterization studies can also provide design parameters to guide 
biomimetic scaffold design and strategies for graft-to-bone integration. This thesis compares the 
fibrochondrogenic potential of multipotent MSCs derived from different clinically and anatomically relevant 
sources, and explores the effects of controlled, scaffold-mediated delivery of transforming growth factor 
(TGF)-β3, hydroxyapatite (HA) mineral, as well as biomimetic, multiaxial mechanical loading on 
fibrochondrogenic differentiation of MSCs. Thus, the four specific aims of this proposal are as follows: 
 
Aim 1: Identify design parameters and evaluation benchmarks for a biomimetic scaffold for 
fibrocartilage interface regeneration 
Hypothesis: Characterization of the native ligament-to-bone interface will provide key guidelines for 
fibrocartilage interface scaffold design as well as benchmarks for subsequent evaluation of 
these designs. 
 
Aim 2: Identify an optimal MSC source for fibrocartilage regeneration 
Hypothesis: Synovium-derived MSCs (SDSCs) will exhibit greater sensitivity to fibrochondrogenic cues 
compared to other MSC types. 
 
Aim 3: Optimize parameters for  MSC-mediated formation of non-mineralized fibrocartilage 
Hypothesis: Local delivery of TGF-β3 and/or dynamic, multiaxial loading can guide MSC-mediated 
formation of non-mineralized fibrocartilage-like matrix. 
  
Aim 4: Optimize parameters for  MSC-mediated formation of mineralized fibrocartilage 
Hypothesis: Scaffold-provided HA from aligned polymer nanofiber scaffolds combined with TGF-β3 will 





Figure 1.1. Schematic of approach to fibrocartilage interface tissue engineering. Quantitative 
characterization of the insertion will provide benchmark criteria for evaluation of engineered tissue. Cell 
source, chemical factors, and mechanical loading are systematically evaluated and optimized in order to 
develop a system for regeneration of fibrocartilage interface. 
 
 Fibrocartilage is a tissue that is typically found in regions subject to complex, multiaxial loads, 
including ligament and tendon entheses21,22,24, the meniscus31, the intervertebral disc32,33, and the 
temporomandibular joint34. With a matrix comprised of type I and type II collagen and proteoglycans, this 
tissue is optimized to withstand both tensile and compressive loads35, such as the complex strains that 
develop at the ACL-to-bone insertions36.  
 In order to obtain design parameters for a biomimetic interface scaffold, as well as to establish 
benchmark criteria for subsequent evaluation of the system, Aim 1 focuses on characterization of the native 
ACL-to-bone interface. As histological examination has shown that the enthesis undergoes extensive 
postnatal remodeling37,38, and the majority of ACL reconstructions are performed in adult patients2, the 
matrix composition and organization of the adult insertion are characterized using Fourier Transform 
infrared spectroscopy imaging (FTIRI), which allows for quantitative spatial mapping of physicochemical 
tissue properties39,40, and optical coherence tomography (OCT), which provides depth resolved, three-
dimensional imaging of biological tissue41 (Chapter 2). Preliminary results indicate that a well-aligned fiber 
structure is maintained over the course of postnatal development, which suggests that this is a key 
parameter for biomimetic scaffold design. Thus, the ex vivo behavior of native insertion fibrochondrocytes 
on nanofiber scaffolds that mimic the native extracellular matrix structure is also assessed to establish cell-
level benchmarks for evaluation of stem cell-mediated fibrocartilage regeneration (Chapter 3). Based on 
findings from these studies, an ideal system for fibrocartilage regeneration should also support organized, 
cell-mediated deposition of type I and type II collagen as well as proteoglycans. Additionally, integration 
growth factor mineralMSC
Bioinspired Design Interface Regeneration
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and interconnectivity with adjacent ligament and bone scaffold or tissue phases, as well as compatibility 
with current surgical repair methods are also associated requirements in interface scaffold design and 
fabrication. 
 The enthesis originates from a unique subset of mesenchymal progenitor cells42-44 that transiently 
expresses transforming growth factor (TGF)-β3 early during fetal development38. The fibrocartilaginous 
insertion develops postnatally via endochondral ossification38,45, and the collagen matrix and mineral are 
remodeled over time37,46 in response to normal physiologic loading47-49 to form a well-organized transition 
between soft tissue and bone. Guided by the process by which the native enthesis develops, subsequent 
aims focus on optimization of various aspects of a tissue engineering system for stem cell-mediated 
fibrocartilage formation. As fibrochondrocytes are mesenchymal in origin50, Aim 2 focuses on first 
identifying an appropriate source of MSCs for fibrocartilage interface tissue engineering. Bone marrow- 
(BMSCs) and synovium-derived MSCs (SDSCs) are both clinically and anatomically relevant MSC 
populations with favorable chondrogenic potential51. BMSC and SDSC response to fibrochondrogenic 
culture conditions, including exogenous TGF-β3 stimulation combined with an aligned nanofiber 
substrate52, as well as scaffold-provided HA for mineralized tissue formation, are systematically compared 
(Chapter 4).  
 Aim 3 focuses on strategies for guiding MSC-mediated fibrocartilage formation. Specifically, a 
controlled-release nanofiber scaffold system that can provide localized delivery of TGF-β3 for chemical 
induction of fibrochondrogenesis is developed and evaluated (Chapter 5). Alternatively, it is anticipated that 
mechanical stimulation can also facilitate fibrochondrogenic differentiation of MSCs as it has long been 
known that physiologic loading plays a key role in postnatal remodeling and maturation of the native 
enthesis47-49. Thus, we describe a bioreactor capable of mimicking the complex loads sustained at the 
ligament-to-bone interface36  and evaluate its effects on MSC response (Chapter 6).  
 Finally, a functional scaffold for integrative ACL repair must support spatial tissue heterogeneity, 
including the establishment of both non-mineralized and mineralized tissue regions. Thus, Aim 4 explores 




 In order to enable fibrocartilage regeneration for integrative and functional ACL reconstruction, the 
studies outlined in this thesis establish fibrocartilage scaffold design and evaluation criteria though 
characterization of the native enthesis, and systematically explore and evaluate cell sources and chemical 
and mechanical stimuli for fibrocartilage tissue engineering. This approach is innovative as it focuses on 
the design of a biomimetic, bioactive nanofiber-based scaffold for fibrocartilage interface regeneration, and 
elucidates scaffold design-related parameters to guide MSC-mediated fibrocartilage tissue engineering. 
The impact of these studies extends beyond integrative ligament reconstruction, as they will likely yield 
valuable scaffold design criteria, establish chemical and physical parameters for MSC differentiation, and 
can be readily adapted for regeneration of other soft tissue-to-bone interfaces, fibrocartilaginous tissues, 
and complex tissue systems. 
 
1.2. Significance 
1.2.1. ACL Injuries and Current Reconstruction Techniques 
 The anterior cruciate ligament (ACL) connects the femur and the tibia, and serves to resist tibial 
translation and rotational loads53. The ACL is the most frequently injured ligament of the knee, with over 
250,000 injuries diagnosed and 125,000 reconstruction surgeries performed annually in the United States 
alone2,3. Due to the avascular nature of the tissue, as well as the synovial joint environment, the ACL 
exhibits poor self-healing and requires surgical intervention following injury6,54-56. ACL reconstruction, in 
which a tendon or ligament graft is used to replace the damaged ligament, remains the gold standard for 
treatment following ACL rupture. Importantly, the graft must be capable of bearing loads almost immediately 
after surgery and withstand the intensive rehabilitation process that follows. This requirement has become 
even more critical in light of the increasing number of ACL injuries in an aging yet active population2. 
 Autologous bone-patellar tendon-bone (BPTB) grafts are among the most widely used graft options 
used for ACL reconstruction57-59. Consisting of the central third of the patellar tendon along with its adjacent 
patellar and tibial bone attachments, BPTB grafts facilitate superior graft integration via bone-to-bone 
healing and exhibit favorable mechanical properties57,59-61. However, concerns regarding donor site 
morbidity and persistent anterior knee pain following BPTB reconstruction have led to increased use of 
hamstring tendon grafts in recent years7-9. Moreover, hamstring tendon grafts have been shown to 
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withstand higher loads at failure as compared to BPTB grafts with similar stiffness62. Despite this, however, 
clinical studies have shown that ACL reconstructions utilizing hamstring tendon grafts do not result in a 
complete return to pre-injury activity levels for over 30% of patients63. This is attributed in part to the inability 
of hamstring tendon grafts to fully integrate with bone and increased knee laxity due to insufficient graft 
fixation64. Unlike BPTB grafts which are secured by bone-to-bone healing, hamstring tendon graft-to-bone 
healing occurs through the formation of fibrovascular scar-tissue at the attachment site13,65. These fixation 
sites are the weakest point along the graft during the early postoperative healing period and the lack of 
mechanical stability can lead to graft failure66-68. These findings underscore the clinical need for techniques 
that promote the regeneration of the well-organized native ligament-to-bone interface following ACL 
reconstruction. 
 
1.2.2. Structure and Function of the ACL Insertion Sites 
 The ACL attaches to bone via a multi-tissue interface consisting of four compositionally distinct but 
structurally continuous regions: ligament, non-mineralized fibrocartilage, mineralized fibrocartilage, and 
bone21-23. The ligament region consists of fibroblasts embedded in a highly aligned matrix comprised of 
type I and type III collagen23,69. Organized type I collagen fibrils persist through the fibrocartilage region, 
which also contains type II collagen and various proteoglycans23,47. The fibrocartilaginous interface region 
can be further subdivided into non-mineralized and mineralized regions: The cells of the non-mineralized 
fibrocartilage region exhibit a rounded morphology similar to chondrocytes, surrounded by a pericellular 
matrix comprised primarily of type II collagen with small amounts of type I and type X collagen, decorin, 
and aggrecan70,71, while the cells of the mineralized fibrocartilage resemble hypertrophic chondrocytes and 
are surrounded by a type X collagen and aggrecan-containing pericellular matrix37,38,72. Finally, the bone 
region consists of osteoblasts, osteocytes, and osteoclasts in a type I collagen matrix73.  
 The unique combination of both type I collagen, which is the primary matrix component in fibrous 
tissues, and type II collagen and proteoglycans, which are typically characteristic of articular cartilage, in 
the fibrocartilaginous insertion makes this tissue uniquely optimized to withstand both tensile and 
compressive loads35,74. Assessment of local strain distributions at the ACL-to-bone insertion has shown that 
complex strains comprising both tensile and compressive forces are generated at the enthesis during 
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loading of the ligament36. Finite element analysis of the medial collateral ligament-to-bone attachment has 
similarly shown region-dependent stress variations, with tensile loading of the ligament resulting in 
compressive stresses along the inner interface between soft and hard tissues75. 
 These variations in strain across the ligament-to-bone insertion suggest regional differences in 
tissue stiffness. Indeed, microcompression experiments show that compressive strain decreases across 
the ACL-to-bone interface, as the compressive elastic modulus of the mineralized fibrocartilage is twice as 
high as that of the non-mineralized region, coinciding with regional differences in mineral content26. 
Spectroscopic analysis shows a continuous, exponential increase in matrix mineral content across the ACL-
to-bone interface76. Biomechanical models suggest that the increase in mineral accumulation within 
collagen fibers has a toughening effect at the molecular level77 and, along with decreased alignment of 
these partially mineralized fibers across the insertion27,37,76, account for the transitional mechanical 
properties across the interface27.  
 This highly organized transition from soft tissue to bone serves to mediate load transfer between 
ligament and bone and minimize the formation of stress concentrations21,22,27,78. This is critical as the 
ligament and bone exhibit severely mismatched mechanical properties, where the elastic modulus of the 
bone is more than an order of magnitude greater than that of the ligament. The graded transition in 
mechanical properties across the intermediary fibrocartilage regions serves to protect soft tissue from 
contact deformation and damage25,79,80. Moreover, micromechanical evaluation of the fibrocartilaginous 
tendon-to-bone interface shows highly localized mechanical response at the insertion, with different subsets 
of collagen fibers sustaining the majority of the applied load depending on the direction of loading, which 
enables the wide range of directional forces that can be sustained by the enthesis81. Given the crucial role 
the fibrocartilage insertion plays in anchoring ligament to bone, reestablishment of this multi-tissue transition 
is critical for successful integration of soft tissue grafts with native bone to improve long-term clinical 
outcomes following ACL reconstruction. 
 
1.2.3. Strategies for Integrative ACL Tissue Engineering 
 In recent years, tissue engineering has emerged as a promising option for regenerating and 
replacing damaged tissues. By combining cells, biomaterial scaffolds, and physical and chemical cues, 
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researchers have made significant advancements in regeneration of ligament and bone tissues. However, 
a critical barrier to clinical translation remains achieving biological fixation or functional integration of these 
tissues with the native host tissue and/or with each other. While traditional efforts to develop tissue-
engineered ACL grafts have predominantly focused on the ligament proper82,83, there has been a recent 
shift towards forming multi-tissue units consisting of ligament-bone or ligament-interface-bone regions. Pre-
engineering ligament-to-bone integration ex vivo can ensure the re-establishment of an organized soft 
tissue-to-bone transition, and may enable faster and more robust graft integration via bone-to-bone 
healing11. 
 Bourke et al. first reported a bone-ligament-bone scaffold consisting of poly(desamino tyrosyl-
tyrosine ethyl ester carbonate) or polylactide (PLA) fibers embedded in poly(methyl methacrylate) plugs14. 
Improving upon this design concept, Cooper et al. developed a continuous multi-phased synthetic ACL 
graft, which consisted of braided poly(lactide-co-glycolide) (PLGA) microfibers arranged to form a ligament 
with two denser fiber regions at either end to facilitate bone formation15,84,85. In vitro84,85 and in vivo15 
evaluation of this design in a rabbit ACL reconstruction model demonstrated biocompatibility and extensive 
collagenous tissue infiltration by 12 weeks postimplantation. More recently, Altman et al. developed a 
similar multi-region silk bone-ligament-bone graft consisting of silk yarns connecting more densely knit 
regions at either end for bony attachment17,86. After 12 months of implantation in a caprine ACL 
reconstruction model, a collagenous ligament-like structure with aligned cells and crimped matrix was 
observed. To harness the potential use of growth factors to enhance graft-bone integration, Kimura et al. 
developed a multi-phased system comprised of a braided PLA-collagen scaffold with basic fibroblast growth 
factor-releasing gelatin hydrogels at either end to be placed within the bone tunnels16. This design 
supported the formation of ligament and bone regions, and resulted in enhanced tensile mechanical 
properties compared to single-phased controls. Similarly, Paxton et al. investigated the incorporation of 
hydroxyapatite (HA) and the RGD cell-adhesion peptide into a poly(ethylene glycol) (PEG) hydrogel for 
engineering ligament-bone attachments and observed that the incorporation of HA improved interface 
formation87. The bioresorbable calcium phosphate brushite replaced HA in subsequent graft anchor 
designs88, with the two ends embedded in fibrin gel to form a bone-ligament-bone construct. Using a cell-
based approach, Ma et al. formed bone-ligament-bone constructs through co-culture of mesenchymal stem 
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cell (MSC)-derived bone constructs with a MSC-derived ligament monolayer rolled between89. In vivo 
evaluation in an ovine model showed graft integration with the native bone and the formation of an interface 
between the ligament and bone phases that structurally resembles fibrocartilage29. Overall, these novel 
bone-ligament-bone designs represent significant advances in forming multi-tissue units, and demonstrate 
the importance of multi-tissue over single-tissue design, especially in terms of graft integration and 
functionality.  
 However, one of the challenges in the implementation of bone-ligament-bone designs is that the 
fibrocartilaginous interface between the ligament and bone regions is not consistently or uniformly 
regenerated. Given the critical mechanical role the fibrocartilaginous transition plays in ligament-to-bone 
attachment, incorporating interface regeneration into graft design will be essential for achieving 
physiological joint function following ACL reconstruction. To this end, our group has previously developed 
a stratified ligament-interface-bone scaffold90,91. Comprised of stratified layers of PLGA mesh, sintered 
PLGA microspheres, and sintered PLGA and 45S5 bioactive glass microspheres, the scaffold was shown 
to support tri-culture of fibroblasts, chondrocytes, and osteoblasts, resulting in the formation of 
interconnected ligament-, fibrocartilage- and bone-like tissues91. In addition to supporting multi-tissue 
formation, the stratified design exhibited graded mechanical properties across the scaffold, with the highest 
elastic modulus and yield strength in the bone phase, mimicking the mechanical transition of the native 
ligament-interface-bone junction. Other groups have also employed similar strategies to engineer stratified, 
tri-phasic scaffolds to ligament-to-bone regeneration30,92. Criscenti et al. demonstrated that a tri-phasic 
scaffold comprised of a region of electrospun aligned PLGA nanofibers (ligament) and a highly porous 
region of 3D printed poly(ε-caprolactone) (PCL) microfibers (bone) with an intermediary region with mixed 
features (interface), exhibits spatial control over MSC response in terms of alkaline phosphatase (ALP) 
activity and glycosaminoglycan (GAG) content30. Building upon these findings, Subramony et al. expanded 
the design to a five-phased, bone-interface-ligament-interface-bone scaffold93. The nanofiber-based 
scaffold consisted of stratified regions of HA-doped PCL-PLGA nanofibers and PCL-PLGA nanofibers, with 
mechanoactive PLGA collars94,95 applied at either ligament-bone junction to form a continuous, five-phased 
construct. In vivo implantation of these scaffolds resulted in accelerated formation of mineralized tissue 
within the bone tunnels, as well as superior mechanical properties compared to single-phased controls. 
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However, despite an upregulation in expression of fibrocartilage markers at the interface phase in in vitro 
studies, fibrocartilaginous tissue was not identified in the interface regions in the in vivo model. Together, 
this body of work emphasizes that biomimetic, stratified scaffold design can allow for spatial control over 
the distribution of interface-relevant cell populations and facilitate formation of phase-specific matrix 
heterogeneity, and represent advancements in integrative ligament scaffold design. However, regeneration 
of a robust fibrocartilaginous insertion remains a significant challenge.  
 
1.2.4. Strategies for Fibrocartilage Tissue Engineering 
 Fibrocartilage is a tissue that is typically found in regions subject to complex, multiaxial loads, 
including ligament and tendon entheses21,22,24, the meniscus31, the annulus fibrosus of the intervertebral 
disc33,96, and the temporomandibular joint (TMJ)34. Unlike hyaline cartilage, fibrocartilage tissues contain 
type I collagen in addition to type II collagen and proteoglycans, though the exact type I:type II collagen 
ratio can vary by tissue. For example, while enthesial fibrocartilage is predominantly comprised of type II 
collagen with type I, type III, and type X collagens and proteoglycans in the pericellular matrix70,71, the TMJ 
disc is almost entirely comprised of type I collagen with trace amounts of type II collagen in the intermediate 
zone97. Type I:type II collagen ratios can also vary spatially within a tissue. For example, the inner meniscus 
consists of approximately 40% type I collagen and 60% type II collagen, while the outer meniscus is almost 
entirely comprised of type I collagen with less than 1% of other types of collagen98. Similarly, the inner and 
outer annulus fibrosus have type I:type II collagen ratios of 0.68 and 0.84, respectively96. The unique 
composition and heterogeneous collagen distribution in fibrocartilage tissues reflect functional adaptations 
to the complex local stresses found in these anatomical regions. In particular, these load-bearing tissues 
are subject to both tensile and compressive stresses in vivo35,36,75,99-101. Examination of postnatal 
fibrocartilage development suggests that these tissues initially produce only type I collagen and that 
compressive stresses subsequently trigger synthesis of cartilage-related molecules25,102,103. 
 Transforming growth factor (TGF)-β is a pleiotropic cytokine involved in regulation of cell growth 
and differentiation, tissue repair, and inflammation, and plays a critical role in cartilage formation and 
maintenance104-106. Mechanical loading of cartilage has been shown to activate TGF-β signaling through 
the release of latent TGF-β stored in the extracellular matrix107-109, resulting in increased downstream 
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SMAD2/3 signaling, and leading to increased proteoglycan synthesis and inhibition of chondrocyte 
hypertrophy110-115. In terms of fibrocartilage regeneration, TGF-β has been shown to stimulate cell 
proliferation and enhance collagen and proteoglycan synthesis in in vitro fibrocartilage cell and explant 
cultures116-121. In fibrochondrocyte-seeded scaffolds, TGF-β stimulation increases collagen synthesis, 
leading to improved functional properties122,123. Moreover, the chondrogenic effects of TGF-β can be 
combined with other chemical124,125 or physical52,126-130 cues to induce fibrochondrogenic differentiation of 
MSCs. For example, spatiotemporally controlled release of TGF-β3 and connective tissue growth factor 
(CTGF) via PLGA microspheres embedded in 3D-printed PCL scaffolds has been successfully used to 
guide fibrochondrogenic differentiation of bone marrow-derived MSCs (BMSCs) for meniscus124 and TMJ125 
fibrocartilage tissue engineering. Other studies have demonstrated that MSCs cultured on fibrous scaffolds 
in the presence of TGF-β-containing chondrogenic media results in the formation of fibrocartilage-like 
constructs52,126.  
 Mechanical loads are also critical for normal formation, development, and maintenance of 
fibrocartilage tissues44,46,48,49,131. In immobilized chick embryos, the meniscus fails to mature and ultimately 
degenerates due to the lack of mechanical stimulation from normal muscle contraction131. These findings 
suggest that controlled mechanical stimulation may be useful for fibrocartilage regeneration. Indeed, 
dynamic mechanical loading has been shown to improve the collagen synthesis and functional mechanical 
properties in fibrochondrocyte-seeded scaffolds132-135. Meniscal fibrochondrocyte-seeded scaffolds subject 
to biomimetic tensile and compressive loads replicated the mechanical properties, collagen and GAG 
content, as well as heterogeneous matrix distribution of the native meniscus134,135. Physiologic loading can 
also be used to guide MSC-mediated fibrocartilage formation and maintenance. For example, Connelly et 
al. demonstrated that cyclic tensile loading of BMSCs seeded in fibrin gels and cultured in chondrogenic 
media stimulated both collagen and proteoglycan synthesis at early time points129. Similarly, Baker et al. 
showed that long term culture of BMSC-seeded nanofiber scaffolds in chondrogenic media and with 
dynamic tensile loading resulted in significant improvements in matrix synthesis and functional properties 
of the resulting fibrocartilage constructs52. Looking more closely at the mechanisms of loading-induced 
fibrochondrogenic differentiation, Zhong et al. showed that the directionality of fluid flow affects 
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differentiation of MSCs seeded on aligned nanofibers, with flow perpendicular to fiber alignment being most 
conducive to fibrochondrogenesis136. 
 
1.2.5. Strategies for Fibrocartilage interface Tissue Engineering 
 The enthesis originates from a unique subset of Hedgehog-responsive progenitor cells that co-
express scleraxis (Scx), SRY-related transcription factor Sox9, and growth and differentiation factor (Gdf5), 
and are found at the interphase of ligament or tendon and primary cartilage in the developing embryo42-
45,137,138. Transforming growth factor-β signaling plays a critical role in regulating lineage specification of 
these progenitor cells42, and transient expression of the TGF-β3 isoform is observed at the enthesis during 
fetal development38. Local delivery of TGF-β1 has also been shown to improve intraosseous healing and 
functional outcomes following ACL reconstruction with a flexor tendon autograft139, while TGF-β3 has been 
shown to accelerate healing and improve functional outcomes in supraspinatus tendon-to-bone repair140,141. 
 Mechanical stimuli also play a critical role in development of the enthesis. Muscle force has been 
shown to regulate progenitor cell proliferation at the developing enthesis142,143, and paralysis of the rotator 
cuff muscles has been shown to severely impact maturation of the supraspinatus tendon-to-bone insertion, 
resulting in reduced tissue volume, decreased fiber organization, and impaired mineralization44,46,48,49. 
Interestingly, physiologic compressive loading has been shown to regulate transdifferentiation of tendon 
cells towards a fibrochondrocyte-like phenotype144-147, while translocation of wrap-around tendons to 
eliminate compressive loading results in decreased size of the fibrocartilage region, as well as looser 
collagen organization and lower glycosaminoglycan content148. Fetal tendon cells have been shown to 
increase TGF-β synthesis in response to compressive loading, leading to the synthesis of extracellular 
matrix proteoglycans and fibrocartilage formation147. Using a similar strategy, Spalazzi et al. developed a 
PLGA nanofiber-based collar that can impart compressive force to tendon grafts for ACL reconstruction, 
resulting in significant upregulation of fibrocartilage-related markers, including type II collagen, aggrecan, 
and TGF-β394. In vivo evaluation of a similar compressive nanofiber collar in a rat ACL reconstruction model 
revealed enhanced graft integration and formation of fibrocartilage-like tissue both around and within the 
neoligament95. Dynamic tensile strain has also been shown to regulate fibrochondrogenic differentiation of 
tenocytes, where low strains (4-8%) stimulate secretion of type I and type II collagen and upregulates 
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expression of parathyroid hormone-related protein (PTHrP), and high strains (12%) result in downregulation 
of type I and type II collagen and upregulation of type X collagen149. Thomopoulos et al. have shown that 
simultaneous compressive and tensile loading, mimetic of the forces seen at the fibrocartilaginous regions 
of wrap-around tendons and at the enthesis, can induce fibrochondrogenic differentiation of BMSCs130. 
 
1.3. Summary 
 Despite advances in surgical techniques, the failure rates of biological grafts and donor site 
morbidity issues related to conventional graft harvesting techniques remain a significant clinical challenge. 
Moreover, the well-organized native ligament-to-bone interface, which is critical for long term knee stability 
and functionality, is not re-established following ACL reconstruction. This thesis aims to develop a 
biomimetic, bioactive scaffold-based tissue engineering strategy for regeneration of the fibrocartilaginous 
ACL-to-bone interface. Scaffold design and evaluation criteria for fibrocartilage interface tissue engineering 
will be established though characterization of the native enthesis (Chapters 2 and 3). Key parameters for 
fibrocartilage tissue engineering, including cell source (Chapter 4) and chemical (Chapters 5 and 7) and 
mechanical stimuli (Chapter 6) are systematically explored and evaluated. This approach is innovative as 
it specifically focuses on elucidating the parameters needed to develop a strategically biomimetic scaffold 
design for stem cell-mediated fibrocartilage tissue engineering. Furthermore, by enabling the non-
mineralized and mineralized tissue regions to be pre-engineered and integrated ex vivo, this design not 
only ensures the re-establishment of an organized soft tissue-to-bone transition, but can ultimately allow 
for faster and more robust graft integration via bone-to-bone healing11. The impact of these studies extends 
beyond integrative ligament reconstruction as they will yield valuable design parameters that can be readily 
adapted for engineering other connective tissues. Specifically, it is anticipated that this thesis will help to 
identify an optimal cell source for insertion fibrocartilage tissue engineering, establish methods for 
fabrication of nanofibers capable of controlled delivery of bioactive factors, including proteins and mineral, 
and elucidate the effects of complex mechanical forces on fibrocartilage formation. These findings can be 
extended to developing scaffold-based systems for regeneration of other soft tissue-to-bone interfaces, 











In order to identify critical scaffold design parameters for ACL-to-bone interface regeneration, as 
well as to establish benchmark criteria for subsequent evaluation, it is necessary to develop an in-depth 
understanding of the structure-function relationships at the enthesis. The objective of this first study is to 
characterize and compare age-related changes in tissue matrix composition, distribution, and organization 
of the ACL-to-bone insertion. Results from this study will provide scaffold design parameters to guide the 
development of a biomimetic scaffold for fibrocartilage interface regeneration. 
 
2.1.1. Background and Motivation 
 The ligament-to-bone insertion is characterized by regional differences in cellularity, composition, 
and structure21-23,37, which result in functional differences across the multi-tissue junction26. Moreover, the 
enthesis undergoes extensive postnatal remodeling, with substantial changes in matrix composition and 
organization over time37,38,46, which likely reflect adaptations to the complex loads sustained at the 
insertion36,75. These observations, along with the well-established age-related changes in ACL healing 
potential150,151 and mechanical properties152,153, as well as the increasing incidence of ACL reconstruction 
in older patients2, suggest the importance of establishing a thorough understanding of the skeletally mature 
ACL-to-bone interface and age-related changes in composition and structure.  
 While the ACL-to-bone insertion has been closely studied using conventional histology and light 
microscopy methods21-23,37,154-156, quantitative understanding of regional variations in matrix composition 
remain limited. Such in-depth analyses are essential for elucidating the structure-function relationships 
across this complex multi-tissue interface. However, direct measurement of insertion properties is 
challenging due to tissue heterogeneity and overall length scale, which ranges from 100 μm to 1 mm 
depending on species and age21,37,157.  
In this study, novel microscale analysis methods are applied to examine the compositional and 
structural properties of the ACL-to-bone insertion. Vibrational spectroscopy-based imaging techniques 
provide a method to generate quantitative, micron-resolution spatial maps of physicochemical properties, 
and have been successfully adapted for characterization of complex tissue interfaces, including those found 
at the junction between ligament and bone76, tendon and bone46,158, as well as cartilage and bone159. In 
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particular, Fourier transform infrared spectroscopy imaging (FTIRI), a high-resolution and high-throughput 
imaging technique, can be used to concurrently analyze multiple extracellular matrix components from a 
single sample. These analyses have been shown to correlate well with biochemical and histological 
analyses of collagen, proteoglycans, and mineral39,40,159. To complement this compositional analysis, optical 
coherence tomography (OCT), which provides depth resolved, three-dimensional imaging of biological 
tissue at video rate with micron-scale resolution41, will be used to characterize microstructural features of 
the ACL-to-bone interface. Specifically, collagen fiber architecture in fresh, unfixed tissues can be 
characterized by applying intensity-based gradients to OCT images160-164. 
 
2.1.2. Objectives 
The objective of this study is to map the matrix composition and organization of the mature ACL-
to-bone insertion, and to evaluate age-related changes in these tissue properties. Specifically, FTIRI is 
used to characterize regional differences in collagen, proteoglycan, and mineral across the ACL-to-bone 
insertion, while OCT is used to evaluate collagen matrix organization. It is hypothesized that at both the 
femoral and tibial insertion sites, a well-organized matrix will be observed, with collagen and mineral content 
increasing across the insertion from ligament to bone, while proteoglycans are localized to the fibrocartilage 
region. 
 The bovine ACL model was selected for this study as it exhibits good structural resemblance to the 
human anatomy165, and has been extensively characterized, enabling direct comparison of our results to 
published histologic37, FTIRI76, and mechanical26,36 studies of the ACL-to-bone interface. Based on previous 
work on age-related changes in connective tissues37,166-173, it is expected that collagen matrix density and 
organization, as well as mineral maturity, will increase with age, while spatial differences in matrix 
composition will be maintained across the multi-tissue enthesis. Moreover, it is anticipated that comparison 
of the results from this study to previous evaluations of the ACL-to-bone insertion in skeletally immature 
animals76 will help to elucidate key matrix features that are conserved over time, which will inform the design 
of a scaffold for interface regeneration. These quantitative and systematic analyses will augment current 
understanding of the maturation of this complex transition, as well as provide benchmark criteria for 
evaluation of regenerated fibrocartilage tissue. 
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2.2. Materials and Methods 
2.2.1. Sample Isolation 
 Bovine tibiofemoral joints from skeletally immature (4 to 6 months old) and mature (2 to 5 years 
old) were obtained from a local abattoir (Green Village Packing Company). Following removal of the 
surrounding muscle, subcutaneous fascia, collateral ligaments, patella, patellar tendon, adipose tissue, and 
menisci, the femoral and tibial ACL insertions were identified and excised. Each sample was comprised of 
the ligament with intact insertion connected to bone.  
 
2.2.2. FTIRI Sample Preparation 
 For analysis of matrix composition and distribution across the mature ACL-to-bone insertion using 
FTIRI, each tissue sample (n=5 per insertion site) was bisected sagittally using a band saw for 
corresponding decalcified and non-decalcified analyses. Decalcified samples were prepared for analysis of 
collagen and proteoglycan content and distribution. Immediately following harvest, samples were fixed for 
72 hours in 80% ethanol supplemented with 1% cetylpyridinium chloride (Sigma-Aldrich) to preserve 
proteoglycans174. Following fixation, samples were rinsed in distilled water and demineralized in tris-
hydroxymethylaminomethane buffer (Sigma-Aldrich, pH 7.2) containing 10% ethylenediaminetetraacetic 
acid (Sigma-Aldrich) over the course of 8 weeks, with solution exchange occurring every 3 days. Next, 
samples were dehydrated using an increasing ethanol series, cleared with xylenes, and embedded in 
paraffin (Fisher Scientific). For FTIRI analysis, samples were sectioned (7 μm; Reichert-Jung RM 2030 
Microtome, Leica) and placed immediately onto barium fluoride (BaF2) infrared-transmissive windows (25 
x 2 mm, Spectral Systems). Sections were then deparaffinized in xylenes, rehydrated, and then dried 
overnight at 25°C. Adjacent sections (7 μm) for histological analysis were collected on glass slides (Fisher 
Scientific) and dried overnight at 56°C. 
Corresponding non-decalcified samples were prepared for mineral analysis, wherein samples were 
fixed for 72 hours in 90% ethanol, dehydrated using an ethanol series, and then embedded in 
polymethylmethacrylate (PMMA; Sigma-Aldrich). For FTIRI analysis, samples were sectioned (2 μm) using 
a sliding microtome (SM2500S, Leica) fitted with a tungsten carbide blade (Delaware Diamond Knives) and 
placed immediately onto BaF2 windows and then dried overnight at 25°C. Adjacent sections (7 μm) for 
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histological analysis were collected on Haupt’s adhesive-treated glass slides, dried overnight at 65°C, and 
subsequently cleared of PMMA using a 1:1 xylene:chloroform (v/v) solution. 
 
2.2.3. FTIRI Acquisition and Analysis 
 Sample analysis was performed using an FTIR spectrometer (Spectrum 100, Perkin Elmer) 
coupled to a microscope imaging system (Spotlight 400, Perkin Elmer) following published 
methods76,159,175,176. Spectra were acquired between 2000 and 800 cm-1 with a spectral resolution of 8 cm-
1 and a spatial resolution of 25 μm. IR spectra were analyzed and spectroscopic maps were generated 
using ISYS chemical imaging software (3.1.1., Spectral Dimensions) and MATLAB (R2014b, Mathworks). 
Prior to analysis, spectra were corrected by baseline subtraction. For non-decalcified sections, sample 
spectra were additionally corrected to eliminate PMMA background and compensate for varying degrees 
of PMMA penetration into the different tissues across the interface. Spectra of pure PMMA were acquired, 
baseline corrected, normalized by the highest peak in the PMMA spectrum (1728 cm-1) and then subtracted 
from similarly baseline corrected and normalized sample spectra to eliminate PMMA background.  
 Signature peaks within the collagen and carbohydrate spectra have been shown to correlate 
linearly with collagen and proteoglycan content177. Relative collagen content (n=5 per group) was mapped 
by integrating the peak area under the amide I band (1720 to 1590 cm-1)177,178. Proteoglycan distribution 
(n=5 per group) in decalcified samples was estimated by integrating under the carbohydrate band 
associated with C-O-C and C-OH vibrations (1140 to 985 cm-1) and normalizing to the amide I band area 
to account for variations in section thickness and overlap between the collagen and carbohydrate 
spectra39,179. Furthermore, collagen alignment (n=5 per group) was determined by collecting spectra with a 
gold-wire polarizer grid (Perkin Elmer) inserted in the path of the infrared light, with the polarizer aligned at 
0° with respect to the ligament-to-bone interface. Because amide I and amide II (1590 to 1492 cm-1) bond 
vibrations are orthogonal, the ratio of their band areas is an indicator of collagen fibril orientation when 
spectra are collected under polarized light180. Numerical indices for collagen orientation were obtained by 
calculating the amide I:amide II area ratio. Collagen fibril orientation was categorized as parallel or 
perpendicular to the fibrocartilage-bone interface for ratio values greater than 2.7 or less than 1.7, 
respectively, while a ratio between 1.7 and 2.7 indicated mixed fibril orientation180. The relative mineral-to-
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matrix ratio (n=5 per group) in non-decalcified samples was calculated by integrating under the ν1, ν3 
phosphate band contour (1200 to 900 cm-1) and dividing by the amide I band area. Mineral crystallinity was 
determined from the 1030 cm-1:1020 cm-1 peak height ratio. As the 1030 cm-1 peak is indicative of 
phosphate in stoichiometric apatites, while the 1020 cm-1 peak represents nonstoichiometric apatites, the 
1030/1020 intensity ratio provides a measure of mineral crystallinity and maturity, with higher ratios being 
associated with more crystalline mineral39,181. The 1030/1020 peak ratio was only calculated for mineralized 
tissue regions, as determined from the mineral distribution map. 
 Line profiles of relative collagen, proteoglycan and mineral content extending across the insertion 
were generated from the spectral data. Tissue regions were identified based on corresponding histology 
and values for 100 equally spaced points spanning from ligament to bone were interpolated using a 
MATLAB bicubic least squares method. This normalization method allowed matrix content to be presented 
as a function of percent distance across the insertion, thereby accounting for any differences in 
fibrocartilage thickness among specimens. Line profiles were obtained across the width of each sample on 
a pixel-by-pixel basis and were then averaged, resulting in a single line profile representing the mean data 
collected for the sample. Regions exhibiting anomalies such as holes or folds were excluded. Average 
relative matrix and mineral content values were also calculated for each tissue region (ligament, non-
mineralized fibrocartilage, mineralized fibrocartilage, and bone) and compared. 
 
2.2.4. Histology 
 To verify the compositional maps obtained using FTIRI, histology was also performed. Collagen 
distribution in decalcified samples was visualized by Picrosirius red staining (0.1% solution, Sigma-Aldrich) 
and collagen orientation was imaged using a light microscope fitted with a polarized light filter (Olympus 
BX60). Proteoglycan distribution in decalcified samples was visualized by Safranin-O staining (0.6% 
solution, Sigma-Aldrich), with collagenous tissues counterstained with Fast green (0.2% solution, Arcos 
Organics). Mineral distribution in non-decalcified samples was visualized by von Kossa staining, in which 
samples were incubated in a 5% silver nitrate solution (Fisher Scientific) in the presence of ultraviolet light, 




2.2.5. OCT Sample Preparation, Acquisition, and Analysis 
 For analysis of collagen fiber organization using OCT, fresh tissue samples were maintained in 
PBS and imaged within 24 hours of isolation. Optical coherence tomography image data sets (n=4 per age 
group) were acquired at 1300 nm using a commercial spectral domain OCT system (TELESTO, ThorLabs) 
with axial and lateral resolutions of 6.5 µm and 15 µm, respectively, and an imaging range of 2.52 mm, all 
in air. Images were acquired at video rate, with an A-line rate of 28 kHz. Multiple three-dimensional datasets 
of the ACL-to-bone interface were obtained, with clear imaging up to 500 μm in depth. Images were 
reconstructed by processing the raw interferometric data in MATLAB. For each sample, one en face image 
(fixed x-y plane at specified z-depth) was selected per volume based on clear presence of fibers. Insertion 
angles were manually measured with respect to the ligament-bone interface using Image-J (NIH). In each 
image, the ligament-bone interface was portioned into 1 mm-wide segments (denoted by yellow lines in 
Figure 2.6). The average angle of each segment of the interface was used as a reference angle for the 
ligament fibers measured in each region with a minimum of four fibers measured per region. Mean and 
standard deviation of orientation measurements normalized to the reference interface angle were 
calculated for the immature and mature samples to describe dominant orientation and dispersion. 
 
2.2.6. Statistical Analysis 
 Results are presented as mean ± standard deviation. Two-way analysis of variance (ANOVA) was 
performed to determine region-, insertion site- and/or age-dependent differences in matrix properties. The 
Tukey-Kramer post-hoc test was used for all pair-wise comparisons (p<0.05). All statistical analyses were 
performed using JMP IN (4.0.4, SAS Institute). Additionally, matrix content profiles across the interface 
were modeled using both linear (y = Ax + B) and exponential (y = CeD + E) functions to determine whether 






2.3.1. Collagen Distribution and Organization 
 Quantitative mapping and histology of mature femoral and tibial insertions show continuous 
collagen matrix spanning across the ligament, fibrocartilage, and bone regions (Figure 2.1). Line profile 
analyses revealed that collagen content increases across the interface from ligament to bone. Linear 
regression analysis yielded positive slopes of 0.24 ± 0.17 for the femoral insertion and 0.28 ± 0.27 for the 
tibial insertion, indicative of spatial increases in collagen content across the insertion. Comparison of the 
qualities of exponential and linear fits revealed that this distribution can be similarly modeled by exponential 
(R2 = 0.57 ± 0.30 for femoral samples, R2 = 0.56 ± 0.34 for tibial samples) and linear (R2 = 0.57 ± 0.30 for 
femoral samples, R2 = 0.56 ± 0.34 for tibial samples) functions (Table 2.1).  
 Collagen matrix organization was assessed by both polarized FTIRI and polarized light microscopy 
of stained sections (Figure 2.2). Collagen fibrils in the ligament region were observed to be oriented 
perpendicularly relative to the ligament-to-bone interface. However, collagen fibrils change alignment 
across the fibrocartilage region, eventually inserting obliquely into the bone region. Overall, no significant 
differences in collagen distribution or alignment were observed between the femoral and tibial insertions. 
 
2.3.2. Proteoglycan Distribution 
 FTIRI mapping and histology of mature femoral and tibial insertions confirmed that proteoglycans 
are primarily localized to the ligament and fibrocartilage regions (Figure 2.3). Line profile analyses revealed 
that the highest relative proteoglycan content is found within the fibrocartilage zone. Linear regression 
analysis of the fibrocartilage region yielded an average slope of (-2.28 ± 1.81) x10-4 for the femoral insertion 
and (-0.08 ± 2.74) x10-4 for the tibial insertion, indicating little change in proteoglycan content across this 
region. Comparison of the qualities of exponential and linear fits revealed that this distribution can be 
similarly modeled by exponential (R2 = 0.40 ± 0.32 for femoral samples, R2 = 0.38 ± 0.39 for tibial samples) 
and linear (R2 = 0.40 ± 0.33 for femoral samples, R2 = 0.38 ± 0.39 for tibial samples) functions (Table 2.1). 
Comparison of mean regional proteoglycan content showed no significant differences in proteoglycan 
distribution between the femoral and tibial insertions. 
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2.3.3. Mineral Distribution 
 Mineralization in mature femoral and tibial insertions was observed to be localized to the 
mineralized fibrocartilage and bone regions, as evidenced from peak integration maps of the phosphate 
band normalized to the amide I band, as well as from mineral staining (Figure 2.4). Region-wise comparison 
revealed significantly higher mean mineral content in these regions compared to the ligament and non-
mineralized fibrocartilage regions (p<0.05, Figure 2.5). Line profiles across the interface similarly showed 
an abrupt increase in mineral content between the non-mineralized and mineralized fibrocartilage regions. 
Regression analysis of just the mineralized interface revealed that the mineral distribution at the interface 
can be modeled by either an exponential (R2 = 0.97 ± 0.02 for femoral samples, R2 = 0.95 ± 0.02 for tibial 
samples) or a linear (R2 = 0.92 ± 0.03 for femoral samples, R2 = 0.93 ± 0.01 for tibial samples) function, 
though the exponential function yields a significantly higher quality of fit for both insertion sites (p<0.05, 
Table 2.1).  
 
2.3.4. Age-Related Changes  
 Evaluation of interface collagen matrix architecture using OCT showed well-organized fibers that 
insert into bone, which exhibits more disorganized fiber architecture compared to the ligament in both 
immature and mature models (Figure 2.6). Sum projections through the entire volume of each OCT scan 
showed different texture patterns within the ligament, interface and bone regions, where the ligament region 
was distinguishable by visible fibers and a characteristic crimp pattern while the bone region exhibited a 
spongy appearance. The interface region of the immature samples showed high signal intensity, whereas 
the interface region of the mature samples appeared more texturally similar to bone and exhibited increased 
density, resulting in decreased image penetration.  
Segmentation of fibers within the interface region revealed that the mature group exhibits near 
perpendicular fiber alignment relative to the interface, whereas insertion angle in the immature group is 
closer to parallel to the interface. Specifically, the mean angle of insertion relative to the ligament-bone 
interface was 100.11° ± 15.27° in the mature group and 22.53° ± 13.48° in the immature group (p<0.05, 
Figure 2.6).  
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 Peak integration maps of mineral-to-matrix ratio indicated that mineral content is localized to the 
mineralized fibrocartilage and bone regions in both immature and mature models (Figure 2.6). Overall 
relative mineral content was higher in the immature group compared to the mature group. Mineral 
crystallinity, as determined by the 1030/1020 peak ratio, was also assessed across the calcified tissue 
regions of the immature and mature insertion (Figure 2.6). Region-wise comparison revealed a significantly 
higher mean 1030/1020 ratio in the bone region (1.04 ± 0.06 for the immature group, 1.12 ± 0.04 for the 
mature group), compared to the mineralized fibrocartilage regions (0.62 ± 0.17 for the immature group and 
0.61 ± 0.03 for the mature group) for both groups (p<0.05). However, no significant differences in mineral 
crystallinity were observed between the immature and mature insertions. 
 
2.4. Discussion 
 The fibrocartilaginous ACL enthesis plays a critical role in ensuring functional ligament attachment 
to bone by providing a graded transition in compositional, structural, and mechanical properties between 
soft tissue and bone. The objective of this study was to quantitatively map matrix content, distribution, and 
organization across the ACL-to-bone interface in a skeletally mature large animal model, and to evaluate 
anatomical site- and age-related compositional and structural differences. Age-related changes in 
collagenous matrix organization and structure indicate significant postnatal remodeling at the enthesis. 
However, mineralized matrix distribution and structural properties are highly conserved over time. 
 Quantitative analysis of the mature ACL enthesis revealed dense collagenous matrix spanning 
across all three regions of the interface with a trend of increasing collagen content progressing from 
ligament to bone. Both polarized FTIRI and OCT analysis of collagen organization showed that well-aligned 
collagen fibers in the ligament region are oriented perpendicular relative to the interface and insert obliquely 
into the bone. These results are consistent with previous descriptions of the adult enthesis, in which 
collagen fibrils were found to bridge the entire junction between ligament and bone, but varying fibril size 
and arrangement was observed between different zones21,175. Theoretical models have shown that this 
organizational gradient aids stress dissipation at the soft tissue to bone junction and helps to reduce 
requisite tissue thickness27,182.  
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 Regional differences in proteoglycan and mineral content were also observed. Proteoglycans are 
produced in response to compressive loads, and, consistent with previous studies of the ligament-to-bone 
insertion37,76,183, were found here to be predominantly localized to the fibrocartilage regions. Although the 
ligament is loaded primarily in tension, the entheses are subject to complex dynamic stress profiles which 
include tensile, shear, and compressive components36,75. Additionally, the junction between the non-
mineralized and mineralized tissue regions was marked by a sharp increase in mineral content, which is 
well modeled as an exponential gradient. Similar monotonic mineral gradients have also been observed at 
the tendon-to-bone enthesis46,158, where they serve to mediate load transfer and reduce the formation of 
stress concentrations. This zonal difference in mineral content has been correlated with an almost two-fold 
increase in compressive modulus between non-mineralized and mineralized regions26.  
 These trends in matrix distribution and organization were consistent between the femoral and tibial 
insertion sites. Despite the known differences in size184, sustained loads36, and compressive mechanical 
properties26 between the femoral and tibial insertions, no statistically significant anatomical site-dependent 
differences in matrix distribution or organization were observed in this study. Factors other than total 
collagen, proteoglycan, and/or mineral content and distribution may be responsible for functional 
differences between the femoral and tibial insertions. For example, differences in collagen fibril diameter 
and density or ratios of different collagen types could contribute to functional differences. However, further 
investigation of these ultrastructural properties would require alternative imaging and analysis methods 
beyond the scope of this study.  
 Comparison to previously published studies of the insertion in skeletally immature cows37,76 reveal 
marked age-related differences in matrix content and organization. FTIRI characterization of the immature 
ACL-to-bone interface showed that collagen content is highest in the ligament and decreases across the 
enthesis76. In contrast, collagen distribution across the mature interface was relatively consistent, reflecting 
compositional changes in the collagenous matrix with age. Indeed, it has been reported that while the 
interzone between ligament and bone in young animals lacks type I collagen and resembles hyaline 
cartilage, type I collagen is found throughout all regions of the mature ligament-to-bone insertion37,185,186. 
Furthermore, the relative collagen content across the mature insertion was observed to be approximately 
twice that of the immature insertion, suggesting an overall increase in matrix density with age. These 
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findings are consistent with published reports of age-related increases in collagen density in ligaments166, 
tendons167, and at the enthesis175, and correspondingly stiffer and more resilient tissue in older animals186. 
 The collagen matrix structure across the ACL-to-bone insertion also changes with age. Whereas 
collagen fibrils in the immature insertion are oriented nearly parallel to the interface, ligament collagen fibrils 
were observed to insert perpendicularly into the mature insertion. These measurements support previous 
characterizations by polarized light microscopy37 and FTIRI76. As collagen fibers in the tendon and ligament 
have been shown to realign in response to mechanical loads187,188, the age-related differences in fiber 
orientation observed likely reflect a structural response to physiologic loads sustained by the ACL. 
Interestingly, however, quantitative analysis showed that the variances of the fiber orientation distributions 
were not different between age groups, which indicates that despite the change in insertion angle over time, 
the degree of fiber organization is conserved over the course of development.  
 In contrast to the age-related differences in collagen distribution, proteoglycan content across both 
the immature76 and mature insertions were found to be relatively uniform. However, relative proteoglycan 
content is reduced in the mature enthesis compared to in immature tissues. Histological studies of the ACL 
insertions37 and other fibrocartilaginous tissues171 have similarly reported decreasing proteoglycan content 
over time. Similar to the observed changes in collagen organization, this change in proteoglycan content is 
likely driven by repeated physiologic tensile loading of the ligament.  
 Mineral was found to be localized to the mineralized fibrocartilage and bone, with relative mineral 
content increasing exponentially across these regions in both the immature76 and the mature enthesis. It 
has been shown that the graded mineralization across this interface serves to reduce stress concentrations 
and improve load transfer between soft tissue and bone27,78. Moreover, it has been postulated that the 
mineral differential between the non-mineralized and mineralized regions serves different functions over 
the course of development, where it plays a mechanotransductive role in early development, and then 
serves increasingly to stabilize the interface as the matrix matures and cellularity decreases46. 
 Mineral maturity describes the progressive transformation of nonapatitic domains into well-
crystallized apatite189, and from the IR spectra, can be assessed by calculating the ratio of the 1030 cm-1 
peak, which is indicative of apatitic phosphate in stoichiometric HA, and the 1020 cm-1 peak, which 
represents nonstoichiometric apatites39,181. Mineral crystallinity was found to be significantly higher in the 
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bone region compared to in the interface region for both immature and mature groups. It has been shown 
that crystallinity within the mineralized fibrocartilage region of the tendon-to-bone enthesis is affected by 
mechanical loading49. Therefore, the difference in mineral crystallinity between the interface and bone 
regions may be indicative of inherently different loads sustained within each of these tissue regions. No 
differences in mineral crystallinity were observed between the immature and mature ACL-to-bone insertion, 
however. It has been shown in a mouse model that a mineral gradient is established at the supraspinatus 
tendon-to-bone insertion within days after birth, and that while carbonate content of apatite mineral at the 
enthesis increases over time, no significant difference in mineral crystallinity is detected46. These findings 
suggest that the mineralized matrix plays a critical functional role and is therefore established and optimized 
early on in development. Indeed, it has been proposed that mineral plays a critical role in the developing 
enthesis by helping to amplify and transduce mechanical signals for induction of cell-mediated 
mineralization190.  
 The spatial differences in composition and organization across the ACL-to-bone insertion 
contribute to progressive changes in mechanical properties across the enthesis26 and reflect adaptions to 
the complex forces generated at this interface36,75. This structured organization minimizes the formation of 
stress concentrations and facilitates the secure attachment of mechanically dissimilar tissues. As the elastic 
modulus of bone is more than an order of magnitude greater than that of the ligament, the gradual transition 
in mechanical properties across the intermediary fibrocartilage regions helps to protect the soft tissue from 
contact deformation and damage79. Moreover, comparison of the ACL-to-bone insertion in juvenile and 
adult models indicates that matrix composition and structure across the enthesis continue to change 
postnatally in response to these mechanical cues. It is well established that physiologic loading plays a 
critical role in enthesis development48,185, and studies of cruciate ligament enthesis development in a rat 
model reported that these changes can yield a multifold increase in tissue stiffness186. 
 
2.5. Conclusions 
 In this study, both region- and age-dependent changes in matrix composition and organization were 
found at the mature ACL-to-bone insertion, which reflect adaptations to the complex loads sustained at this 
junction. Collectively, these findings may be used to guide the design of biomimetic scaffolds for interface 
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tissue engineering and integrative ligament repair. Specifically, the results from this study indicate that the 
aligned collagen matrix structure and distinctive mineral distribution pattern across the insertion are highly 
conserved over time and should therefore be pre-established as part of the scaffold design. An ideal 
scaffold for fibrocartilage interface regeneration should consist of highly aligned nano-scale fibers and must 
be able to support the formation of both non-mineralized and mineralized fibrocartilage tissues. The 
exponential increase in mineral content across the insertion can be approximated as a step-wise change 
and can be recapitulated by a stratified design consisting of contiguous mineral-free and mineral-containing 
regions. Other matrix parameters, such as relative collagen and proteoglycan content, change substantially 
over time and underscore the importance of physiologic loading in enthesis maturation and suggest that 
mechanical stimulation could also be harnessed to guide tissue regeneration. Moreover, the compositional 
and structural similarities between the mature femoral and tibial entheses suggest that a single scaffold 
design could be effectively used for regeneration of either or both insertions. The results from this study 
enhance current understanding of the structure-function relationships at soft tissue-to-bone interfaces and 





2.6. Figures & Tables 
 
Figure 2.1. Collagen distribution across the mature ACL-to-bone interface. Light micrograph shows 
the tissue regions across the ACL-to-bone insertion (L: ligament, NFC: non-mineralized fibrocartilage, MFC: 
mineralized fibrocartilage, B: bone). Picrosirius red staining confirmed collagen presence across the 
insertion while FTIR spectroscopic maps (blue and red indicate low and high matrix content, respectively) 
and corresponding line profile analyses (n=5; each solid line represents mean peak ratios and shaded area 
shows standard deviation for each sample) revealed a continuous increase in collagen content from 
ligament to bone, with the highest collagen content found in the bone region. Regression analysis of line 
profiles found linear gradients in collagen content across the non-mineralized and mineralized fibrocartilage 
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Figure 2.2. Collagen organization across the mature ACL-to-bone interface. Light micrograph shows 
the tissue regions across the ACL-to-bone insertion (L: ligament, NFC: non-mineralized fibrocartilage, MFC: 
mineralized fibrocartilage, B: bone). Polarized light images of Picrosirius red-stained sections correspond 
to FTIR imaging analysis (blue: perpendicular to ligament-bone interface, yellow: mixed orientation, red: 
parallel to ligament-bone interface, respectively).  Corresponding line profile analyses (n=5; each solid line 
represents mean peak ratios and shaded area shows standard deviation for each sample) revealed that 
collagen fibrils in the ligament region are predominantly oriented perpendicularly to the bone, while fibrils 
in the fibrocartilage regions are less organized and insert obliquely into the bone region. No differences 






































































































































Figure 2.3. Proteoglycan distribution across the mature ACL-to-bone interface. Light micrograph 
shows the tissue regions across the ACL-to-bone insertion (L: ligament, NFC: non-mineralized 
fibrocartilage, MFC: mineralized fibrocartilage, B: bone). Safranin-O with Fast green counterstaining 
confirms proteoglycan presence at the insertion while FTIR imaging (blue and red indicate low and high 
matrix content, respectively) and corresponding line profile analyses (n=5; each solid line represents mean 
peak ratios and shaded area shows standard deviation for each sample) revealed the highest proteoglycan 
content is found in the fibrocartilage region. Regression analysis of line profiles finds little change in 
proteoglycan content across the non-mineralized and mineralized fibrocartilage regions. No differences 
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Figure 2.4. Mineral distribution across the mature ACL-to-bone interface. Light micrograph shows the 
tissue regions across the ACL-to-bone insertion (L: ligament, NFC: non-mineralized fibrocartilage, MFC: 
mineralized fibrocartilage, B: bone). Von Kossa staining confirmed mineral presence at the MFC and Bone 
regions while FTIR imaging (blue and red indicate low and high matrix content, respectively) and 
corresponding line profile analyses (n=5; each solid line represents mean peak ratios and shaded area 
shows standard deviation for each sample) revealed an increase in mineral content from MFC to bone. 
Regression analysis of line profiles fiound an exponential increase in mineral content across the mineralized 


























































































































































Figure 2.5. Regional comparison of matrix distribution across the ACL-to-bone interface. On 
average, collagen content (red, n=5) increases monotonically across the ACL-to-bone transition, though 
region-wise comparison showed no significant differences among tissue regions. Proteoglycan content 
(blue, n=5) is highest in the fibrocartilage zones, but region-wise comparison also showed no significant 
differences among tissue regions. Mineral content (green, n=5) increases significantly between the non-
mineralized (NFC) and mineralized (MFC) fibrocartilage zones, with the highest mineral content measured 
in the bone region. (n=5, *p<0.05: differences between regions).  No differences were found between 






































































































































































































Figure 2.6. Age-related changes across the ACL-to-bone interface. Three-dimensional OCT imaging 
datasets are displayed as sum projections within representative immature and mature ACL-to-bone 
insertion samples (L: ligament, NFC: non-mineralized fibrocartilage, MFC: mineralized fibrocartilage, B: 
bone). Collagen fibers were visible within the ligament regions, and the angle of fibers relative to the 
interface were measured from images at a fixed distance within each volume (n=4/group). While collagen 
fibers are oriented near parallel to the ligament-to-bone interface in immature samples, fibers are nearly 
perpendicular in mature samples. FTIR imaging (blue and red indicate low and high matrix content, 
respectively) revealed a higher mineral-to-matrix ratio in immature samples compared to mature samples. 
Maturity of mineral across the ACL-to-bone insertion was determined by analysis of the 1030/1020 peak 
height ratio. Regional comparison showed significantly higher crystallinity in the bone region compared to 
the MFC for both immature and mature samples (n=3, *p<0.05: differences between regions), but no 
significant difference between immature and mature tissues.  
  

















































































  Collagen Proteoglycans Mineral 
R2Femoral 
Exponential 0.57 0.40   0.97* 
Linear 0.57 0.40 0.92 
p 0.99 0.98 0.01 
R2Tibial 
Exponential 0.56 0.38   0.95* 
Linear 0.56 0.38 0.93 
p 0.99 0.99 0.03 
Table 2.1. Modeling matrix distribution across insertion fibrocartilage. Comparison of the quality of 
exponential versus linear fits indicated that the region-dependent difference in mineral content is best 
modeled by an exponential function (*p < 0.05), whereas collagen and proteoglycan distribution can also 













 In addition to the thorough characterization of fibrocartilage interface tissue composition and 
structure established in Chapter 2, it is also necessary to develop an understanding of the behavior of the 
cells found natively at the ACL-to-bone insertion. Thus, this study will on focus characterizing the behavior 
of insertion fibrochondrocytes ex vivo, especially when cultured on biomimetic nanofiber scaffolds. It is 
anticipated that findings from this study will serve to establish cell-level benchmarks for subsequent 
evaluation of stem cell-mediated fibrocartilage regeneration.  
 
3.1.1. Background and Motivation 
 Fibrocartilage tissue is typically found in regions subject to both tensile and compressive loading, 
such as the ligament and tendon entheses21,22,24, the meniscus31, the annulus fibrosus of the intervertebral 
disc33,96, and the temporomandibular joint34. The structure and composition of fibrocartilage reflects 
adaptations to these complex stress profiles and these tissues exhibit characteristic matrix properties of 
both fibrous and cartilaginous tissues47. Specifically, fibrocartilage is characterized by the presence of type 
I collagen, which is primarily responsible for resistance to tensile loads, as well as type II collagen and 
proteoglycans, which help the tissue withstand compressive loads35,47,70. Moreover, the age-related 
structural and compositional changes observed in insertion fibrocartilage (see Chapter 2) suggest that 
fibrochondrocytes are able to alter extracellular matrix composition and structure in response to physiologic 
loading. However, there are few studies that have systematically characterized the phenotype and 
metabolic activity of isolated ligament-to-bone insertion fibrochondrocytes. 
 The term “fibrochondrocyte” was first introduced by Webber et al. to describe cells isolated from 
the meniscus191. These cells have been shown to be capable of proliferation and synthesis of types I and 
II collagen and proteoglycans in monolayer culture191,192. More recent studies have demonstrated that 
fibrochondrocytes derived from different fibrocartilage tissues, or even different anatomical regions within 
the same tissue, exhibit slight phenotypic differences. For example, cells in the inner, non-vascularized 
region of the meniscus exhibit a more chondrocyte-like phenotype and synthesize higher levels of type II 
collagen and proteoglycans than cells from the outer, vascularized region192-195. Previous work from our 
group has shown that in monolayer culture, neonatal ACL insertion fibrochondrocytes behave more similarly 
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to articular chondrocytes than meniscal fibrochondrocytes in terms of proliferative capacity and matrix 
synthesis196. However, both meniscal fibrochondrocytes and articular chondrocytes have been reported to 
dedifferentiate rapidly in monolayer culture, with significant changes in matrix synthesis occurring as early 
as the first passage194,197-199. In particular, dedifferentiation of both cell types is characterized by increased 
expression or synthesis of type I collagen along with decreased type II collagen and proteoglycan 
deposition. Thus, insertion fibrochondrocyte behavior in two-dimensional monolayer culture may not be 
representative of in vivo cell behavior.  
 The morphology and phenotype of isolated fibrochondrocytes can be modulated by altering 
culturing conditions. For example, type I collagen and aggrecan coatings on tissue culture plastic have 
been shown to reverse the changes in expression of type I collagen and COMP, a type II collagen-
associated glycoprotein, in passaged fibrochondrocytes194. Three-dimensional culture conditions can also 
reduce deviation of fibrochondrocyte phenotype. For example, alginate hydrogel scaffolds, which are 
commonly used for cartilage tissue engineering, have been shown to be effective for improving meniscal 
fibrochondrocyte expression of type II collagen and can help these cells to maintain greater similarity overall 
to native meniscal phenotypes192,200. Similarly, meniscal fibrochondrocytes seeded in type I collagen 
hydrogels have been shown to retain their ability to synthesize types I and II collagen and proteoglycans 
over a two-week culture period in vitro201. Recent work has also demonstrated the potential of nanofiber-
based scaffolds for fibrochondrocyte expansion and fibrocartilage tissue engineering52,126,136,202-204. The 
nano-scale fibers are similar in size to collagen fibers of the native extracellular matrix205 and can regulate 
cell attachment and matrix deposition126,206-208. Meniscal fibrochondrocytes cultured on aligned collagen 
nanofibers in a macroporous poly(lactide-co-glycolide) foam coated with alginate were shown to maintain 
synthesis of types I and II collagen as well as the proteoglycan aggrecan in in vitro culture204.  
 
3.1.2. Objectives 
 The objective of this study is to evaluate the ex vivo behavior of ACL insertion fibrochondrocytes 
on nanofiber scaffolds. As the native enthesis consists of both non-mineralized and mineralized regions, 
fibrochondrocyte response on scaffolds with and without nano-hydroxyapatite (HA) particles will be 
assessed. Differential cell response as a function of scaffold composition are anticipated and will serve to 
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inform material selection for interface scaffold design, and to establish benchmark criteria for evaluation of 
stem cell-mediated fibrocartilage regeneration. 
 
3.2. Materials and Methods 
3.2.1. Scaffold Fabrication and Characterization 
 Blends of poly(ε-caprolactone) (PCL) and poly(lactide-co-glycolide) (PLGA) were fabricated via 
electrospinning209. Briefly, PCL (M� w~70,000-90,000; Sigma-Aldrich) and PLGA (85:15, M� w~123.6 kDa; 
Evonik) were dissolved at a weight ratio of 5:1 in a 3:2 solution of dichloromethane (Sigma-Aldrich) and 
N,N-dimethylformamide (Sigma-Aldrich), resulting in an 18% w/v polymer solution. In addition, blends 
containing hydroxyapatite (HA) were fabricated by adding HA (100-150 nm; Nanocerox, 15% w/w) to the 
PCL-PLGA mixture. The polymer and polymer-HA solutions were vortexed for an hour, loaded into a 5 mL 
syringe fitted with a stainless steel blunt-tip needle (26G for PCL-PLGA, 23G for PCL-PLGA/HA) and then 
electrospun at 10-12 kV for PCL-PLGA or 13-15 kV for PCL-PLGA/HA. To form aligned meshes, the 
solutions were dispensed at 1 mL/hour via a syringe pump (Harvard Apparatus) over a distance of 12 cm 
onto a grounded rotating (20 m/s) collecting mandrel. 
 Fiber morphology of as-fabricated meshes evaluated using secondary scanning electron 
microscopy (SEM; 5 kV, Hitachi 4700, Hitachi Ltd.). Samples were pre-coated with gold-palladium to reduce 
charging effects (Sputter Coater 108 Auto, Cressington Scientific). Fiber diameter was quantified by 
analysis of SEM micrographs (2500x, n=3 images/group, 10 random fibers/image; ImageJ, NIH).  
 Polymer blend composition (n=3) was ascertained via Fourier transform infrared spectroscopy 
(FTIR; Frontier, Perkin Elmer). Briefly, spectra were collected in attenuated total reflectance mode (ATR, 
200 scans, 4 cm−1 resolution) and analyzed for characteristic PCL (carbonyl C=O stretching, 1724 cm-1210), 
PLGA (ester C=O stretching, 1760 cm-1211) and phosphate peaks (564 cm-1, 603 cm-1, and 1031 cm-1212-
214). Mesh mineral content (n=3) was quantified by thermogravimetric analysis (TGA, Q50, TA Instruments). 
Briefly, samples were loaded into a calibrated platinum pan and then heated to 100°C, followed by a 
20°C/minute ramp to 700°C. As the degradation temperature of PCL and PLGA is approximately 400°C, 





3.2.2. Cell Isolation and Culture 
 Neonatal (1-7 days old) bovine tibiofemoral joints were obtained from a local abattoir (n=3; Green 
Village Packing Company). Prior to harvest, joints were sterilized by soaking in soapy water for 40 minutes, 
followed by 70% ethanol for 20 minutes. Joints were then opened aseptically in a sterile environment. 
Following removal of the surrounding muscle, subcutaneous fascia, collateral ligaments, patella, patellar 
tendon, adipose tissue, and menisci, the femoral and tibial ACL insertions were identified and excised, 
yielding tissue samples containing contiguous regions of ligament, fibrocartilage, and bone. After removal 
of the attached ligament and bone tissue, harvested fibrocartilage was minced and digested for 16 hours 
at 37°C in 10% v/v collagenase II (Worthington Biochemical) in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Cellgro-Mediatech) supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals), 2% 
penicillin/streptomycin (P/S; Cellgro-Mediatech), 0.2% amphotericin B (Amp-B; Cellgro-Mediatech), and 
0.2% gentamicin sulfate (G/S; Cellgro-Mediatech). The cell suspension was then filtered (30 μm, Spectrum 
Labs), and the cells were collected by centrifugation and then plated at a density of 5x105 cells/cm2 on 
tissue culture plastic. Cells were maintained in fully-supplemented (F/S) DMEM containing 10% FBS, 1% 
P/S, 1% non-essential amino acids (NEAA; Cellgro-Mediatech), 0.1% Amp-B, and 0.1% G/S under 
humidified conditions at 37°C and 5% carbon dioxide for one week.  
 Prior to cell seeding, electrospun meshes (1x1 cm) were sterilized by ultraviolet radiation (15 
minutes/side) and incubated in DMEM supplemented with 20% FBS, 2% P/S, 0.2% Amp-B, and 0.2% G/S 
overnight at 37°C to enhance cell attachment. Fibrochondrocytes were seeded onto PCL-PLGA or PCL-
PLGA/HA meshes at a density of 3x104 cells/cm2, and were cultured in F/S DMEM, with media exchange 
occurring every three days. Monolayer cultures served as control. Cell viability, proliferation, mineralization 
potential, and matrix deposition on the meshes were evaluated at 1, 7, 14, and 28 days.  
 
3.2.3. Cell Viability, Morphology, and Proliferation 
 At each time point, cell viability (n=3) was assessed by Live/Dead staining (Invitrogen) according 
to the manufacturer’s suggested protocol. Briefly, samples were rinsed with phosphate-buffered saline 
(PBS; Sigma-Aldrich), stained, and then imaged by confocal microscopy (Fluoview FV1000, Olympus) at 
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488 nm and 594 nm to assess cell viability and death, respectively. Cell alignment (n=3) was quantified by 
analyzing confocal images using circular statistics software customized for evaluating fiber alignment215,216. 
Cell morphology (n=2) was observed via SEM (5 kV). Briefly, cell-seeded scaffolds were fixed in 
neutral-buffered formalin, dehydrated in an ethanol series, and then pre-coated with gold-palladium to 
reduce charging effects. 
 Cell proliferation (n=5) was measured by quantifying the amount of DNA in each sample (Quant-iT 
PicoGreen dsDNA Assay, Invitrogen). Briefly, at each time point, samples were rinsed with PBS and then 
homogenized with 0.1% Triton-X (Sigma-Aldrich). Samples were subjected to 15 seconds of ultrasonication 
at 5W. Fluorescence was measured at 485 nm excitation and 535 nm emission wavelengths (SpectraFluor 
Plus, Tecan). Measured fluorescence intensity was correlated to a DNA standard curve, and a conversion 
factor of 7.7 pg DNA/cell was then used to determine total cell number in each sample. 
 
3.2.4. Matrix Synthesis 
 Total collagen (n=5) and glycosaminoglycan (GAG; n=5) content were quantified using the 
hydroxyproline assay217 and a modified 1,9-dimethylmethylene blue (DMMB) dye-binding assay218,219, 
respectively. Sample lysates were dehydrated overnight and then subjected to an 18 hour digestion in 
papain buffer (Sigma-Aldrich) to solubilize matrix proteins. For collagen quantification, samples were 
hydrolyzed in 2N sodium hydroxide (Sigma-Aldrich) and subsequently incubated with Chloramine-T 
solution (Sigma-Aldrich) and Ehrlich’s Reagent217. Absorbance was measured (SpectraFluor Plus) at 555 
nm and collagen content of each sample was determined by correlating measured optical density to a 
collagen standard curve. For GAG quantification, samples were mixed with DMMB dye (pH 3.5, Sigma-
Aldrich) and absorbance was immediately measured (μQuant, Bio-Tek) at both 540 nm and 595 nm. 
Proteoglycan content was determined by correlating measured absorbance to a chondroitin-6-sulfate 
standard curve. 
 
3.2.5. Matrix Mineralization Potential 
 Matrix mineralization potential (n=5) was assessed by quantifying cell alkaline phosphatase (ALP) 
activity, an enzyme associated with matrix mineralization. ALP activity was measured based on its ability 
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to dephosphorylate p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenyl (pNP). The same lysate used for 
DNA quantification was mixed at a 1:3 v/v ratio with 10 nM pNP-PO4 (Sigma-Aldrich), and then incubated 
at 37°C for 30 minutes. Absorbance was measured (SpectraFluor Plus) at 405 nm and ALP activity level in 
each sample was determined by correlating measured optical density to a pNP standard curve. 
 
3.2.6. Histology 
 Collagen (n=2), proteoglycan (n=2), and mineral distribution (n=2) were also visualized by 
Picrosirius red, Alcian blue, and von Kossa staining, respectively, of frozen sections. Samples harvested 
on day 28 were fixed immediately in 10% neutral-buffered formalin supplemented with 1% cetylpyridinium 
chloride (CPC; Sigma-Aldrich) to preserve proteoglycans174,220. Following fixation, samples were embedded 
in 5% poly(vinyl alcohol) (PVA; Sigma-Aldrich) and 10 μm sections spanning the entire thickness of the 
scaffold were obtained using a cryostat (Hacker-Bright OTF, Hacker Instruments and Industries). Stained 
sections were imaged by light microscopy (Axiovert 25, Zeiss). 
 Deposition of type I (n=2) and type II collagen (n=2) was evaluated by immunohistochemistry. 
Scaffold sections were incubated overnight at 4°C with antibodies for type I (ab90395, Abcam) or type II 
collagen (ab34712, Abcam), which were diluted 1:100 in serum-free Protein Block (Dako Cytomation) prior 
to use. After a PBS wash, FITC-conjugated secondary antibodies (type I collagen: ab6785, Abcam; type II 
collagen: ab6798, Abcam) diluted 1:200 in PBS were added and samples were incubated for an additional 
hour at room temperature. DAPI (Sigma-Aldrich) was used as a nuclear counterstain. Samples were 
imaged using a confocal microscope with a 495 nm excitation wavelength. 
 
3.2.7. FTIRI Acquisition and Analysis 
 Quantitative analysis of collagen, proteoglycan, and mineral distribution on cryosectioned scaffolds 
was performed using an FTIR spectrometer (Spectrum 100, Perkin Elmer) coupled to a microscope imaging 
system (Spotlight 400, Perkin Elmer) following published methods76,159,175,176. Spectra were acquired 
between 2000 and 800 cm-1 with a spectral resolution of 8 cm-1 and a spatial resolution of 6.25 μm. IR 
spectra were analyzed and spectroscopic maps were generated using ISYS chemical imaging software 
(3.1.1., Spectral Dimensions) and MATLAB (R2014b, Mathworks). Prior to analysis, sample spectra were 
43 
 
corrected by subtracting normalized spectra of pure PCL-PLGA to eliminate PCL-PLGA scaffold 
background and isolate signal corresponding to cell-mediated matrix and mineral deposition.
 Signature peaks within the collagen and carbohydrate spectra have been shown to correlate 
linearly with collagen and proteoglycan content177. Relative collagen content (n=3 per group) was mapped 
by integrating the peak area under the amide I band (1720 to 1590 cm-1)177,178. Proteoglycan distribution 
(n=3 per group) was estimated by integrating under the carbohydrate band associated with C-O-C and C-
OH vibrations (1140 to 985 cm-1). For PCL-PLGA/HA groups, samples were first decalcified in tris-
hydroxymethylaminomethane buffer (Sigma-Aldrich, pH 7.2) containing 10% ethylenediaminetetraacetic 
acid (Sigma-Aldrich) to eliminate overlapping phosphate signal prior to signal acquisition. The mineral 
distribution (n=3 per group) in non-decalcified samples was calculated by integrating under the ν1, ν3 
phosphate band contour (1200 to 900 cm-1), and then subtracting the area under the carbohydrate band to 
eliminate contributions from the overlapping carbohydrate signal. 
 Line profiles of relative collagen, proteoglycan and mineral content extending across the thickness 
of each scaffold were generated from the spectral data. Values for 100 equally spaced points spanning 
across the entire thickness of the cell-seeded scaffold were interpolated using a MATLAB bicubic least 
squares method. This normalization method allowed matrix content to be presented as a function of percent 
distance across each sample, thereby accounting for any differences in scaffold thickness among 
specimens. Line profiles were obtained across the width of each sample on a pixel-by-pixel basis and were 
then averaged, resulting in a single line profile representing the mean data collected for the sample. 
Regions exhibiting anomalies such as holes or folds were excluded.  
 
3.2.8. Mechanical Properties 
 Mechanical properties of acellular and cell-seeded scaffolds (n=7 per group) were determined after 
1 and 28 days of culture. At each time point, samples were secured on a mechanical testing device (Instron 
Model 8841, Instron) with an average gauge length of 3 cm and were tested to failure at a strain rate of 5 
mm/minute, with uniaxial load applied in the direction of fiber alignment. Scaffold elastic modulus was 
calculated from the linear region of the stress-strain curve, and yield strength, ultimate tensile stress, and 




3.2.9. Statistical Analysis 
 Results are presented as mean ± standard deviation. Two-way analysis of variance (ANOVA) was 
performed to determine time-, scaffold-, and/or cell-type-dependent differences in cell proliferation, matrix 
production, matrix mineralization potential, and mechanical properties. The Tukey-Kramer post-hoc test 
was used for all pair-wise comparisons (p<0.05). All statistical analyses were performed using JMP IN 
(4.0.4, SAS Institute). 
 
3.3. Results 
3.3.1. Scaffold Characterization 
 Aligned PCL-PLGA and PCL-PLGA/HA scaffolds were fabricated by electrospinning (Figure 3.1). 
The resulting scaffolds were identical with respect to alignment and fiber diameter (PCL-PLGA: 691 ± 181 
nm; PCL-PLGA/HA: 619 ± 122 nm). Mineral presence in PCL-PLGA/HA scaffolds was confirmed by FTIR, 
with characteristic phosphate absorption peaks at 564 cm-1, 603 cm-1, and 1031 cm-1 observed in the PCL-
PLGA/HA spectra only. Mineral content was quantified by TGA, where residual weight of the PCL-PLGA 
and PCL-PLGA/HA nanofibers were 0.38 ± 0.003% and 15.4 ± 0.004%, respectively.  
 Evaluation of scaffold tensile mechanical properties showed that PCL-PLGA and PCL-PLGA/HA 
nanofibers have a similar Young’s Modulus (Figure 3.1). However, PCL-PLGA scaffolds exhibit significantly 
higher ultimate tensile strength, yield strength, and ductility compared to the mineral-containing scaffolds. 
Mechanical properties of acellular scaffolds were maintained over a 28-day culture period in standard cell 
culture conditions. 
3.3.2. Cell Attachment and Proliferation 
 Fibrochondrocytes derived from the tibial ACL insertion were cultured on PCL-PLGA and PCL-
PLGA/HA nanofiber scaffolds. On both scaffold types, cells were observed to attach to the underlying 
nanofibers and elongate preferentially along the underlying fibers within one day of seeding (Figure 3.2). 
Circular statistics analysis of cell alignment showed that insertion fibrochondrocytes exhibited a high degree 
of alignment and were oriented at a similar angle as the underlying nanofibers on day 1.  
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 Insertion fibrochondrocytes remained viable on both scaffold groups and proliferated significantly 
over time (Figure 3.2). Proliferation was enhanced on mineral-containing scaffolds, with significantly higher 
cell number on PCL-PLGA/HA scaffolds compared to PCL-PLGA scaffolds by day 7. This trend persisted 
through the 28-day culture period. 
 
3.3.3. Collagen Deposition 
 Both scaffold groups supported deposition of collagen matrix by ACL-to-bone insertion-derived 
fibrochondrocytes (Figure 3.3). Histological and FTIRI analysis showed that collagen matrix was primarily 
localized to the scaffold surface where cells were initially seeded. Examination of the collagenous matrix 
by immunohistochemistry showed that the matrix contained both type I and type II collagen. Significantly 
higher collagen deposition was observed on PCL-PLGA/HA scaffolds compared to on control scaffolds 
starting from day 14. However, the increased matrix deposition over time did not result in detectable 
functional changes in the cell-seeded scaffolds. There were no significant differences in the ultimate tensile 
strength, yield strength, Young’s Modulus, or ductility between 1 and 28 days of culture for either scaffold 
group. 
 
3.3.4. Proteoglycan Deposition 
Both scaffold groups also supported deposition of proteoglycans by insertion-derived 
fibrochondrocytes (Figure 3.4). Histological and FTIRI analysis showed that proteoglycans were primarily 
localized to the scaffold surface where cells were initially seeded. No significant differences in total 
proteoglycan deposition were observed between scaffold groups. 
 
3.3.5. Matrix Mineralization 
 Matrix mineralization potential, as assessed by ALP activity, was initially enhanced on PCL-PLGA 
scaffolds compared to HA-containing scaffolds at early time points (Figure 3.5). A peak in ALP activity was 
observed at 8 hours after seeding, and by 24 hours there were no significant differences in ALP activity 
between scaffold groups. Histological and FTIRI analysis showed similar mineralization on the scaffold 




3.3.6. Anatomical Site-Dependent Differences 
 Tibial- and femoral insertion-derived fibrochondrocytes exhibited similar trends in cell proliferation, 
with cell number increasing steadily over time on both scaffold groups (Figure 3.6). However, significantly 
higher total cell numbers were observed in the femoral cell groups by day 28 for both scaffold groups. Tibial- 
and femoral insertion-derived cells also synthesized similar amounts of collagen and proteoglycan on both 
scaffold groups until day 28, where proteoglycan deposition was significantly higher on all femoral cell-
seeded scaffolds (Figure 3.6). No significant differences in ALP activity were observed between cell groups, 
with ALP activity peaking around 8 hours after seeding for all cell and scaffold groups (Figure 3.6). In 




 Fibrochondrocytes are responsible for producing and maintaining the unique fibrocartilage tissues 
found in regions subject to tensile and compressive loading, such as at the ACL-to-bone enthesis. To better 
understand the role of these cells in matrix synthesis and remodeling, as well as to establish benchmark 
criteria for evaluation of interface regeneration strategies, the objective of this study was to characterize the 
ex vivo behavior of ACL-to-bone insertion fibrochondrocytes on biomimetic nanofiber scaffolds. 
Fibrochondrocyte phenotype was maintained on polymeric nanofiber scaffolds and matrix synthesis was 
modulated by nanofiber composition. 
 Nanofiber scaffolds provide a biomimetic substrate that support the proliferation of ACL insertion 
fibrochondrocytes in vitro and, importantly, enable maintenance of their fibrochondrocytic phenotype. 
Fibrochondrocytes are typically characterized by their ability to synthesize both types I and II collagen as 
well as proteoglycans191,192. However, previous studies have shown that these cells dedifferentiate rapidly 
in monolayer culture, with increased synthesis of type I collagen and decreased deposition of type II 
collagen and proteoglycans over time194,199. In contrast, in this study, ACL insertion cells cultured on 
nanofiber scaffolds maintained synthesis of types I and II collagen and proteoglycans through 28 days of 
in vitro culture. Other studies have similarly demonstrated that three-dimensional culture conditions that 
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recapitulate the native extracellular environment can support maintenance of fibrochondrocyte phenotype 
in vitro192,200,201,204. In particular, the highly aligned nanofiber scaffolds used in this study mimic the well-
organized collagenous matrix of the native ACL-to-bone insertion21,37,175,176. Fiber architecture can regulate 
cell alignment, proliferation, and matrix synthesis126,206-208, and similar to what has previously been observed 
with meniscal221,222 and annulus fibrosus223 fibrochondrocytes, fibroblasts206,224-227, and mesenchymal stem 
cells (MSCs)216,228-230, the underlying fiber architecture guided insertion fibrochondrocyte attachment and 
orientation. 
 Given the presence of both non-mineralized and mineralized fibrocartilage tissue regions at the 
native ACL-to-bone insertion, the behavior of isolated insertion fibrochondrocytes on hydroxyapatite (HA)-
containing scaffolds was also evaluated in this study. Hydroxyapatite is the primary mineral in mineralized 
fibrocartilage175 and bone231, and it has previously been incorporated into a variety of polymeric matrices 
for calcified cartilage232-234 and bone212,235-240 regeneration applications. In the present study, insertion 
fibrochondrocyte proliferation and collagen matrix synthesis were enhanced on HA scaffolds compared to 
on mineral-free control scaffolds. Higher cell proliferation and matrix deposition in the presence of HA has 
similarly been reported for chondrocytes232, osteoblasts236,240,241, and MSCs242,243. Previous studies have 
proposed that nano-HA particles may promote cell growth and protein synthesis by increasing surface area-
to-volume ratio and enhancing protein adsorption and local serum concentrations around the cells241,242. 
For immature chondrocytes, increased concentration of extracellular inorganic phosphate has been shown 
to upregulate expression of cyclin D1, a positive regulator of cell cycle progression, which facilitates 
increased proliferation244. Given the similarity between juvenile insertion fibrochondrocytes and articular 
chondrocytes196, extracellular HA may enhance fibrochondrocyte proliferation through similar mechanisms.  
 Interestingly, however, matrix mineralization potential, as evaluated by ALP activity, was initially 
lower on HA scaffolds compared to control scaffolds, and overall mineralization at day 28 was similar 
between PCL-PLGA and PCL-PLGA/HA scaffold groups. While HA has been shown to enhance ALP 
activity in osteoblasts236,237,241, the presence of HA in chondrocyte-seeded hydrogel scaffolds has been 
shown to promote chondrocyte hypertrophy without an accompanying increase in mineralization232. Other 
studies have demonstrated that increased concentration of extracellular inorganic phosphate results in 
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downregulation of ALP expression in chondrocytes, likely due to reduced need for cell-mediated phosphate 
production244.  
 Comparison of the behavior of femoral and tibial insertion-derived cells showed similar overall 
trends in proliferation and matrix synthesis, though femoral cells exhibited higher total cell proliferation and 
proteoglycan deposition by day 28. The femoral and tibial insertions are known to differ slightly in size184, 
sustained loads36, and compressive mechanical properties26. However, no tissue-level differences in matrix 
composition, distribution, or organization between the femoral and tibial insertions have been reported in 
juvenile or adult models37,76,176. Other factors, such as collagen fibril diameter and density or ratio of different 
collagen types, may be responsible for functional differences between the femoral and tibial insertions.  
 
3.5. Conclusions 
 In summary, the findings from this study demonstrate that fibrochondrocytes isolated from the 
femoral and tibial ACL-to-bone insertions exhibit strong proliferative capabilities and maintain the ability to 
synthesize fibrocartilaginous matrix comprising both types I and II collagen and proteoglycans when 
cultured on biomimetic nanofibrous scaffolds. Additionally, these cells are responsive to changes in their 
extracellular environment, as evidenced by the differential response to scaffolds with and without 
hydroxyapatite. The results from this study enhance current understanding of the fibrochondrocytes found 
at soft tissue-to-bone interfaces and the role they play in matrix synthesis and maintenance. Moreover, 
these findings also establish benchmark guidelines for evaluation of interface tissue engineering efforts. 
The functional integration of soft connective tissue with bone is essential for musculoskeletal function, and 
these findings can also be extended to other critical attachments, such as the supraspinatus tendon-to-
bone insertion in the rotator cuff, and will help guide ongoing efforts to design soft tissue grafts that are both 






Figure 3.1. HA scaffold characterization. Aligned PCL-PLGA nanofiber scaffolds with and without 
hydroxyapatite (HA) were fabricated by electrospinning. HA presence in PCL-PLGA/HA scaffolds was 
confirmed by FTIR, with peaks corresponding to PO43- absorption at 564 cm-1, 603 cm-1, and 1031 cm-1 
present in the PCL-PLGA/HA spectra only. Ceramic content was quantified by thermogravimetric analysis 
(n=3), where residual weight of the PCL-PLGA and PCL-PLGA/HA nanofibers were 0.38 ± 0.003% and 
15.4 ± 0.004%, respectively. Evaluation of as-fabricated scaffold tensile mechanical properties show that 
while PCL-PLGA and PCL-PLGA/HA nanofibers have a similar Young’s Modulus, PCL-PLGA scaffolds 
exhibit significantly higher ultimate tensile strength, yield strength, and ductility compared to PCL-PLGA/HA 
scaffolds. Mechanical properties of acellular scaffolds were maintained over a 28-day culture period in 










Day 1 9.98 ± 1.71 5.42 ± 0.78 65.41 ± 15.23 29.60 ± 4.60
Day 28 10.70 ± 1.51 5.91 ± 0.88 68.60 ± 7.99 27.13 ± 2.12
PCL-PLGA/HA
Day 1 5.81 ± 1.12^ 3.76 ± 0.85^ 58.27 ± 6.68 13.18 ± 3.63^






































Figure 3.2. Insertion fibrochondrocyte viability, proliferation, and alignment on nanofiber scaffolds. 
ACL insertion fibrochondrocytes seeded on nanofiber scaffolds were viable on both scaffold groups and 
proliferated over the 28-day culture period, with significantly higher cell number on PCL-PLGA/HA scaffolds 
by day 7 (n=5; *p<0.05, between consecutive time points; ^p<0.05, between scaffold groups). Cells were 
observed to span across fibers and were oriented along the direction of underlying fiber alignment within 
one day of seeding (n=3; 0°=parallel to fibers, ±90°=perpendicular to fibers). No difference in cell alignment 
was observed between PCL-PLGA and PCL-PLGA/HA scaffold groups. 
 
  
MVA ± AD (°) MVL
PCL-PLGA 3.11 ± 20.23 0.75 ± 0.06






















Mean Vector Angle (MVA): -90° ≤ θ ≤ 90°, 0°=horizontal
Angular Deviation (AD): 0°=aligned, 40.5°=random
















































Figure 3.3. Insertion fibrochondrocyte collagen matrix deposition. Both PCL-PLGA and PCL-
PLGA/HA nanofiber scaffolds supported fibrochondrocyte-mediated deposition of collagen, with 
significantly higher matrix deposition observed on PCL-PLGA/HA scaffolds (n=5; *p<0.05, between 
consecutive time points; ^p<0.05, between substrate groups). Picrosirus red staining and FTIR imaging 
(n=3) of day 28 samples showed that collagen matrix was primarily localized to the scaffold surface where 
cells were initially seeded. Immunohistochemistry staining revealed the deposition of both type I and II 
collagen (green=type I or II collagen; blue=cell nuclei). Tensile mechanical properties of fibrochondrocyte-
seeded scaffolds were comparable to those of acellullar scaffolds (Figure 1), and were maintained through 










Modulus (MPa) Ductility (%)
PCL-PLGA
Day 1 11.8 ± 2.1 10.90 ± 0.86 5.91 ± 0.40 69.79 ± 5.65 28.52 ± 4.14
Day 28 20.9 ± 7.1* 10.15 ± 1.75 5.20 ± 0.74 72.05 ± 18.03 29.21 ± 5.20
PCL-PLGA/HA
Day 1 11.5 ± 1.0 6.00 ± 0.72^ 3.91 ± 0.42^ 55.78 ± 7.59 14.05 ± 1.01^
























































Figure 3.4. Insertion fibrochondrocyte proteoglycan deposition. Both PCL-PLGA and PCL-PLGA/HA 
nanofiber scaffolds supported fibrochondrocyte-mediated deposition of proteoglycan matrix over time (n=5; 
*p<0.05, between consecutive time points; ^p<0.05, between substrate groups). Alcian blue staining and 
FTIR imaging (n=3) of day 28 samples showed that proteoglycans were primarily localized to the scaffold 


















































Figure 3.5. Insertion fibrochondrocyte matrix mineralization. Matrix mineralization potential, as 
assessed by alkaline phosphatase (ALP) activity, was enhanced on PCL-PLGA scaffolds compared to PCL-
PLGA/HA scaffolds at early time points, peaking at 8 hours of culture. No significant difference in ALP 
activity between PCL-PLGA and PCL-PLGA/HA scaffolds was measured following the initial peak, and Von 
Kossa staining and FTIR imaging (n=3) of day 28 samples showed similar matrix mineralization on the 





























































Figure 3.6. Comparison of tibial- and femoral-derived insertion fibrochondrocytes. Similar trends in 
cell proliferation, matrix deposition, and matrix mineralization potential were observed between tibial- and 
femoral-derived cells cultured on PCL-PLGA and PCL-PLGA/HA scaffolds: Cell numbers were similar 
among cell and scaffold groups through day 14; cell numbers were enhanced on HA-containing scaffolds 
compared to PCL-PLGA scaffolds by day 28. Though similar collagen deposition was observed between 
tibial- and femoral-derived fibrochondrocytes, significantly higher GAG deposition was observed on both 
femoral fibrochondrocyte-seeded scaffolds by day 28. On average, matrix deposition was enhanced on 
PCL-PLGA/HA scaffolds for both cell groups after day 7. ALP activity was also similar between cell groups, 
with matrix mineralization potential initially enhanced on PCL-PLGA/HA scaffolds (n=5; *p<0.05, between 






















































































































COMPARISION OF FIBROCHONDROGENIC POTENTIAL OF 






 In addition to scaffold design, cell source is a critical parameter for clinical translation of tissue 
engineering strategies. An optimal cell source for fibrocartilage interface regeneration should be easy to 
harvest with minimal donor site impact, exhibit high proliferative capacity, and capable of synthesis and 
maintenance of a fibrocartilaginous matrix. Moreover, these cells must be able to support the development 
of both non-mineralized and mineralized fibrocartilage tissues. Thus, this study will focus on characterizing 
and comparing the fibrochondrogenic potential of different mesenchymal stem cells (MSCs) in order to 
identify an ideal cell type for fibrocartilage regeneration. 
 
4.1.1. Background and Motivation 
 While primary cells are useful for preclinical testing of tissue engineering systems, low cell yield, 
de-differentiation during ex vivo expansion, and donor site morbidity limit the feasibility and usefulness of 
mature primary cells in clinical settings245. In contrast, multipotent adult stem cells can be harvested from a 
variety of tissues throughout the body, and are considered to be an ideal cell source for regenerative 
medicine applications245-247. In particular, mesenchymal stem cells are a population of somatic progenitor 
cells with high self-renewal capability and multi-lineage differentiation potential50,248. First identified in bone 
marrow249, multipotent progenitor cells with osteogenic, chondrogenic, and adipogenic differentiation 
potential have since been isolated from a variety of tissues, including periosteum250, synovium251, adipose 
tissue252, skeletal muscle253, umbilical cord tissue254 and blood255, and placenta256, among others. While all 
MSCs are multipotent and immune-privileged, cells from different tissue sources exhibit varying proliferative 
rates, gene expression patterns, and differentiation efficiencies51,257-262. For example, bone marrow- 
(BMSC) and synovium-derived MSCs (SDSCs) exhibit higher proliferative capacity and superior 
chondrogenic potential compared to MSCs derived from periosteal, adipose, or muscle tissue51.  
 To date, BMSCs have been widely explored for musculoskeletal tissue engineering 
applications247,263-268 and have demonstrated capacity for fibrochondrogenic differentiation52,126,129,130. 
However, it has been shown that MSCs from intraarticular tissues share a more similar gene expression 
profiles with other intraarticular cells (e.g. chondrocytes) compared to MSCs from extraarticular tissues269, 
suggesting the superiority of SDSCs as a cell source for regeneration of intraarticular tissues, such as the 
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ACL and its insertions. Indeed, resident SDSCs have been shown to naturally increase proliferation, initiate 
chondrogenic differentiation, and migrate to the defect site following cartilage injury270,271. Implanted SDSCs 
have also been shown to promote meniscal regeneration in rabbit272-274, rat275,276, and porcine277,278 models 
and accelerate early tendon-to-bone remodeling following ACL reconstruction in rats279. Given their superior 
chondrogenic potential51,261,280 and natural proximity to the enthesis site within the intraarticular joint space, 
SDSCs may therefore be a more favorable cell source for insertion fibrocartilage regeneration.  
 
4.1.2. Objectives 
 The objective of this study is to identify an ideal source for insertion fibrocartilage regeneration. 
Specifically, this study will compare the response of BMSCs and SDSCs in fibrochondrogenic culture 
conditions. Both BMSCs52,129,130 and SDSCs127,128,281 have been shown to exhibit fibrochondrogenic 
differentiation when cultured on fibrous scaffolds in the presence of transforming growth factor (TGF)-β. 
Given the superior chondrogenic potential of SDSCs, it is anticipated that SDSCs will exhibit enhanced 
response to fibrochondrogenic culture conditions compared to BMSCs, as evaluated by cell proliferation 
and matrix synthesis. 
Furthermore, as the ACL-to-bone interface consists of both non-mineralized and mineralized tissue 
regions, a scaffold system for fibrocartilage interface regeneration must also support formation and 
maintenance of mineralized fibrocartilage tissue. Hydroxyapatite (HA)-containing scaffolds have been 
widely explored for bone tissue engineering applications282,283, and there is also evidence that HA-
containing scaffolds can promote chondrocyte hypertrophy232, enhance matrix deposition and 
mineralization potential of hypertrophic chondrocytes233,284, and induce chondrogenic differentiation of 
MSCs285. The results from Chapter 3 similarly show that HA-containing nanofibers enhance matrix 
deposition by insertion fibrochondrocytes. Thus, BMSC and SDSC mineralization potential and response 
to HA-containing nanofiber scaffolds will also be compared in this study. Given the superior osteogenic 
potential of BMSCs, it is anticipated that BMSCs will exhibit enhanced response to mineral-containing 
scaffolds compared to SDSCs, as evaluated by cell proliferation, matrix synthesis, and matrix mineralization 
potential. Results from this set of studies will provide guidance on selection of an appropriate cell source 




4.2. Materials and Methods 
4.2.1. Cell Isolation and Characterization 
 BMSCs286,287 and SDSCs288 were harvested from bovine knee joints following established 
protocols. Briefly, neonatal (1-7 days old) bovine tibiofemoral joints were obtained from a local abattoir (n=2; 
Green Village Packing Company). Prior to harvest, joints were sterilized by soaking in soapy water for 40 
minutes, followed by 70% ethanol for 20 minutes, and then the surrounding muscle and subcutaneous 
fascia were removed. To harvest BMSCs, each tibia was cut at the mid-diaphysis with a sterile handheld 
jig saw (Tuff Stuff). Marrow was removed from the medullary canal and a Percoll density gradient (MP 
Biomedicals) was used to isolate BMSCs. Cells were initially plated at a density of 1.8x105 nucleated 
cells/cm2 and were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; Cellgro-Mediatech) 
supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals) and 1% penicillin/streptomycin (P/S; 
Cellgro-Mediatech), under humidified conditions at 37°C and 5% carbon dioxide. The cell culture media 
was exchanged after 3 days to eliminate non-adherent blood cells. Upon reaching confluency, cells were 
re-plated at a density of 5x103 cells/cm2 and were then cultured for 4 passages by splitting confluent cells 
in each passage at a ratio of 1:3. Passage 4 BMSCs were used for all subsequent characterization and 
differentiation studies. 
 To harvest SDSCs, the joint capsules were opened aseptically in a sterile environment, and the 
synovial membrane lining the femoral condyles was harvested. The synovial tissue was then digested for 
4 hours at 37°C in 10% v/v collagenase II (Worthington Biochemical) in Minimum Essential Medium Alpha 
(αMEM; Cellgro-Mediatech) supplemented with 10% FBS, 2% P/S, 0.2% amphotericin B (Amp-B; Cellgro-
Mediatech), and 0.2% gentamicin sulfate (G/S; Cellgro-Mediatech). The cell suspension was then filtered 
(30 μm, Spectrum Labs), and the cells were collected by centrifugation and then plated at a density of 
1.8x103 cells/cm2 on tissue culture plastic. SDSCs were maintained in fully-supplemented (F/S) αMEM 
containing 10% FBS, 1% P/S, 1% non-essential amino acids (NEAA; Cellgro-Mediatech), 0.1% Amp-B, 
and 0.1% G/S, under humidified conditions at 37°C and 5% carbon dioxide. To eliminate contaminating 
macrophages and obtain a pure population of SDSCs, cells were subsequently cultured for 4 passages289 
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by splitting confluent cells in each passage at a ratio of 1:4. Passage 4 SDSCs were used for all subsequent 
characterization and differentiation studies. 
 The adipogenic248, osteogenic290, and chondrogenic291 differentiation potential of the isolated cells 
were evaluated following conventional protocols. For adipogenic (n=3) and osteogenic (n=3) differentiation, 
BMSCs and SDSCs were plated at a density of 100 cells/cm2 and cultured in their respective expansion 
media for 10 days. For adipogenic differentiation, the medium was replaced with F/S DMEM supplemented 
with 1 μM dexamethasone (Sigma-Aldrich), 500 μM isobutyl-1-methyl-xanthine(Sigma-Aldrich), 100 μM 
indomethacin (Sigma-Aldrich), and 10 μg/mL insulin (Sigma-Aldrich). The cells were cultured for an 
additional 14 days and were then fixed in 10% neutral-buffered formalin and stained with Oil Red-O (0.18% 
solution, Sigma-Aldrich). For osteogenic differentiation, the medium was replaced with F/S low-glucose 
DMEM (Gibco) supplemented with 10 mM β-glycerolphosphate (Sigma-Aldrich), 0.1 μM dexamethasone, 
and 200 μM ascorbic acid (Sigma-Aldrich). The cells were cultured for an additional 14 days and were then 
fixed in 10% neutral-buffered formalin and stained with Alizarin Red (1% solution, Sigma-Aldrich). For 
chondrogenic differentiation (n=3), cells were pelleted by centrifugation (2x105 cells/pellet) and cultured in 
DMEM supplemented with antibiotics, 1% ITS+ (Corning), 50 μg/mL L-proline (Sigma-Aldrich), 0.1 μM 
dexamethasone, 50 μg/mL ascorbic acid, and 10 ng/mL TGF-β3 (Sigma-Aldrich) for 21 days. Pellets were 
then fixed in 10% neutral-buffered formalin, embedded in paraffin, cut into 7 μm sections, and stained with 
Safranin-O (0.6% solution, Sigma- Aldrich). 
 
4.2.2. Scaffold Fabrication and Characterization 
 Blends of poly(ε-caprolactone) (PCL) and poly(lactide-co-glycolide) (PLGA) were fabricated via 
electrospinning209. Briefly, PCL (M� w~70,000-90,000; Sigma-Aldrich) and PLGA (85:15, M� w~123.6 kDa; 
Evonik) were dissolved at a weight ratio of 5:1 in a 3:2 solution of dichloromethane (Sigma-Aldrich) and 
N,N-dimethylformamide (Sigma-Aldrich), resulting in an 18% w/v polymer solution. In addition, blends 
containing hydroxyapatite (HA) were fabricated by adding HA (100-150 nm; Nanocerox, up to 35% w/w) to 
the PCL-PLGA mixture. The polymer and polymer-HA solutions were vortexed for an hour, loaded into a 5 
mL syringe fitted with a stainless steel blunt-tip needle (26G for PCL-PLGA, 23G for PCL-PLGA/HA) and 
then electrospun at 10-12 kV for PCL-PLGA or 13-15 kV for PCL-PLGA/HA. To form aligned meshes, the 
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solutions were dispensed at 1 mL/hour via a syringe pump (Harvard Apparatus) over a distance of 12 cm 
onto a grounded rotating (20 m/s) collecting mandrel.  
 Fiber morphology of as-fabricated meshes evaluated using secondary scanning electron 
microscopy (SEM; 5 kV, Hitachi 4700, Hitachi Ltd.). Samples were pre-coated with gold-palladium to reduce 
charging effects (Sputter Coater 108 Auto, Cressington Scientific).  
 Polymer blend composition (n=3) was ascertained via Fourier transform infrared spectroscopy 
(FTIR; Frontier, Perkin Elmer). Briefly, spectra were collected in attenuated total reflectance mode (ATR, 
200 scans, 4 cm−1 resolution) and analyzed for characteristic phosphate peaks (564 cm-1, 603 cm-1, and 
1031 cm-1212-214). Mesh mineral content (n=3) was quantified by thermogravimetric analysis (TGA, Q50, TA 
Instruments). Briefly, samples were loaded into a calibrated platinum pan and then heated to 100°C, 
followed by a 20°C/minute ramp to 700°C. As the degradation temperature of PCL and PLGA is 
approximately 400°C, the residual weight at the end of the heating cycle corresponds to the weight percent 
of mineral in the fibrous meshes. 
 
4.2.3. Fibrochondrogenic Differentiation 
 Scaffold discs (1 cm diameter) were prepared and then sterilized by ultraviolet radiation (15 
minutes/side). Prior to cell seeding, scaffolds were incubated in DMEM supplemented with 20% FBS, 2% 
P/S, 0.2% Amp-B, and 0.2% G/S overnight at 37°C to enhance cell attachment. BMSCs and SDSCs were 
seeded onto PCL-PLGA, PCL-PLGA/15% HA, or PCL-PLGA/35% HA meshes at a density of 3x104 
cells/cm2, and were cultured in F/S DMEM, with media exchange occurring every three days. For TGF-β3-
treated groups, the cell culture media was supplemented with 200 pg/mL TGF-β3 at every feeding. 
Monolayer cultures served as control. Cell viability, proliferation, mineralization potential, and matrix 
deposition on the meshes were evaluated at 1, 7, 14, and 28 days.  
 
4.2.4. Cell Viability and Proliferation  
 At each time point, cell viability (n=3) was assessed by Live/Dead staining (Invitrogen) according 
to the manufacturer’s suggested protocol. Briefly, samples were rinsed with phosphate-buffered saline 
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(PBS; Sigma-Aldrich), stained, and then imaged by confocal microscopy (Fluoview FV1000, Olympus) at 
488 nm and 594 nm to assess cell viability and death, respectively. 
 Cell proliferation (n=5) was measured by quantifying the amount of DNA in each sample (Quant-iT 
PicoGreen dsDNA Assay, Invitrogen). Briefly, at each time point, samples were rinsed with PBS and then 
homogenized with 0.1% Triton-X (Sigma-Aldrich). Samples were subjected to 15 seconds of ultrasonication 
at 5W. Fluorescence was measured at 485 nm excitation and 535 nm emission wavelengths (SpectraFluor 
Plus, Tecan). Measured fluorescence intensity was correlated to a DNA standard curve, and a conversion 
factor of 7.7 pg DNA/cell was then used to determine total cell number in each sample. 
 
4.2.5. Matrix Production 
 Total collagen (n=5) and glycosaminoglycan (GAG; n=5) content were quantified using the 
hydroxyproline assay217 and a modified 1,9-dimethylmethylene blue (DMMB) dye-binding assay218,219, 
respectively. Sample lysates were dehydrated overnight and then subjected to an 18 hour digestion in 
papain buffer (Sigma-Aldrich) to solubilize matrix proteins. For collagen quantification, samples were 
hydrolyzed in 2N sodium hydroxide (Sigma-Aldrich) and subsequently incubated with Chloramine-T 
solution (Sigma-Aldrich) and Ehrlich’s Reagent217. Absorbance was measured (SpectraFluor Plus) at 555 
nm and collagen content of each sample was determined by correlating measured optical density to a 
collagen standard curve. For GAG quantification, samples were mixed with DMMB dye (pH 3.5, Sigma-
Aldrich) and absorbance was immediately measured (μQuant, Bio-Tek) at both 540 nm and 595 nm. 
Proteoglycan content was determined by correlating measured absorbance to a chondroitin-6-sulfate 
standard curve. 
 
4.2.6. Matrix Mineralization Potential 
 Matrix mineralization potential (n=5) was assessed by quantifying cell alkaline phosphatase (ALP) 
activity, an enzyme associated with matrix mineralization. ALP activity was measured based on its ability 
to dephosphorylate p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenyl (pNP). The same lysate used for 
DNA quantification was mixed at a 1:3 v/v ratio with 10 nM pNP-PO4 (Sigma-Aldrich), and then incubated 
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at 37°C for 30 minutes. Absorbance was measured (SpectraFluor Plus) at 405 nm and ALP activity level in 
each sample was determined by correlating measured optical density to a pNP standard curve. 
 
4.2.7. Statistical Analysis 
 Results are presented as mean ± standard deviation. Two-way analysis of variance (ANOVA) was 
performed to determine time-, culture condition-, and/or cell-type-dependent differences in cell proliferation, 
matrix production, and matrix mineralization potential. The Tukey-Kramer post-hoc test was used for all 
pair-wise comparisons (p<0.05). All statistical analyses were performed using JMP IN (4.0.4, SAS Institute). 
 
4.3. Results 
4.3.1. MSC Characterization 
 Cells isolated from the bone marrow and synovium were adherent to tissue culture plastic and 
displayed a characteristic spindle-like shape in monolayer (Figure 4.1). Both cell types exhibited multipotent 
differentiation potential characteristic of MSCs, where after 3 weeks of culture in adipogenic, osteogenic, 
and chondrogenic culture conditions, both cell groups stained positively for lipids, mineral, and 
proteoglycans, respectively. 
 
4.3.2. Scaffold Characterization 
 Aligned PCL-PLGA scaffolds with up to 35% HA were fabricated by electrospinning (Figure 4.2). 
Mineral presence in PCL-PLGA/HA scaffolds was confirmed by FTIR, with characteristic phosphate 
absorption peaks at 564 cm-1, 603 cm-1, and 1031 cm-1 observed in the 15% HA and 35% HA scaffold 
spectra only. Mineral content was quantified by TGA, where residual weight of the control, 15% HA, and 
35% HA meshes were 0.38 ± 0.003%, 15.4 ± 0.004%, and 33.8 ± 0.007% respectively.  
 
4.3.3. Cell Viability and Proliferation 
 BMSCs and SDSCs were cultured in monolayer, on PCL-PLGA scaffolds with and without 
exogenous TGF-β3, and on PCL-PLGA/HA nanofiber scaffolds with up to 35% HA. Both cell types remained 
viable in all culture conditions over the 28-day culture period (Figure 4.3). In monolayer culture, both BMSCs 
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and SDSCs steadily proliferated over time, with a 2.9-fold increase in cell number over 28 days for BMSCs 
and a 2.2-fold increase for SDSCs. SDSC proliferation was enhanced on nanofiber scaffolds and these 
cells were observed to proliferate rapidly during the first week of culture, with a 4.7-fold increase in cell 
number in just the first 7 days. This resulted in consistently higher cell numbers in SDSC groups compared 
to BMSC groups from day 7 onward. These effects were further amplified by the addition of TGF-β3 to the 
culture media or the incorporation of HA in the underlying scaffold. 
 
4.3.4. Collagen Deposition 
 BMSC and SDSC collagen synthesis in monolayer culture remained relatively constant, with no 
significant differences over time or between groups except at day 28, where higher total collagen was 
measured in SDSC groups (Figure 4.4). Similarly, collagen synthesis on control scaffolds was similar 
between cell groups from day 7 onward, with no significant changes over time. The addition of exogenous 
TGF-β3 enhanced SDSC collagen matrix deposition relative to SDSCs on control scaffold groups, and 
SDSC collagen synthesis was higher than BMSC collagen synthesis in the same culture conditions. 
Collagen deposition was also enhanced in a dose-dependent manner on HA scaffolds for both cell types, 
with the highest collagen synthesis observed on 35% HA scaffolds on day 28.  
 
4.3.5. Proteoglycan Deposition 
 BMSC and SDSC proteoglycan deposition were similar in monolayer culture at early time points, 
but higher GAG deposition was detected SDSC groups by day 28 (Figure 4.5). BMSC proteoglycan 
synthesis was not significantly affected by culture on nanofiber scaffolds, even in the presence of TGF-β3 
or HA. In contrast, SDSC proteoglycan deposition was enhanced on nanofiber scaffolds compared to 
monolayer culture and this difference was further amplified by the addition of exogenous TGF-β3. SDSC 
proteoglycan synthesis on HA fibers was similar to on control scaffolds. 
 
4.3.6. Matrix Mineralization 
 BMSCs consistently exhibited higher matrix mineralization potential, as assessed by ALP activity, 
compared to SDSCs for all culture conditions (Figure 4.6). BMSC ALP activity was enhanced on control 
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nanofibers compared to in monolayer. These effects were diminished with the addition of exogenous TGF-
β3, resulting in similar ALP activity levels as observed in monolayer. BMSC matrix mineralization potential 
was also enhanced on HA scaffolds in a dose-dependent manner, with the highest ALP activity observed 
on the 35% HA scaffolds at day 1. No significant differences in ALP activity among SDSC culture condition 
groups were detected, and on average, ALP activity decreased over the 28 day period for both cell types. 
 
4.4. Discussion 
 Due to their multipotency, ease of isolation, capacity for self-renewal, and low immunogenicity, 
mesenchymal stem cells are a promising cell source for regeneration of the multi-tissue ligament-to-bone 
interface. However, MSCs from different tissue sources are known to vary in terms of differentiation 
potential. The objective of this study was to identify an optimal MSC source for fibrocartilage interface 
regeneration and focused on comparing the fibrochondrogenic potential of bone marrow- and synovium-
derived MSCs. Overall, SDSCs were observed to exhibit higher proliferation and baseline synthesis of 
cartilaginous matrix, as well as greater sensitivity to TGF-β3 stimulation compared to BMSCs. 
 In this study, SDSCs exhibited greater proliferative potential compared to BMSCs in both 
monolayer culture and on nanofiber scaffolds. Other studies have similarly demonstrated the superior 
proliferative potential of SDSCs compared to stem cells from other tissues, including bone marrow, adipose, 
periosteum, and muscle51,260. Moreover, these findings are consistent across many species and have been 
observed with human51, rat260, and rabbit261 MSCs. While it is not clear what the underlying mechanism for 
this difference is, some studies have suggested that SDSCs’ greater in vitro proliferation can be attributed 
in part to their higher relative expression of platelet-derived growth factor (PDGF) receptor-α262. PDGF 
signaling plays a role in regulating the survival and mitogenic pathways, and this difference in PDGFRα 
expression may affect downstream signaling of pathways involved in cell proliferation.  
SDSC proliferation was further enhanced by culture on nanofiber scaffolds. While the aligned PCL-
PLGA nanofiber scaffolds supported attachment, viability, and proliferation of both cell types, higher cell 
numbers were consistently observed in SDSC groups. Other studies have similarly demonstrated that PCL-
based nanofiber scaffolds enhance MSC proliferation compared to culture on tissue culture plastic292,293. 
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With their nanoscale architecture and high surface area-to-volume ratio, polymer nanofiber scaffolds 
provide a more biomimetic surface for culture and expansion of MSCs216,228-230,292,293. 
While BMSCs and SDSCs exhibited overall similar levels of baseline collagen synthesis, SDSCs 
consistently produced more proteoglycans than BMSCs on both tissue culture plastic and control scaffolds. 
This is consistent with other work that has shown that compared to BMSCs, SDSCs exhibit higher 
expression of proline arginine-rich end leucine-rich repeat protein (PRELP), a glycoprotein that is abundant 
in cartilage269. These findings suggest that SDSCs are inherently more similar to other intraarticular cells 
such as chondrocytes and fibrochondrocytes than BMSCs are, which may account for the well-established 
superior chondrogenic potential of SDSCs51,261,280. 
 The observed differences in proliferation and matrix synthesis were further amplified by the addition 
of TGF-β3. TGF-β is a pleiotropic cytokine that plays a critical role in cartilage formation and 
maintenance104-106, and is commonly used for chemical induction of MSC chondrogenesis291,294. The 
addition of just 200 pg/mL TGF-β3 dramatically enhanced SDSC proliferation, collagen deposition, and 
GAG synthesis. In contrast, TGF-β3 did not result in any significant difference in BMSC proliferation or 
matrix synthesis. Interestingly, this dose of TGF-β is a 50-fold lower concentration than what is typically 
used in chondrogenic differentiation assays248,291,295. It is possible that SDSCs are inherently more sensitive 
to TGF-β signaling and that the optimal conditions for SDSC chondrogenesis are different from the 
conditions needed to induce chondrogenic response from BMSCs. Indeed, other studies have 
demonstrated that despite the similarities in their surface epitope profiles, BMSCs and SDSCs exhibit key 
differences in their gene expression profiles259,262,269. In particular, TGF-β mRNA expression in BMSCs was 
found to be 2.8-fold lower than in SDSCs259. 
 In contrast to the superior SDSC proliferation and matrix synthesis, BMSCs consistently 
demonstrated greater matrix mineralization potential than SDSCs. While SDSC alkaline phosphatase 
activity remained consistent across all culture conditions, BMSCs were observed to exhibit a dose-
dependent response on HA scaffolds, with higher ALP activity on 35% HA scaffolds compared to 15% HA 
scaffolds. Other studies have similarly reported increased ALP activity of MSCs cultured on polymer-HA 
composite nanofibers296,297. Furthermore, despite the lack of detectable response in terms of cell 
proliferation and matrix synthesis, TGF-β3 stimulation was observed to reduce ALP activity in BMSCs. 
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Other work has similarly shown that TGF-β inhibits ALP activity in osteoblast-precursor cells298. Just as 
SDSCs seem to share greater similarity to cartilage cells and be more primed for chondrogenesis, BMSCs 
may be inherently more primed for mineralization.  
 
4.5. Conclusions 
Here we demonstrate that SDSCs exhibit superior sensitivity to fibrochondrogenic cues compared 
to BMSCs, and are a favorable cell source for fibrocartilage interface regeneration. In particular, the 
nanofibrous substrate and addition of TGF-β3 synergistically increased SDSC proliferation and relevant 
matrix synthesis. As the native ACL-to-bone interface consists of both uncalcified and calcified fibrocartilage 
regions, matrix mineralization potential of the cells was also compared. While BMSCs exhibited higher ALP 
activity overall, SDSCs demonstrated the potential for mineralization in the presence of osteogenic media, 
which suggests that these cells would be capable of synthesizing mineralized fibrocartilaginous tissue under 
optimized conditions. Additionally, the greater proliferative capacity of SDSCs makes these cells an 
advantageous choice for clinical applications. Based on the findings detailed in this chapter, all subsequent 








Figure 4.1. MSC characterization. Cells isolated from the bone marrow (BMSC) and synovium (SDSC) of 
bovine tibiofemoral joints adhere to tissue culture plastic and undifferentiated cells exhibit fibroblast-like 
morphology. Both cell types can be differentiated toward adipogenic, osteogenic, and chondrogenic 


















Figure 4.2. HA scaffold characterization. Aligned PCL-PLGA nanofiber scaffolds with up to 35% 
hydroxyapatite (HA) were fabricated by electrospinning. HA presence in PCL-PLGA/HA scaffolds was 
confirmed by FTIR, with peaks corresponding to PO43- absorption at 564 cm-1, 603 cm-1, and 1031 cm-1 
present in the 15% and 35% HA scaffold spectra only. Mineral content was verified using thermogravimetric 
analysis, with residual weights of 0.38 ± 0.003%, 15.4 ± 0.003%, and 33.8 ± 0.007% for the control, 15% 


















0% HA 0.38 ± 0.003 
15% HA 15.4 ± 0.004




Figure 4.3. MSC viability and proliferation. BMSCs and SDSCs were viable in all culture conditions. 
SDSCs proliferated significantly over the 28-day culture period, with consistently higher cell number 
compared to BMSCs in all culture conditions. SDSC proliferation was enhanced on nanofiber scaffolds 
compared to in monolayer, and these effects were further amplified by the addition of exogenous TGF-β3 
or incorporation of hydroxyapatite (n=5; *p<0.05, between consecutive time points; #p<0.05, between cell 
types; ^p<0.05, different from corresponding control scaffold).   
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Figure 4.4. MSC collagen matrix deposition. BMSC and SDSC collagen synthesis were similar in 
monolayer and control scaffold groups. Addition of exogenous TGF-β3 enhanced SDSC collagen matrix 
deposition relative to both control scaffold groups and BMSCs. Collagen synthesis was significantly 
enhanced on 35% HA scaffold groups compared to control scaffold groups for both cell types on day 28 
(n=5; *p<0.05, between consecutive time points; #p<0.05, between cell types; ^p<0.05, different from 
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Figure 4.5. MSC proteoglycan deposition. BMSC and SDSC proteoglycan synthesis were similar in 
monolayer groups up through day 14. SDSC GAG synthesis was enhanced on control scaffolds, resulting 
in higher total GAG compared to BMSCs after day 14. Addition of exogenous TGF-β3 significantly 
enhanced SDSC proteoglycan deposition relative to both control scaffold groups and BMSCs. GAG 
synthesis was not significantly different between 15% and 35% HA groups for either cell type and overall 
higher GAG was observed in SDSC groups compared to BMSC groups for these scaffolds (n=5; *p<0.05, 
between consecutive time points; #p<0.05, between cell types; ^p<0.05, different from corresponding 
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Figure 4.6. MSC matrix mineralization potential. BMSCs consistently exhibited higher ALP activity 
compared to SDSCs in every culture condition. BMSC matrix mineralization potential was further enhanced 
by culture on nanofiber scaffolds, but this effect was diminished  by the addition of TGF-β3. BMSCs also 
exhibited a dose-dependent response on HA scaffolds on day 1, with higher ALP activity observed on 35% 
HA scaffolds (n=5; *p<0.05, between consecutive time points; #p<0.05, between cell types; ^p<0.05, 
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The results from Chapter 4 demonstrate that a nanofibrous substrate combined with exogenous 
delivery of transforming growth factor (TGF)-β3 can guide fibrochondrogenic differentiation of synovium-
derived mesenchymal stem cells (SDSCs). To adapt this strategy for clinical translation, this study will focus 
on the fabrication and optimization of a controlled-release nanofiber scaffold system that can provide 
localized delivery of TGF-β3 for SDSC-mediated fibrocartilage interface regeneration. 
 
5.1.1. Background and Motivation 
 Studies focused on elucidating the chemical and physical factors involved in fibrocartilage interface 
development have demonstrated that transforming growth factor (TGF)-β signaling plays a critical role in 
regulating lineage specification of the progenitor cells from which the enthesis originates42. TGF-β is a 
pleiotropic cytokine involved in regulation of cell growth and differentiation, tissue repair, and inflammation, 
and is essential for cartilage formation and maintenance104-106. In in vitro fibrocartilage cell and tissue 
explant cultures, the addition of TGF-β has been shown to stimulate cell proliferation and enhance collagen 
and proteoglycan synthesis116-121. In fibrochondrocyte-seeded scaffold constructs, TGF-β stimulation 
similarly increases collagen synthesis, leading to improved functional properties122,123. Moreover, Local 
delivery of TGF-β1 has been shown to improve intraosseous healing and functional outcomes following 
ACL reconstruction with a flexor tendon autograft139, while TGF-β3 has been shown to accelerate healing 
and improve functional outcomes in supraspinatus tendon-to-bone repair140,141.  
 Fibrochondrogenic differentiation of MSCs in vitro can be guided by administration of TGF-β 
alongside other chemical124,125 or physical52,126-130 cues. In particular, culture of MSCs on polymer nanofiber 
scaffolds in the presence of TGF-β-supplemented chondrogenic media has been shown to facilitate the 
formation of fibrocartilage-like tissue52,126. However, effective protein delivery remains a challenge for 
clinical application of growth factor-based tissue regeneration strategies. Current methods often rely on 
systemic or bolus injection, but the growth factors can rapidly diffuse away from the target tissue and cause 
undesirable side effects. Given the pleiotropic effects of TGF-β, it is especially important to ensure 





The objective of this study is to fabricate and optimize a controlled-release nanofiber scaffold 
system that can provide localized delivery of TGF-β as well as appropriate physical cues for SDSC-
mediated fibrocartilage interface regeneration. Specifically, this study will use the TGF-β3 isoform, which is 
expressed at the enthesis during fetal development38. It is anticipated that scaffold-mediated delivery of 
TGF-β3 will enhance SDSC proliferation and facilitate synthesis of a fibrocartilaginous matrix, comprising 
types I and II collagen as well as proteoglycans, in a dose-dependent manner. This scaffold system 
represents a more clinically-relevant strategy for fibrocartilage interface regeneration that can eliminate the 
need for exogenous TGF-β3 administration. 
 
5.2. Materials and Methods 
5.2.1. Scaffold Fabrication 
 Aligned protein-containing polymer blend fibers of poly-ε-caprolactone (PCL) and polylactide-co-
glycolide (PLGA) were fabricated by electrospinning209. Briefly, PCL (M�w~70,000-90,000; Sigma-Aldrich) 
and PLGA (85:15, M� w~123.6 kDa; Evonik) were dissolved at a 5:1 weight ratio in a 3:2 solution of 
dichloromethane (Sigma-Aldrich) and N,N-dimethylformamide (Sigma-Aldrich), resulting in an 18% w/v 
polymer solution. As previous work has demonstrated that co-encapsulation of bovine serum albumin (BSA) 
helps to stabilize incorporated growth factor during the electrospinning process299,300, up to 10% w/w of 
finely ground BSA (Sigma-Aldrich) was added to the PCL-PLGA mixture and then vortexed for 1 hour. Next, 
TGF-β3 (Sigma-Aldrich) was reconstituted in deionized water (1 μg/μL) and added to the PCL-PLGA/BSA 
mixture (10 μg for low-dose and 20 μg for high dose) and then vortexed for an additional hour. The PCL-
PLGA/BSA/TGF-β3 mixture was then loaded into a 5 mL syringe fitted with an 18G stainless steel blunt-tip 
needle, and then electrospun at 11-13 kV. To form aligned meshes, the solutions were dispensed at 1 





5.2.2. Scaffold Characterization 
 Fiber morphology of as-fabricated meshes was evaluated by secondary scanning electron 
microscopy (SEM; 2 kV, Hitachi 4700, Hitachi Ltd.). Samples were pre-coated with gold-palladium to reduce 
charging effects (Sputter Coater 108 Auto, Cressington Scientific). Fiber diameter was quantified via image 
analysis of SEM micrographs (2500x, n=6 images/group; 10 random fibers/image, ImageJ, NIH). 
 To quantify growth factor incorporation efficiency, 8 mm-diameter discs of as-fabricated TGF-β3 
meshes (n=5/group) were completely dissolved in a 1:2 solution of chloroform (Fisher) and Dulbecco’s 
Modified Eagle’s Medium (DMEM, Cellgro-Mediatech) supplemented with 1.25 mg/mL BSA. The mixtures 
were vortexed for 30 minutes and then centrifuged at 20,000 RCF for 5 minutes to separate the organic 
and aqueous phases. The amount of TGF-β3 in the aqueous phase was measured by ELISA (R&D 
Systems), following the manufacturer’s suggested protocol. 
 To assess the TGF-β3 release kinetics, 10 mm-diameter discs of as-fabricated TGF-β3 meshes 
(n=5/group) were sterilized by ultraviolet irradiation (15 minutes/side) and then incubated in DMEM 
supplemented with 1.25 mg/mL BSA, 2% penicillin/streptomycin (P/S, Cellgro-Mediatech), 0.2% 
amphotericin B (amp-B, Cellgro-Mediatech), and 0.2% gentamicin sulfate (G/S, Cellgro-Mediatech). 
Samples were maintained at 37°C in humidified conditions and at each time point, media from each sample 
was collected and replaced with fresh media. Media TGF-β3 concentrations were measured by ELISA. In 
order to better understand the mechanism of release, the release data was fit to the Ritger-Peppas 
model301, where, assuming one-dimensional release under perfect sink conditions, the release from a 
monodispersion of cylinders can be described by: 
 𝑀𝑀𝑡𝑡
𝑀𝑀∞
= 𝑘𝑘𝑡𝑡𝑛𝑛  (Equation 5.1) 
where Mt/M∞ is the fractional release at time t, k is a constant, and n is the diffusional exponent. 
 
5.2.3. Cell Isolation and Culture 
 SDSCs were harvested from bovine knee joints following established protocols288. Briefly, neonatal 
(1-7 days old) bovine tibiofemoral joints were obtained from a local abattoir (n=2; Green Village Packing 
Company). Prior to harvest, joints were sterilized by soaking in soapy water for 40 minutes, followed by 
70% ethanol for 20 minutes, and then the surrounding muscle and subcutaneous fascia were removed. 
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The joint capsules were then opened aseptically in a sterile environment, and the synovial membrane lining 
the femoral condyles was harvested. The synovial tissue was digested for 4 hours at 37°C in 10% v/v 
collagenase II (Worthington Biochemical) in Minimum Essential Medium Alpha (αMEM; Cellgro-Mediatech) 
supplemented with 10% fetal bovine serum (FBS), 2% P/S, 0.2% Amp-B, and 0.2% G/S. The cell 
suspension was then filtered (30 μm, Spectrum Labs), and the cells were collected by centrifugation and 
then plated at a density of 1.8x103 cells/cm2 on tissue culture plastic. SDSCs were maintained in fully-
supplemented (F/S) αMEM containing 10% FBS, 1% P/S, 1% non-essential amino acids (NEAA; Cellgro-
Mediatech), 0.1% Amp-B, and 0.1% G/S, under humidified conditions at 37°C and 5% carbon dioxide. To 
eliminate contaminating macrophages and obtain a pure population of SDSCs, cells were subsequently 
cultured for 4 passages289 by splitting confluent cells in each passage at a ratio of 1:4. Passage 4 SDSCs 
were used for all subsequent studies. 
 Scaffold discs (1 cm diameter) were prepared and then sterilized by ultraviolet radiation (15 
minutes/side). Prior to cell seeding, scaffolds were incubated in DMEM supplemented with 20% FBS, 2% 
P/S, 0.2% Amp-B, and 0.2% G/S overnight at 37°C to enhance cell attachment. SDSCs were seeded onto 
control (BSA only), low-dose TGF-β3, or high-dose TGF-β3 scaffolds at a density of 3x104 cells/cm2, and 
were cultured in F/S DMEM, with media exchange occurring every three days. For exogenous TGF-β3 
groups, the cell culture media was supplemented with 200 pg/mL TGF-β3 at every feeding. To evaluate 
rate of growth factor consumption, media samples were collected at every feeding and TGF-β3 
concentration was quantified by ELISA. Cell viability, proliferation, mineralization potential, and matrix 
deposition on the scaffolds were evaluated at 1, 7, 14, and 28 days.  
 
5.2.4. Cell Viability and Proliferation  
 At each time point, cell viability (n=3) was assessed by Live/Dead staining (Invitrogen) according 
to the manufacturer’s suggested protocol. Briefly, samples were rinsed with phosphate-buffered saline 
(PBS; Sigma-Aldrich), stained, and then imaged by confocal microscopy (Fluoview FV1000, Olympus) at 
488 nm and 594 nm to assess cell viability and death, respectively. 
 Cell proliferation (n=5) was measured by quantifying the amount of DNA in each sample (Quant-iT 
PicoGreen dsDNA Assay, Invitrogen). Briefly, at each time point, samples were rinsed with PBS and then 
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homogenized with 0.1% Triton-X (Sigma-Aldrich). Samples were subjected to 15 seconds of ultrasonication 
at 5W. Fluorescence was measured at 485 nm excitation and 535 nm emission wavelengths (SpectraFluor 
Plus, Tecan). Measured fluorescence intensity was correlated to a DNA standard curve, and a conversion 
factor of 7.7 pg DNA/cell was then used to determine total cell number in each sample. 
 
5.2.5. Matrix Production 
 Total collagen (n=5) and glycosaminoglycan (GAG; n=5) content were quantified using the 
hydroxyproline assay217 and a modified 1,9-dimethylmethylene blue (DMMB) dye-binding assay218,219, 
respectively. Sample lysates were dehydrated overnight and then subjected to an 18 hour digestion in 
papain buffer (Sigma-Aldrich) to solubilize matrix proteins. For collagen quantification, samples were 
hydrolyzed in 2N sodium hydroxide (Sigma-Aldrich) and subsequently incubated with Chloramine-T 
solution (Sigma-Aldrich) and Ehrlich’s reagent217. Absorbance was measured (SpectraFluor Plus) at 555 
nm and collagen content of each sample was determined by correlating measured optical density to a 
collagen standard curve. For GAG quantification, samples were mixed with DMMB dye (pH 3.5, Sigma-
Aldrich) and absorbance was immediately measured (μQuant, Bio-Tek) at both 540 nm and 595 nm. 
Proteoglycan content was determined by correlating measured absorbance to a chondroitin-6-sulfate 
standard curve. 
 Total collagen (n=2) and proteoglycan (n=2) were also visualized by Picrosirius red and Alcian blue 
staining, respectively, of frozen sections. Samples harvested on day 28 were fixed immediately in 10% 
neutral-buffered formalin (NBF) supplemented with 1% cetylpyridinium chloride (CPC; Sigma-Aldrich) to 
preserve proteoglycans174,220. Following fixation, samples were embedded in 5% poly(vinyl alcohol) (PVA; 
Sigma-Aldrich) and 10 μm sections spanning the entire thickness of the scaffold were obtained using a 
cryostat (Hacker-Bright OTF, Hacker Instruments and Industries). Stained sections were imaged by light 
microscopy (Axiovert 25, Zeiss). 
 Deposition of type I (n=2) and type II collagen (n=2) was evaluated by immunohistochemistry. 
Scaffold sections were incubated overnight at 4°C with antibodies for type I (ab90395, Abcam) or type II 
collagen (ab34712, Abcam), which were diluted 1:100 in serum-free Protein Block (Dako Cytomation) prior 
to use. After a PBS wash, FITC-conjugated secondary antibodies (type I collagen: ab6785, Abcam; type II 
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collagen: ab6798, Abcam) diluted 1:200 in PBS were added and samples were incubated for an additional 
hour at room temperature. DAPI (Sigma-Aldrich) was used as a nuclear counterstain. Samples were 
imaged using a confocal microscope with a 495 nm excitation wavelength. 
 
5.2.6. SMAD Activation 
 Activation of phosphorylated SMAD (pSMAD) 2/3 and pSMAD 1/5/9 after 24 hours of culture was 
evaluated by whole-mount immunohistochemistry. Samples harvested on day 1 were fixed immediately in 
10% NBF supplemented with 1% CPC and then rinsed briefly in PBS and transferred onto glass slides. 
Samples were incubated overnight at 4°C with antibodies for pSMAD 2/3 (8828, Cell Signaling Technology) 
or pSMAD 1/5/9 (13820, Cell Signaling Technology), which were diluted 1:200 and 1:800, respectively, in 
serum-free Protein Block prior to use. After a PBS wash, a FITC-conjugated secondary antibody (ab6798, 
Abcam) diluted 1:200 in PBS was added and samples were incubated for an additional hour at room 
temperature. DAPI was used as a nuclear counterstain. Samples were imaged using a confocal microscope 
with a 495 nm excitation wavelength. 
 
5.2.7. Statistical Analysis 
 Results are presented as mean ± standard deviation. Two-way analysis of variance (ANOVA) was 
performed to determine time- and culture condition-dependent differences in cell proliferation or matrix 
production. The Tukey-Kramer post-hoc test was used for all pair-wise comparisons (p<0.05). All statistical 
analyses were performed using JMP IN (4.0.4, SAS Institute). 
 
5.3. Results 
5.3.1. Scaffold Characterization 
 To assess the protective effects of BSA, aligned PCL-PLGA scaffolds with varying concentrations 
of BSA and TGF-β3 were fabricated via electrospinning (Fig. 5.1). Growth factor release from PCL-PLGA 
fibers was shown to increase as a function of BSA incorporation, with meshes that contained 10% BSA 
exhibiting approximately three-fold higher release over 15 days compared to meshes with only 5% BSA 
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(Fig. 5.1). Based on these results, all subsequent studies were conducted using PCL-PLGA meshes with 
10% BSA incorporated. 
Evaluation of fiber morphology showed no significant difference in fiber diameter among control 
(10% BSA only), low- and high-dose TGF-β3 scaffold groups (Fig. 5.1). Growth factor incorporation was 
evaluated by ELISA, with an incorporation efficiency of 46.0 ± 2.5% measured in low-dose scaffolds and 
41.7 ± 2.5% in high-dose scaffolds (Figure 5.1). Based on evaluation of as-fabricated meshes, each low-
dose scaffold disc (10 mm diameter) used for cell culture is expected to contain an average of 6.0 ± 0.3 ng 
of TGF-β3, while high-dose scaffold discs are anticipated to contain 12.7 ± 0.4 ng TGF-β3. 
 Evaluation of release kinetics showed an initial burst release of TGF-β3 within the first six hours of 
incubation, followed by slower, sustained release (Fig. 1). Over the course of 14 days, high-dose scaffolds 
released 6.2 ± 0.4% of total incorporated TGF-β3, which was more than two-fold higher than the total 
cumulative release from the low-dose scaffolds. Fitting the data to Equation 5.1, the diffusional coefficient 
n was determined to be 0.24 (R2 = 0.9957) for low-dose scaffolds and 0.30 (R2 = 0.9915) for high-dose 
scaffolds. 
 
5.3.2. Cell Viability and Proliferation 
 Cells remained viable on all scaffold groups and proliferated significantly over time (Figure 5.2). 
Proliferation was significantly enhanced on both TGF-β3 scaffold groups compared to on control scaffolds 
at day 7, and significantly more cells were found in the high-dose group compared to both control and low-
dose scaffolds on day 14. By day 28 there were no significant differences in cell number among groups. 
 
5.3.3. Proteoglycan Deposition 
 All scaffold groups supported deposition of proteoglycans by SDSCs, with increasing GAG 
synthesis over time for all groups (Figure 5.3). GAG synthesis was significantly enhanced on TGF-β3 
scaffolds compared to on control scaffolds from day 7 onwards. Moreover, a dose-dependent response 
was observed, with consistently higher proteoglycan content detected on high-dose scaffolds compared to 
low-dose scaffolds. Histological analysis showed that proteoglycans were primarily localized to the scaffold 




5.3.4. Collagen Deposition 
 All scaffold groups also supported deposition of collagen matrix by SDSCs (Figure 5.3). While 
collagen synthesis was on average higher on high-dose TGF-β3 scaffolds, no significant differences were 
found among groups or over time. Histological analysis showed that collagen matrix was primarily localized 
to the scaffold surface where cells were initially seeded. Examination of the collagenous matrix by 
immunohistochemistry showed that both type I and type II collagen were evident on TGF-β3 scaffolds, but 
only type I collagen was evident on control scaffolds.  
 
5.3.5. Comparison of Local vs. Exogenous Delivery 
 Evaluation of media TGF-β3 concentration at 3-4 day intervals showed that during the first four 
days of culture, the high-dose TGF-β3 scaffolds provided a significantly greater amount of growth factor 
than was available after exogenous addition of TGF-β3 to control groups (Figure 5.4). Overall, the rate of 
TGF-β3 consumption, which was calculated as the ratio between theoretical media TGF-β3 concentration 
based on release kinetics and detected media TGF-β3 concentration, was similar between the two groups.  
  The presence of pSMAD 2/3 and pSMAD 1/5/9 were detected surrounding the nuclei of cells 
cultured on high-dose TGF-β3 scaffolds within 24 hours of seeding, whereas no prominent staining was 
observed in control or exogenously stimulated groups (Figure 5.4). 
 
5.4. Discussion 
 In vitro MSC-mediated fibrocartilage formation can be guided by culture on a biomimetic fibrous 
scaffold with exogenous addition of the chondrogenic growth factor TGF-β3. However, targeted growth 
factor delivery and maintenance of effective local concentrations remain challenges for adaptation of this 
strategy for interface regeneration in a clinical setting. To improve delivery efficiency and minimize the risk 
of off-target effects often associated with systemic administration of growth factors, the objective of this 
study was to develop, characterize, and evaluate the bioactivity of a biomimetic nanofiber scaffold system 
that can also provide controlled, localized delivery of TGF-β3. Here, we fabricated TGF-β3-releasing 
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nanofiber meshes that provide sustained growth factor delivery and demonstrated that these scaffolds can 
guide SDSC proliferation and synthesis of fibrocartilage-like matrix in a dose-dependent manner. 
 To effectively guide stem cell-mediated fibrocartilage regeneration, an optimal scaffold should 
provide and maintain an effective local concentration of TGF-β3302. Here, we demonstrate that bioactive 
TGF-β3-releasing nanofiber meshes can be fabricated by electrospinning. These fibers provided 
continuous release of TGF-β3, with an initial burst release within the first 24 hours of in vitro culture, followed 
by slower, sustained release. This release profile is typical of blend electrospun scaffolds303, wherein 
scaffolds are produced by mixing biomolecules directly into the polymer solution prior to electrospinning. 
For scaffolds fabricated using this method, growth factors are mostly localized within the fibers, providing a 
depot of biomolecules that can be slowly released over time299,300,303,304. According to Ritger and Peppas301, 
this release can be modeled as an exponential function of time (Equation 5.1), where a diffusional exponent 
n of 0.45 indicates release by Fickian diffusion and n between 0.45 and 1 indicates non-Fickian mechanisms 
of release. In this study, the diffusional exponent was found to be 0.24 and 0.30 for low- and high-dose 
TGF-β3 scaffolds, respectively. As n is known to depend on the width of the particle size distribution, the 
deviation of the experimental diffusional exponent values from the expected range is likely due to the 
polydispersity of fiber diameters, which range from approximately 300 nm to 700 nm. Based on other 
mechanistic studies of drug release from blend electrospun PCL nanofibers300,304, it can be surmised that 
TGF-β3 release is likely driven by non-Fickian mechanisms. For polymer-protein blend fibers, the initial 
burst release is typically attributed to desorption of growth factor from the fiber surface, while subsequent, 
slower, linear release is driven by gradual erosion of the polymer fiber core303,304. Although release was 
only monitored for the first 14 days in this study, given that PCL is known to exhibit slow degradation on the 
scale of years305,306, it is anticipated that these PCL-based scaffolds will continue to provide sustained 
delivery of encapsulated TGF-β3 for a prolonged period.  
 Scaffold-mediated TGF-β3 delivery was shown to be equally or even more effective than 
exogenous TGF-β3 stimulation in inducing fibrochondrogenic cell response. It was observed that despite 
consuming TGF-β3 at a similar rate, cells cultured on the bioactive TGF-β3-releasing scaffolds exhibited 
more prominent positive staining for phosphorylated SMADs, which are key mediators of TGF-β signaling. 
The TGF-β signaling cascade is initiated by binding of TGF-β to membrane-anchored TGF-β type I and 
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type II receptors. These receptors subsequently phosphorylate downstream effectors (SMAD 2/3 or SMAD 
1/5/9), which can then form complexes with SMAD 4 and translocate into the nucleus307-309. Accumulation 
of SMADs in the nucleus results in activation or repression of downstream target genes via recruitment of 
transcriptional co-activators or co-repressors. In articular cartilage, canonical TGF-β signaling via SMAD 
2/3 is associated with increased proteoglycan synthesis and inhibition of hypertrophy, while activation of 
SMAD 1/5/9 is associated with hypertrophy and mineralization112,310. Recently, SMAD 2/3-mediated 
signaling has been shown to play a similar key role in modulating differentiation potential of progenitor cells 
derived from meniscal fibrocartilage311. 
 SDSC proliferation was enhanced by scaffold-mediated TGF-β3 delivery at early time points. While 
TGF-β has varying effects on proliferation in different cell types, its pro-proliferative effects on MSCs are 
well established312,313. In BMSCs, it has been shown that TGF-β stimulation induces rapid, SMAD 3-
dependent nuclear translocation of β-catenin, a key mediator of the Wnt signaling pathway, which is 
required for stimulation of MSC proliferation312. Moreover, inhibition of activin receptor-like kinase (ALK) 5, 
which is the TGF-β type I receptor responsible for activation of SMAD 2/3, slows down BMSC growth314. 
Robust SMAD 2/3 activation is observed early on in SDSCs cultured on the bioactive scaffolds and may 
play a similar role in mediating the enhanced proliferation observed at early time points. However, after one 
week, no significant additional proliferation was observed in cells cultured on TGF-β3 scaffolds. This is 
consistent with other studies that have similarly shown that following a period of high proliferation, cell 
number in TGF-β1-treated MSC cultures remained relatively unchanged after 7 days291,306,315. 
 Importantly, TGF-β3-releasing scaffolds also supported deposition of fibrocartilage-like matrix by 
SDSCs. Fibrocartilage is uniquely optimized to withstand both tensile and compressive forces and is 
characterized by the presence of both types I and II collagen and proteoglycans in the extracellular 
matrix70,71,96,98. In the present study, while no significant differences in total collagen synthesis were 
observed, the presence of both type I and type II collagen were observed on high-dose TGF-β3 scaffolds. 
This is consistent with previous studies which have demonstrated that TGF-β stimulation increases 
synthesis of type II collagen in chondrocytes316,317, fibrochondrocytes195,311, and MSCs295,318,319 via SMAD 
2/3-mediated signaling. Scaffold-mediated TGF-β3 delivery was also observed to significantly enhance 
synthesis of proteoglycans, which facilitate tissue hydration and swelling pressure, enabling the tissue to 
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withstand compressive forces320. It is well known that TGF-β signaling also enhances proteoglycan 
synthesis by chondrocytes107,317,321, fibrochondrocytes116,322, and MSCs315,318,319.  
 Together, our findings demonstrate that our TGF-β3-releasing nanofiber scaffolds are effective for 
guiding fibrochondrogenic differentiation of SDSCs. While previous work has established that exogenous 
addition of TGF-β3 combined with aligned PCL nanofibers is effective for guiding BMSC-mediated 
formation of a fibrocartilage-like tissue52, the scaffold developed here provides a more clinically-relevant 
design. Other studies have demonstrated that spatiotemporally controlled release of TGF-β3 and 
connective tissue growth factor from PLGA microspheres embedded in 3D-printed PCL microfiber scaffolds 
can guide BMSC-mediated regeneration of meniscal124 and TMJ125 fibrocartilage tissue in vivo, which 
underscores the potential of controlled-release scaffold systems for functional fibrocartilage interface 
regeneration. Interestingly, fibrochondrogenic response was achieved in this study with a much lower 
concentration of TGF-β3 than what has previously been reported in studies of fibrochondrogenesis52,130. 
Most of these studies have simply used chondrogenic media formulations, which typically use 5 – 10 ng/mL 
TGF-β3)248,291,295, and are optimized for formation of hyaline-like cartilage. In contrast, the maximum amount 
of TGF-β3 released from the high-dose scaffold used in this study yields a 50-fold lower concentration. 
Nevertheless, a robust response is observed, which suggests that a lower dose of TGF-β is sufficient to 
induce fibrochondrogenic differentiation of SDSCs. Additionally, SDSCs are known to be more inherently 
chondrogenic than BMSCs51,261,294 (see Chapter 4), which may also contribute to the overall lower growth 
factor dose requirement observed. Future work will focus on elucidating the specific TGF-β3 dose 
concentration and temporal requirements for SDSC-mediated fibrocartilage regeneration, as well as further 
optimization of the scaffold system. Advanced scaffold fabrication methods which allow for further 
modulation of fiber structure and, consequently, release kinetics, will be explored. Preliminary work has 
demonstrated, for example, the potential to generate core-shell fibers by emulsion electrospinning (Figure 
5.5), which may allow for more optimal release. Release kinetics may also be modulated by incorporation 
of materials with different degradation properties. For example, incorporation of PLGA 50:50 in place of 





Here we have developed a bioactive TGF-β3-delivering nanofiber scaffold and demonstrated its 
potential for guiding SDSC-mediated fibrocartilage interface regeneration. Scaffold-mediated TGF-β3 
delivery enhanced cell proliferation and synthesis of fibrocartilaginous matrix in a dose-dependent manner. 
By developing a system that eliminates the need for exogenous or systemic administration of growth factor 
and demonstrating that fibrochondrogenesis requires a lower growth factor dose compared to 
chondrogenesis, this study represents a critical step towards developing a clinical solution for fibrocartilage 
interface regeneration. The functional integration of soft connective tissue with bone is essential for 
musculoskeletal function, and these findings can also be extended to other critical attachments throughout 
the body, including the supraspinatus tendon-to-bone insertion in the rotator cuff, as well as to other 







Figure 5.1. TGF-β3 scaffold characterization. Aligned polymer nanofiber scaffolds with and without TGF-
β3 were fabricated by electrospinning, with no differences in fiber architecture among groups. TGF-β3 
release from PCL-PLGA nanofibers was modulated by changing the concentration of co-incorporated BSA, 
with significantly more bioactive TGF-β3 released from the 10% BSA meshes (n=5; ^p<0.05). TGF-β3 was 
incorporated at two doses, where TGF-β3 concentration in high-dose scaffolds was more than double that 
of low-dose scaffolds, with no significant difference in growth factor incorporation efficiency (n=5). Growth 
factor release (n=5) exhibited an initial burst release for both scaffold groups. Fitting release data to the 
Ritger-Peppas model (Mt/M∞: Fractional release at time t; k: constant; n: diffusional exponent) indicates 
release follows non-Fickian kinetics. (Note: ^p<0.05, between scaffold groups). 
 
  













Control 508.6 ± 192.1 - - - - -
Low-Dose 514.4 ± 186.6 6.0 ± 0.3 46.0% ± 2.5% 2.9% ± 0.6% 0.24 0.9957
High-Dose 495.5 ± 202.2 12.7 ± 0.4^ 41.7% ± 2.5% 6.2% ± 0.4%^ 0.30 0.9915
Scaffold Morphology
TGF-β3 Release

































































































Figure 5.2. SDSC viability and proliferation on TGF-β3 scaffolds. SDSCs seeded on control and TGF-
β3 scaffolds remained viable and proliferated over time, with significantly higher initial cell proliferation on 




































Figure 5.3. SDSC matrix synthesis on TGF-β3 scaffolds. GAG synthesis was enhanced on TGF-β3 
scaffolds compared to on control scaffolds in a dose-dependent manner, with consistently higher GAG 
deposition observed on high-dose scaffolds (n=5; *p<0.05, between consecutive time points; ^p<0.05, 
between groups). Alcian blue staining of day 28 samples showed the most prominent staining for 
proteoglycans on the high-dose scaffolds. Total collagen synthesis was similar among groups throughout 
the 28-day culture period. Picrosirus red staining showed that collagen matrix was primarily localized to the 
scaffold surface where cells were initially seeded. Immunohistochemistry staining revealed the deposition 

















































































Figure 5.4. Comparison of exogenous and scaffold-mediated TGF-β3 delivery. Phosphorylated SMAD 
2/3 and SMAD 1/5/9 were observed surrounding and within the cell nuclei of SDSCs cultured on TGF-β3 
scaffolds within one day of culture (green=pSMAD; blue=cell nuclei). TGF-β3 scaffolds provided higher 
concentration of growth factor at early time points, with greater depletion of media TGF-β3 in scaffold 






















































































Figure 5.5. Fabrication strategies for modulation of release kinetics. Strategies for further modulation 
and optimization of growth factor release kinetics from nanofiber scaffolds include fabrication of core-shell 
structure fibers, as well as altering material selection. Preliminary data indicates it is possible to fabricate 
nanofibers with a core-shell structure, comprising a FITC-BSA core and a PCL-PLGA shell, can be 
fabricated by emulsion electrospinning techniques. These fibers were generated by mixing 25% w/v 5:1 
PCL:PLGA in dichloromethane (shell) mixed with 1% v/v surfactant (Tween-80) and 2.5% v/v 100 mg/mL 
FITC-BSA in water (resulting in a final 1% w/w BSA in emulsion solution). Additionally, release kinetics can 
likely be tuned by incorporation of materials with different degradation properties. Comparison of PCL-
PLGA blends with varying ratios of PLGA 50:50 exhibit drastically different rates of degradation compared 



























NON-MINERALIZED FIBROCARTILAGE: COMPLEX 






 The unique composition of fibrocartilage tissues reflects functional adaptation to complex local 
stresses. Moreover, comparison of the juvenile and adult ACL-to-bone insertion showed that enthesis 
matrix composition and structure continue to change postnatally in response to these mechanical cues 
(Chapter 2). Given the critical role mechanical loading plays in native fibrocartilage development, 
maintenance, and remodeling, it is anticipated that mechanical stimulation can serve as an alternative or 
complementary method for guiding mesenchymal stem cell-mediated insertion fibrocartilage regeneration. 
Thus, this study will focus on the design, optimization, and characterization of a custom bioreactor that 
mimics the complex loads sustained at the ligament-to-bone interface. 
 
6.1.1. Background and Motivation 
 Mechanical stimulation plays a critical role in development, healing, and maintenance of 
musculoskeletal tissues44,46,48,49,108,109,131,142,143,323,324. At the developing enthesis, proliferation of progenitor 
cells is regulated by muscle force142,143, and paralysis of the rotator cuff muscles has been shown to 
severely impact maturation of the supraspinatus tendon-to-bone insertion, resulting in reduced tissue 
volume, decreased fiber organization, and impaired mineralization44,46,48,49. Moreover, physiologic 
compressive loading can also initiate metaplasia of tendinous matrix into fibrocartilage-like tissue144-147. It 
has been reported that fibrocartilage markers such as type II collagen and aggrecan are not expressed in 
the wrap-around regions of fetal and neonatal flexor tendons, but are strongly expressed in mature 
animals325, which suggests that the complex loads sustained these regions induce post-natal fibrocartilage 
formation in vivo. Furthermore, translocation of wrap-around tendons to eliminate compressive loading 
results in decreased size of the fibrocartilage region, looser collagen organization and lower 
glycosaminoglycan content148. These findings underscore the important role physiologic loading plays in 
fibrocartilage formation and maintenance, and suggest that controlled mechanical stimulation may be a 
viable strategy for guiding insertion fibrocartilage regeneration. 
 It is well established that physiologic mechanical loading can direct stem cell differentiation in 
vitro129,130,326-331. In particular, dynamic tensile loading has been extensively explored for ligament and 
tendon tissue engineering and can guide bone marrow-derived MSCs (BMSCs) towards a fibroblastic 
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phenotype even in the absence of additional chemical induction factors327,329,331. However, a more complex 
chemical and/or mechanical environment is needed for fibrocartilage regeneration. A number of studies 
have demonstrated that dynamic tensile strain in the presence of chondrogenic media enhances BMSC 
synthesis of fibrocartilaginous matrix52,129. More recent work has suggested that biomimetic loading 
regimens that impart both tensile and compressive strains may be a promising approach for fibrocartilage 
tissue engineering. Meniscal fibrochondrocyte-seeded scaffolds subject to biomimetic tensile and 
compressive loads replicated matrix content and distribution and mechanical properties of native meniscus 
tissue134,135. Moreover, the simultaneous application of tensile and compressive force using a pulley-like 
system, similar to what is observed at the fibrocartilaginous regions of wrap-around tendons and at the 




 The objective of this study is to design and optimize a bioreactor capable of simultaneously applying 
tensile and compressive loads to mimic the complex mechanical environment found at the native enthesis, 
which includes tensile, shear, and compressive components36,75. Specifically, the bioreactor will make use 
of a pulley-like design which has previously been shown to be effective for inducing fibrochondrogenic 
differentiation of BMSCs in collagen gels130, and adapt this strategy for synovium-derived MSCs (SDSCs) 
cultured on aligned nanofiber scaffolds. It is hypothesized that while scaffold regions suspended between 
the loading rods would be loaded only in tension, regions in contact with the rods would be subject to an 
additional compressive force. It is anticipated that fibrochondrogenic differentiation of SDSCs will be 
observed in these regions that are subject to both tensile and compressive mechanical stimulation. 
 
6.2. Materials and Methods 
6.2.1. Scaffold Fabrication 
 Blends of poly(ε-caprolactone) (PCL) and poly(lactide-co-glycolide) (PLGA) were fabricated via 
electrospinning209. Briefly, PCL (M� w~70,000-90,000; Sigma-Aldrich) and PLGA (85:15, M� w~123.6 kDa; 
Evonik) were dissolved at a weight ratio of 5:1 in a 3:2 solution of dichloromethane (Sigma-Aldrich) and 
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N,N-dimethylformamide (Sigma-Aldrich), resulting in an 18% w/v polymer solution. The polymer solutions 
were vortexed for an hour, loaded into a 5 mL syringe fitted with a 26G stainless steel blunt-tip needle and 
then electrospun at 10-12 kV. To form aligned meshes, the solutions were dispensed at 1 mL/hour via a 
syringe pump (Harvard Apparatus) over a distance of 12 cm onto a grounded rotating (20 m/s) collecting 
mandrel.  
 
6.2.2. Bioreactor Design and Characterization 
 Nanofiber meshes were secured in a custom bioreactor capable of applying both tensile and 
compressive strains. The modular bioreactor consisted of a pulley-like system with two custom 3D-printed 
cylindrical rods (4.76 mm diameter), where one rod remained fixed while the motion of the other was 
controlled via a linear actuator and stepper motor (Figure 6.1). Strips of nanofiber mesh (3.5 x 11.5 cm) 
were formed into a continuous loop (circumference of 10.5 cm) that was suspended by the two rods.  
 To validate the mechanical loading imparted by the system, optical coherence tomography (OCT) 
image data sets were acquired at multiple regions along the scaffold during cyclic loading (3% applied 
tensile strain, 1 Hz) using a commercial spectral domain OCT system (TELESTO, ThorLabs) with axial and 
lateral resolutions of 6.5 µm and 15 µm, respectively, and an imaging range of 2.52 mm, all in air. Images 
were acquired at video rate, with an A-line rate of 28 kHz. Three-dimensional datasets of the scaffold were 
obtained for both the tensile and compressive regions, with clear imaging up to 500 μm in depth. Images 
were reconstructed by processing the raw interferometric data in MATLAB (R2017b, Mathworks) and B-
scans were then filtered to reduce noise using Image-J (NIH).  
 For tensile strain analysis, two physical indentations were made on the surface of the scaffold in 
the tensile region to provide visually trackable markers. The x-positions of both indentations were tracked 
for each image (Python 3.6, Anaconda) and strain was calculated by: 
 𝜀𝜀 = 𝐿𝐿−𝐿𝐿0
𝐿𝐿0
 (Equation 6.1) 
where ε is strain, L is the distance between the two indentations during loading, and Lo is the initial distance 
between the indentations in the unloaded scaffold.  
 Compressive strain was analyzed by measuring changes in scaffold thickness. For each image, 
the top and bottom surfaces of the scaffold were fit to 6th order polynomial regressions, and the thickness 
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at each x-position was calculated as the length of the line segment that is normal to the top surface 
regression and intersects both the top and bottom surface regressions. Compressive strain was calculated 
using Equation 6.1, where L is the thickness of the scaffold during loading, and Lo is the initial thickness of 
the unloaded scaffold. Compressive strain analysis was performed at three positions along the x-axis (2 
mm, 4 mm, and 6 mm). 
 
6.2.3. Cell Isolation and Culture 
 SDSCs were harvested from bovine knee joints following established protocols288. Briefly, neonatal 
(1-7 days old) bovine tibiofemoral joints were obtained from a local abattoir (n=2; Green Village Packing 
Company). Prior to harvest, joints were sterilized by soaking in soapy water for 40 minutes, followed by 
70% ethanol for 20 minutes, and then the surrounding muscle and subcutaneous fascia were removed. 
The joint capsules were then opened aseptically in a sterile environment, and the synovial membrane lining 
the femoral condyles was harvested. The synovial tissue was digested for 4 hours at 37°C in 10% v/v 
collagenase II (Worthington Biochemical) in Minimum Essential Medium Alpha (αMEM; Cellgro-Mediatech) 
supplemented with 10% fetal bovine serum (FBS), 2% P/S, 0.2% Amp-B, and 0.2% G/S. The cell 
suspension was then filtered (30 μm, Spectrum Labs), and the cells were collected by centrifugation and 
then plated at a density of 1.8x103 cells/cm2 on tissue culture plastic. SDSCs were maintained in fully-
supplemented (F/S) αMEM containing 10% FBS, 1% P/S, 1% non-essential amino acids (NEAA; Cellgro-
Mediatech), 0.1% Amp-B, and 0.1% G/S, under humidified conditions at 37°C and 5% carbon dioxide. To 
eliminate contaminating macrophages and obtain a pure population of SDSCs, cells were subsequently 
cultured for 4 passages289 by splitting confluent cells in each passage at a ratio of 1:4. Passage 4 SDSCs 
were used for all subsequent studies. 
 For cell culture, scaffold strips (3.5 x 11.5 cm) were sterilized by ultraviolet radiation (15 
minutes/side) prior to assembly in the bioreactor. Prior to cell seeding, scaffolds were incubated in DMEM 
supplemented with 20% FBS, 2% P/S, 0.2% Amp-B, and 0.2% G/S overnight at 37°C to enhance cell 
attachment. SDSCs were seeded dynamically onto scaffolds using an orbital shaker. Briefly, constructs 
were submerged in a cell suspension of 1.7x105 cells/mL and placed on an orbital shaker, rotating at a rate 
of 50 RPM, for 6 hours in a cell culture incubator. The scaffold loop was rotated every 2 hours to ensure 
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even seeding on both surfaces of the scaffold. Following the seeding process, constructs were cultured 
statically in F/S DMEM for 7 days to allow for cell proliferation and matrix elaboration.  
 After the pre-culture period, constructs were transferred to the bioreactor, and a physiologically 
relevant loading regimen332 consisting of 2% applied strain at 1 Hz was applied for 90 minutes twice daily 
(10.5 hours rest between cycles)331. This loading regimen was selected based on previous work that has 
demonstrated that physiologic to sub-physiologic levels of strain applied at a frequency of 1 Hz are optimal 
for in vitro tissue formation333, and that a rest period between strain cycles is needed to maintain cell 
mechanosensitivity334,335. Constructs cultured in identical bioreactor cartridges without loading served as 
controls. Cell proliferation and matrix production were evaluated after 1, 7, 14 and 21 days of mechanical 
stimulation. At each time point, samples were harvested by cutting the scaffold loops through the middle of 
the tensile regions, yielding 2 portions each with a compressive region centered between tensile regions. 
Samples from the tensile and compressive regions were then isolated using a 6 mm biopsy punch (Integra) 
for subsequent analyses.  
 
6.2.4. Cell Viability and Proliferation  
 At each time point, cell viability (n=2) was assessed by Live/Dead staining (Invitrogen) according 
to the manufacturer’s suggested protocol. Briefly, samples were rinsed with phosphate-buffered saline 
(PBS; Sigma-Aldrich), stained, and then imaged by confocal microscopy (Fluoview FV1000, Olympus) at 
488 nm and 594 nm to assess cell viability and death, respectively. 
 Cell proliferation (n=5) was measured by quantifying the amount of DNA in each sample (Quant-iT 
PicoGreen dsDNA Assay, Invitrogen). Briefly, at each time point, samples were rinsed with PBS and then 
homogenized with 0.1% Triton-X (Sigma-Aldrich). Samples were subjected to 15 seconds of ultrasonication 
at 5W. Fluorescence was measured at 485 nm excitation and 535 nm emission wavelengths (SpectraFluor 
Plus, Tecan). Measured fluorescence intensity was correlated to a DNA standard curve, and a conversion 
factor of 7.7 pg DNA/cell was then used to determine total cell number in each sample. 
6.2.5. Matrix Production 
 Total collagen (n=5) and GAG (n=5) content were quantified using the hydroxyproline assay217 and 
a modified 1,9-dimethylmethylene blue (DMMB) dye-binding assay218,219, respectively. Sample lysates were 
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dehydrated overnight and then subjected to an 18 hour digestion in papain buffer (Sigma-Aldrich) to 
solubilize matrix proteins. For collagen quantification, samples were hydrolyzed in 2N sodium hydroxide 
(Sigma-Aldrich) and subsequently incubated with Chloramine-T solution (Sigma-Aldrich) and Ehrlich’s 
reagent217. Absorbance was measured (SpectraFluor Plus) at 555 nm and collagen content of each sample 
was determined by correlating measured optical density to a collagen standard curve. For GAG 
quantification, samples were mixed with DMMB dye (pH 3.5, Sigma-Aldrich) and absorbance was 
immediately measured (μQuant, Bio-Tek) at both 540 nm and 595 nm. Proteoglycan content was 
determined by correlating measured absorbance to a chondroitin-6-sulfate standard curve. 
 Total collagen (n=2) and proteoglycan (n=2) were also visualized by Picrosirius red and Alcian blue 
staining, respectively, of frozen sections. Samples harvested on day 21 were fixed immediately in 10% 
neutral-buffered formalin (NBF) supplemented with 1% cetylpyridinium chloride (CPC; Sigma-Aldrich) to 
preserve proteoglycans174,220. Following fixation, samples were embedded in 5% poly(vinyl alcohol) (PVA; 
Sigma-Aldrich) and 10 μm sections spanning the entire thickness of the scaffold were obtained using a 
cryostat (Hacker-Bright OTF, Hacker Instruments and Industries). Stained sections were imaged by light 
microscopy (Axiovert 25, Zeiss). 
 Deposition of type I (n=2) and type II collagen (n=2) was evaluated by immunohistochemistry. 
Scaffold sections were incubated overnight at 4°C with antibodies for type I (ab90395, Abcam) or type II 
collagen (ab34712, Abcam), which were diluted 1:100 in serum-free Protein Block (Dako Cytomation) prior 
to use. After a PBS wash, FITC-conjugated secondary antibodies (type I collagen: ab6785, Abcam; type II 
collagen: ab6798, Abcam) diluted 1:200 in PBS were added and samples were incubated for an additional 
hour at room temperature. DAPI (Sigma-Aldrich) was used as a nuclear counterstain. Samples were 
imaged using a confocal microscope with a 495 nm excitation wavelength. 
 
6.2.6. Statistical Analysis 
 Results are presented as mean ± standard deviation. Two-way analysis of variance (ANOVA) was 
performed to determine time-, region, and loading-dependent differences in cell proliferation or matrix 
production. The Tukey-Kramer post-hoc test was used for all pair-wise comparisons (p<0.05). All statistical 





6.3.1. Bioreactor validation 
 To characterize the strains applied by the bioreactor, scaffold deformation during loading was 
tracked via OCT imaging. Tensile strain was analyzed by tracking the change in distance between two 
indentations made on the surface of the scaffold (Figure 6.1). Strains approximated a sinusoidal waveform 
and 17 peak-to-peak cycles were observed over the course of the 19.86 second video recording, 
corresponding to an actual loading frequency of 0.86 Hz. The actual peak tensile strain was 6.65% ± 0.89% 
(n=17).  
 Compressive strain imparted by the rod was assessed by tracking the change in scaffold thickness 
at three different positions along the scaffold (Figure 6.1). Strains at each position also approximated a 
sinusoidal waveform, with 17 peak-to-peak cycles observed in each data set. The greatest average peak 
compressive strain was observed at 4 mm (8.43 ± 1.69%), which was significantly higher than the peak 
compressive strains observed at the other two positions (7.17 ± 1.35% and 6.82 ± 1.36% at 2 mm and 6 
mm, respectively). 
 
6.3.2. Cell Viability and Proliferation 
 After the 7-day static pre-culture period, cells were found on all scaffold regions, though significantly 
more cells were found in the tensile regions compared to the compressive regions for both unloaded and 
loaded groups (Figure 6.2). Cell number in the tensile region of the loaded group decreased after 1 week 
of loading but recovered by day 14. On average, cell number in the compressive regions consistently 
increased over time. Qualitative comparison of cell distribution on the outside and inside surfaces of the 
scaffolds shows similar cell distribution on the outside surface of the scaffold across groups at day 21, but 
suggests that fewer cells were present on the inside surface of the compressive region in the loaded group. 




6.3.3. Collagen Deposition 
 Collagen matrix deposition was observed on all scaffold regions for both loading conditions (Figure 
6.3). While total collagen synthesis was initially higher on the tensile region, by day 21, the highest total 
collagen was found in the compressive regions in both the unloaded and loaded groups, with no differences 
between unloaded and loaded groups. Normalization to cell number showed that cells in the compressive 
regions produced the highest amount of collagen per cell by day 21. Histological analysis showed that 
collagen matrix was found on both surfaces of the scaffold. Examination of the collagenous matrix by 
immunohistochemistry showed that both type I and type II collagen were found on in both the tensile and 
compressive regions of loaded scaffolds. Little positive staining for type I collagen was observed on 
unloaded controls, though the presence of type II collagen was detected in the control compressive region, 
though to a lesser extent compared to the loaded groups.  
 
6.3.4. Proteoglycan Deposition 
Proteoglycan deposition was observed on all scaffold regions for both loading conditions (Figure 
6.3). Total GAG deposition was similar among all groups throughout the most of the 21-day culture period. 
However, normalization to cell number showed that cells in the compressive regions initially produced the 
highest amount of GAG per cell, and, on average, this trend persisted through day 14. Histological analysis 
showed that proteoglycan matrix was found on both surfaces of the scaffold. 
 
6.4. Discussion 
 Complex mechanical loads are known to play a critical role in the formation and maintenance of 
fibrocartilaginous tissues in vivo. The objective of this study was to design a bioreactor that mimics the 
loads generated at the insertions and to investigate the effects of combined tensile and compressive 
stresses on SDSC differentiation. Here we show that tensile and compressive stresses can be 
simultaneously generated in a nanofiber scaffold construct by application of simple cyclic linear motion in a 
bioreactor consisting of a pulley-like design. Moreover, matrix synthesis of SDSCs cultured in the bioreactor 
was modulated by the mechanical environment, where higher per-cell synthesis of collagen and 
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proteoglycans was observed in the compressive regions compared to tensile regions, and robust synthesis 
of types I and II collagen were observed on scaffolds subjected to mechanical loading.   
 The mechanosensitivity of MSCs is well established336, and the effects of biomimetic tensile and 
compressive loading on MSC differentiation have been extensively studied. While uniaxial tensile stress 
leads to fibroblastic differentiation327,329,331, uniaxial compressive stress drives chondrogenic 
differentiation326,328,337. However, the stress field sustained by fibrocartilaginous tissues is much more 
complex, comprising tensile, shear, and compressive components36,47,75. Thus, a custom bioreactor 
capable of imparting multiaxial stresses was developed here. Consisting of a pair of cylindrical rods around 
which a nanofiber scaffold is wrapped, this design is intended to mimic the physiology of wrap-around 
tendons, where compressive force has been shown to drive metaplasia of tendinous matrix into 
fibrocartilage-like tissue146,147. This approach is similar to a bioreactor design previously described by 
Thomopoulos et al.130, though the bioreactor in the present study is intended for use with a nanofibrous 
scaffold, rather than a hydrogel-based scaffold. Nevertheless, based on analysis performed by 
Thomopoulos et al. of their design, it is anticipated that the entire region of contact between the scaffold 
and loading rod is subject to a compressive radial stress and a tensile tangential stress130. Analysis of our 
design via OCT imaging confirmed that both tensile and compressive strains were imparted on the 
nanofiber scaffold. In validation studies, the measured tensile strain rate was approximately double the 
theoretical applied strain rate. Thus, it is expected that cell-seeded constructs loaded with 2% applied strain 
actually experienced closer to 4% tensile strain. However, this strain rate remains well within the range of 
physiological strains expected for ligament and tendon332,338. Compressive strain was evaluated by tracking 
changes in scaffold thickness. As expected, higher compressive strain was observed in regions of scaffold 
in direct contact with the loading rod. 
While a general trend in increasing cell number was observed over time, there were no significant 
differences in cell proliferation in the control groups between consecutive time points. Based on our 
previous observation of SDSC proliferation on aligned nanofiber scaffolds (see Chapters 4 and 5), this 
finding is unsurprising, as cell proliferation was not assessed in this study until after an initial 7-day static 
culture period. For SDSCs seeded on aligned nanofiber scaffolds, rapid cell proliferation is consistently 
observed in the first 7 days after seeding, but then slows dramatically, even with growth factor stimulation. 
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Mechanical loading had no discernible effect on cell proliferation in the compressive region, but was 
associated with an initial decline in cellularity in the tensile region. While some work has shown that MSC 
proliferation can be enhanced by dynamic tensile loading331, others have shown that cyclic loading can also 
cause a decrease in overall MSC number52. This suggests that further optimization of the strain rate and/or 
loading frequency may be needed to enhance cell response.  
Despite the negligible differences in cell proliferation, regional differences in matrix synthesis were 
observed over time, with per-cell collagen and proteoglycan synthesis on the compressive regions following 
opposing trends: While proteoglycan synthesis was elevated on the compressive regions at early time 
points, by day 21 there were no apparent differences in GAG synthesis among groups. In contrast, though 
there were no discernible differences in collagen synthesis at early time points, by day 21, the highest 
collagen deposition was observed on the compressive regions for both loading conditions. This change in 
matrix synthesis suggests the possibility of ongoing cell differentiation and a shift from a more chondrocytic 
phenotype towards a more fibroblastic or fibrochondrocytic phenotype. Interestingly, while loading had no 
significant effect on total collagen and GAG synthesis, the presence of types I and II collagen were observed 
on loaded scaffolds, which, in addition to the presence of proteoglycans, is a hallmark of fibrocartilaginous 
tissue70,71,96,98. Previous work has suggested that TGF-β3 co-stimulation is necessary for BMSC-mediated 
formation of fibrocartilaginous matrix, even in the presence of physiologic multiaxial loading130. The findings 
in the present study suggest that mechanical loading alone may be sufficient to induce fibrochondrogenic 
differentiation of SDSCs. It is possible that given the greater inherent chondrogenic51,261,280 and 
fibrochondrogenic potential of SDSCs (see Chapter 4), additional growth factor stimulation is not needed 
to induce the synthesis of cartilaginous matrix components for these cells.  
 
6.5. Conclusions 
Here we have developed a custom bioreactor that mimics the complex, multiaxial loads that are 
critical for enthesial fibrocartilage formation and maintenance in vivo, and demonstrated its potential for 
guiding SDSC-mediated fibrocartilage interface regeneration. Matrix synthesis of SDSCs cultured in the 
bioreactor was modulated by the mechanical environment, where higher per-cell synthesis of collagen and 
proteoglycans was observed in the compressive regions compared to tensile regions. Moreover, the 
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synthesis of types I and II collagen, which, in addition to proteoglycans are characteristic matrix components 
of fibrocartilage tissue, was observed on scaffolds subjected to mechanical loading in the absence of any 
additional growth factor co-stimulation. This study demonstrates the potential for complex, physiologic 
loading to drive fibrochondrogenic differentiation. It is envisioned that with further optimization of loading 
parameters, this strategy could be implemented to guide or enhance SDSC-mediated fibrocartilage 
interface regeneration. The functional integration of soft connective tissue with bone is essential for 
musculoskeletal function, and this strategy can also be extended to other critical attachments throughout 
the body, including the supraspinatus tendon-to-bone insertion in the rotator cuff, as well as to other 







Figure 6.1. Custom bioreactor for applying combined tensile and compressive strains. The modular 
bioreactor consisted of a pulley-like system with two cylindrical rods around which an aligned polymer 
nanofiber scaffold loop was suspended. One rod remained fixed while the controlled linear motion of the 
other enabled application of cyclic tensile strain (3%, 1Hz). While scaffold regions suspended between the 
rods were loaded only in tension, regions in contact with the rods were subject to an additional compressive 
force. To validate the system, OCT image sets were acquired at multiple regions along the scaffold during 
loading. Tensile strain was analyzed by tracking the x-position of two indentations (blue circles) made on 
the surface of the scaffold in the tensile region. The actual loading frequency was found to be 0.86 Hz with 
an average peak strain of 6.65% ± 0.89% (n=17). Compressive strain was tracked at three positions (x = 2 
mm, 4mm, and 6 mm) by evaluating the change in scaffold thickness over time. The highest compressive 
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Figure 6.2. SDSC viability and proliferation in bioreactor. More cells were initially observed on the 
tensile regions for both the unloaded controls and loaded groups after one week of static pre-culture (n=5; 
*p<0.05, between consecutive time points; #p<0.05 between loading conditions; ̂ p<0.05 between regions). 
On average, cell number in the compressive regions gradually increased over time, while cell numbers in 
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Figure 6.3. SDSC collagen deposition in bioreactor. While total collagen synthesis was initially higher 
on the tensile region, by day 21, the highest total collagen was found in the compressive regions in both 
the unloaded and loaded groups, with no differences between loading conditions (n=5; *p<0.05, between 
consecutive time points; #p<0.05 between loading conditions; ^p<0.05 between regions). Normalization to 
cell number showed that cells in the compressive regions produced the highest amount of collagen per cell 
by day 21. Picrosirus red staining of day 21 samples showed that collagen matrix was found on both 
surfaces of the scaffold. Immunohistochemistry staining revealed the deposition of both type I and II 
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Figure 6.4. SDSC proteoglycan deposition in bioreactor. Total glycosaminoglycan (GAG) deposition 
was similar among all groups throughout the 21-day culture period (n=5; *p<0.05, between consecutive 
time points; #p<0.05 between loading conditions; ̂ p<0.05 between regions). However, normalization to cell 
number showed that cells in the compressive regions initially produced the highest amount of GAG per cell, 
and this trend persisted through day 14. Alcian blue staining of day 21 samples showed that proteoglycan 
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MINERALIZED FIBROCARTILAGE: COMBINED EFFECTS OF 






 The results from the previous chapters establish that SDSC-mediated fibrocartilage formation can 
be driven by both chemical (Chapter 5) and mechanical (Chapter 6) cues. However, as the ACL-to-bone 
insertion consists of both non-mineralized and mineralized tissue regions (Chapter 2), a scaffold system for 
fibrocartilage interface regeneration must also support formation and maintenance of mineralized 
fibrocartilage tissue. Thus, this study will focus on optimizing culture conditions for guiding SDSC-mediated 
formation of mineralized fibrocartilage. 
 
7.1.1. Background and Motivation 
 The fibrocartilaginous interface is subdivided into non-mineralized and mineralized regions. While 
the non-mineralized region is comprised of cells that exhibit a rounded, chondrocyte-like morphology70,71, 
the cells of the mineralized fibrocartilage more closely resemble hypertrophic chondrocytes and are 
surrounded by a type X collagen and aggrecan-containing pericellular matrix37,38,72. Mineral content 
increases exponentially between the non-mineralized and mineralized regions76,176 (see Chapter 2), and 
these compositional differences contribute to significant functional differences between the non-mineralized 
and mineralized fibrocartilage regions. Microcompression analysis has shown that the compressive elastic 
modulus of the mineralized fibrocartilage is twice as high as that of the non-mineralized region26. Moreover, 
biomechanical models suggest that the increase in mineral accumulation within collagen fibers has a 
toughening effect at the molecular level77 and, along with decreased alignment of these partially mineralized 
fibers across the insertion27,37,76,176, account for the transitional mechanical properties across the interface27. 
Thus, the mineralized fibrocartilage at the enthesis plays a critical role in helping to mediate load transfer 
between soft tissue and bone and minimizing the formation of stress concentrations21,22,27,78. The graded 
transition in mechanical properties across the fibrocartilage regions serves to protect soft tissue from 
contact deformation and damage25,79,80. Thus, stem cell-mediated formation of mineralized fibrocartilage is 
also critical for functional enthesis regeneration and ligament repair. 
 Mesenchymal stem cell-mediated formation of mineralized tissue can be guided by mineral-
containing scaffolds. In particular, hydroxyapatite (HA), which is the primary mineral in mineralized 
fibrocartilage175 and bone231, has previously been incorporated into a variety of polymeric matrices for 
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calcified cartilage232-234 and bone212,235-240 regeneration applications. There is evidence that HA-containing 
scaffolds can induce chondrogenic differentiation of MSCs285, promote chondrocyte hypertrophy232, and 
enhance matrix deposition and mineralization potential of hypertrophic chondrocytes233,284. Moreover, the 
results from Chapter 3 of this thesis indicate that HA-containing nanofibers support phenotype maintenance 
and enhance matrix deposition by insertion fibrochondrocytes. Thus, it is anticipated that incorporation of 
HA alongside fibrochondrogenic cues can guide SDSC-mediated formation of mineralized fibrocartilage. 
 
7.1.2. Objectives 
 The objective of this study is to optimize scaffold mineral content and culture conditions for SDSC-
mediated mineralized fibrocartilage formation. The results from Chapters 4 and 5 show that exogenous 
administration of TGF-β3 in combination with a nanofibrous scaffold is sufficient to guide fibrochondrogenic 
differentiation of SDSCs. Additionally, evaluation of MSC behavior on polymer-HA nanofiber scaffolds in 
Chapter 4 suggest that these mineral-containing scaffolds can modulate SDSC matrix mineralization 
potential. Thus, this study will focus on evaluating the combined effects of scaffold HA content and 
exogenous TGF-β3 on SDSC matrix synthesis. It is anticipated that SDSCs cultured on polymer-HA 
scaffolds in the presence of TGF-β3 will synthesize mineralized fibrocartilaginous matrix, comprising types 
I, II, and X collagen as well as proteoglycans, in a dose-dependent manner. 
 
7.2. Materials and Methods 
7.2.1. Scaffold Fabrication and Characterization 
 Blends of poly(ε-caprolactone) (PCL) and poly(lactide-co-glycolide) (PLGA) were fabricated via 
electrospinning209. Briefly, PCL (M� w~70,000-90,000; Sigma-Aldrich) and PLGA (85:15, M� w~123.6 kDa; 
Evonik) were dissolved at a weight ratio of 5:1 in a 3:2 solution of dichloromethane (Sigma-Aldrich) and 
N,N-dimethylformamide (Sigma-Aldrich), resulting in an 18% w/v polymer solution. In addition, blends 
containing hydroxyapatite (HA) were fabricated by adding HA (100-150 nm; Nanocerox, up to 35% w/w) to 
the PCL-PLGA mixture. The polymer and polymer-HA solutions were vortexed for an hour, loaded into a 5 
mL syringe fitted with a stainless steel blunt-tip needle (26G for PCL-PLGA, 23G for PCL-PLGA/HA) and 
then electrospun at 10-12 kV for PCL-PLGA or 13-15 kV for PCL-PLGA/HA. To form aligned meshes, the 
110 
 
solutions were dispensed at 1 mL/hour via a syringe pump (Harvard Apparatus) over a distance of 12 cm 
onto a grounded rotating (20 m/s) collecting mandrel.  
 Fiber morphology of as-fabricated meshes evaluated using secondary scanning electron 
microscopy (SEM; 5 kV, Hitachi 4700, Hitachi Ltd.). Samples were pre-coated with gold-palladium to reduce 
charging effects (Sputter Coater 108 Auto, Cressington Scientific).  
 Polymer blend composition (n=3) was ascertained via Fourier transform infrared spectroscopy 
(FTIR; Frontier, Perkin Elmer). Briefly, spectra were collected in attenuated total reflectance mode (ATR, 
200 scans, 4 cm−1 resolution) and analyzed for characteristic phosphate peaks (564 cm-1, 603 cm-1, and 
1031 cm-1212-214). Mesh mineral content (n=3) was quantified by thermogravimetric analysis (TGA, Q50, TA 
Instruments). Briefly, samples were loaded into a calibrated platinum pan and then heated to 100°C, 
followed by a 20°C/minute ramp to 700°C. As the degradation temperature of PCL and PLGA is 
approximately 400°C, the residual weight at the end of the heating cycle corresponds to the weight percent 
of mineral in the fibrous meshes. 
 
7.2.2. Cell Isolation and Culture 
 SDSCs were harvested from bovine knee joints following established protocols288. Briefly, neonatal 
(1-7 days old) bovine tibiofemoral joints were obtained from a local abattoir (n=2; Green Village Packing 
Company). Prior to harvest, joints were sterilized by soaking in soapy water for 40 minutes, followed by 
70% ethanol for 20 minutes, and then the surrounding muscle and subcutaneous fascia were removed. 
The joint capsules were then opened aseptically in a sterile environment, and the synovial membrane lining 
the femoral condyles was harvested. The synovial tissue was digested for 4 hours at 37°C in 10% v/v 
collagenase II (Worthington Biochemical) in Minimum Essential Medium Alpha (αMEM; Cellgro-Mediatech) 
supplemented with 10% fetal bovine serum (FBS), 2% P/S, 0.2% Amp-B, and 0.2% G/S. The cell 
suspension was then filtered (30 μm, Spectrum Labs), and the cells were collected by centrifugation and 
then plated at a density of 1.8x103 cells/cm2 on tissue culture plastic. SDSCs were maintained in fully-
supplemented (F/S) αMEM containing 10% FBS, 1% P/S, 1% non-essential amino acids (NEAA; Cellgro-
Mediatech), 0.1% Amp-B, and 0.1% G/S, under humidified conditions at 37°C and 5% carbon dioxide. To 
eliminate contaminating macrophages and obtain a pure population of SDSCs, cells were subsequently 
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cultured for 4 passages289 by splitting confluent cells in each passage at a ratio of 1:4. Passage 4 SDSCs 
were used for all subsequent studies. 
 Scaffold discs (1 cm diameter) were prepared and then sterilized by ultraviolet radiation (15 
minutes/side). Prior to cell seeding, scaffolds were incubated in DMEM supplemented with 20% FBS, 2% 
P/S, 0.2% Amp-B, and 0.2% G/S overnight at 37°C to enhance cell attachment. SDSCs were seeded onto 
PCL-PLGA, PCL-PLGA/15% HA, or PCL-PLGA/35% HA meshes at a density of 3x104 cells/cm2, and were 
cultured in F/S DMEM, with media exchange occurring every three days. For TGF-β3-treated groups, the 
cell culture media was supplemented with 200 pg/mL TGF-β3 at every feeding. Cell viability, proliferation, 
mineralization potential, and matrix deposition on the meshes were evaluated at 1, 7, 14, and 28 days.  
 
7.2.3. Cell Viability and Proliferation  
 At each time point, cell viability (n=3) was assessed by Live/Dead staining (Invitrogen) according 
to the manufacturer’s suggested protocol. Briefly, samples were rinsed with phosphate-buffered saline 
(PBS; Sigma-Aldrich), stained, and then imaged by confocal microscopy (Fluoview FV1000, Olympus) at 
488 nm and 594 nm to assess cell viability and death, respectively. 
 Cell proliferation (n=5) was measured by quantifying the amount of DNA in each sample (Quant-iT 
PicoGreen dsDNA Assay, Invitrogen). Briefly, at each time point, samples were rinsed with PBS and then 
homogenized with 0.1% Triton-X (Sigma-Aldrich). Samples were subjected to 15 seconds of ultrasonication 
at 5W. Fluorescence was measured at 485 nm excitation and 535 nm emission wavelengths (SpectraFluor 
Plus, Tecan). Measured fluorescence intensity was correlated to a DNA standard curve, and a conversion 
factor of 7.7 pg DNA/cell was then used to determine total cell number in each sample. 
 
7.2.4. Matrix Production 
 Total collagen (n=5) and GAG (n=5) content were quantified using the hydroxyproline assay217 and 
a modified 1,9-dimethylmethylene blue (DMMB) dye-binding assay218,219, respectively. Sample lysates were 
dehydrated overnight and then subjected to an 18 hour digestion in papain buffer (Sigma-Aldrich) to 
solubilize matrix proteins. For collagen quantification, samples were hydrolyzed in 2N sodium hydroxide 
(Sigma-Aldrich) and subsequently incubated with Chloramine-T solution (Sigma-Aldrich) and Ehrlich’s 
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reagent217. Absorbance was measured (SpectraFluor Plus) at 555 nm and collagen content of each sample 
was determined by correlating measured optical density to a collagen standard curve. For GAG 
quantification, samples were mixed with DMMB dye (pH 3.5, Sigma-Aldrich) and absorbance was 
immediately measured (μQuant, Bio-Tek) at both 540 nm and 595 nm. Proteoglycan content was 
determined by correlating measured absorbance to a chondroitin-6-sulfate standard curve. 
 Total collagen (n=2) and proteoglycan (n=2) were also visualized by Picrosirius red and Alcian blue 
staining, respectively, of frozen sections. Samples harvested on day 21 were fixed immediately in 10% 
neutral-buffered formalin (NBF) supplemented with 1% cetylpyridinium chloride (CPC; Sigma-Aldrich) to 
preserve proteoglycans174,220. Following fixation, samples were embedded in 5% poly(vinyl alcohol) (PVA; 
Sigma-Aldrich) and 10 μm sections spanning the entire thickness of the scaffold were obtained using a 
cryostat (Hacker-Bright OTF, Hacker Instruments and Industries). Stained sections were imaged by light 
microscopy (Axiovert 25, Zeiss). 
 
7.2.5. Matrix Mineralization 
 Matrix mineralization potential (n=5) was assessed by quantifying cell alkaline phosphatase (ALP) 
activity, an enzyme associated with matrix mineralization. ALP activity was measured based on its ability 
to dephosphorylate p-nitrophenyl phosphate (pNP-PO4) to p-nitrophenyl (pNP). The same lysate used for 
DNA quantification was mixed at a 1:3 v/v ratio with 10 nM pNP-PO4 (Sigma-Aldrich), and then incubated 
at 37°C for 30 minutes. Absorbance was measured (SpectraFluor Plus) at 405 nm and ALP activity level in 
each sample was determined by correlating measured optical density to a pNP standard curve. 
Mineral distribution (n=2) was visualized by von Kossa staining, in which frozen sections samples 
were incubated in a 5% silver nitrate solution (Fisher Scientific) in the presence of ultraviolet light. Stained 
sections were imaged by light microscopy (Axiovert 25, Zeiss). 
 
7.2.6. Statistical Analysis 
 Results are presented as mean ± standard deviation. Two-way analysis of variance (ANOVA) was 
performed to determine time- and culture condition-dependent differences in cell proliferation, matrix 
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production, and matrix mineralization potential. The Tukey-Kramer post-hoc test was used for all pair-wise 
comparisons (p<0.05). All statistical analyses were performed using JMP IN (4.0.4, SAS Institute). 
 
7.3. Results 
7.3.1. Cell Viability and Proliferation 
 Cells remained viable on all scaffold groups (0% HA, 15% HA, and 35% HA) and proliferated 
significantly over time (Figure 7.1). Proliferation was significantly enhanced on HA scaffolds, with 
significantly higher cell number on 15% HA and 35% HA scaffolds compared to on control scaffolds from 
day 7 onward. Cell proliferation on HA scaffolds was further enhanced by exogenous addition of TGF-β3, 
with the highest overall cell number observed on 35% HA scaffolds cultured in the presence of TGF-β3. 
 
7.3.2. Collagen Deposition 
 All scaffold groups also supported deposition of collagen matrix by SDSCs (Figure 7.2). Total 
collagen synthesis was similar among groups up through day 14. The highest collagen synthesis on day 
28 was observed on the 35% HA scaffold groups, with no difference between untreated and TGF-β3-treated 
groups Exogenous TGF-β3 treatment also significantly increased collagen deposition on control scaffolds. 
Histological analysis showed that collagen matrix was primarily localized to the scaffold surface where cells 
were initially seeded. 
 
7.3.3. Proteoglycan Deposition 
 All scaffold groups supported deposition of proteoglycans by SDSCs, with increasing GAG 
synthesis over time (Figure 7.3). GAG synthesis was significantly enhanced on HA scaffolds in a dose-
dependent manner, with consistently higher proteoglycan content detected on 35% scaffolds compared to 
control scaffolds after day 7. Protoeglycan deposition on HA scaffolds was further enhanced by exogenous 
addition of TGF-β3, with the highest GAG deposition observed on 35% HA scaffolds cultured in the 
presence of TGF-β3. Histological analysis showed that proteoglycans were primarily localized to the 




7.3.4. Matrix Mineralization 
 Matrix mineralization potential, as assessed by ALP activity, was initially similar on control and 15% 
HA scaffolds, and  was reduced on  35% HA scaffolds (Figure 7.4). The addition of TGF-β3 reduced ALP 
activity on control scaffolds but enhanced matrix mineralization potential on 35% HA scaffolds at day 1. By 
day 7 there were no significant differences in ALP activity between scaffold groups. Histological analysis 
showed similar mineralization on the scaffold surface in all groups, though more prominent mineral nodules 
were observed in both 35% HA scaffold groups compared to corresponding control and 15% HA scaffolds. 
 
7.4. Discussion 
 The mineralized fibrocartilage region of the ACL-to-bone insertion plays a critical functional role as 
the graded transition in mechanical properties across the interface mediate load transfer between soft tissue 
and bone and minimizing the formation of stress concentrations. The objective of this study was to optimize 
culture conditions for SDSC-mediated mineralized fibrocartilage formation by evaluating the combined 
effects of scaffold mineral content and exogenous TGF-β3 stimulation. It was observed that HA and TGF-
β3 had a synergistic effect on increasing cell proliferation and matrix synthesis. 
 SDSC proliferation was enhanced on polymer-HA nanofiber scaffolds in a dose-dependent 
manner, similar to what has previously been observed with other MSCs242,243, as well as with insertion 
fibrochondrocytes (see Chapter 3), chondrocytes232, and osteoblasts236,240,241. It has been proposed that 
nano-HA particles incorporated in the underlying scaffold may promote cell growth by increasing surface 
area-to-volume ratio and enhancing protein adsorption and local serum concentrations around the 
cells241,242. Cell proliferation was further enhanced by the addition of TGF-β3 to the culture media. TGF-β 
signaling is well known to exert pro-proliferative effects in MSCs, where it induces rapid nuclear 
translocation of β-catenin, a key mediator of the Wnt signaling pathway, which is required for stimulation of 
MSC proliferation312. However, similar to what has been observed in our previous studies (see Chapters 4-
6), no significant additional proliferation was observed after the first week of culture. Other studies have 
also shown that cell number in TGF-β-treated MSC cultures remained relatively unchanged after an initial 
7-day period of rapid proliferation291,306,315. 
115 
 
 Despite the lack of change in cellularity over time, increased matrix deposition, especially of 
proteoglycans, was observed over the course of the study. Moreover, both collagen and GAG synthesis 
were enhanced on HA scaffolds in a dose-dependent manner. In addition to potentially promoting matrix 
synthesis by increasing local concentrations of biomolecules241,242, nano-HA in the underlying scaffold may 
also enhance retention of synthesized matrix proteins, as collagen and GAG have been shown to 
preferentially adsorb to nano-HA339-341. Matrix synthesis was further enhanced by the addition of TGF-β3 to 
the culture media. This is consistent with previous studies which have demonstrated that TGF-β stimulation 
increases synthesis of collagen and proteoglycans in MSCs295,315,318,319, fibrochondrocytes116,195,311,322, and 
chondrocytes107,316,317,321. These effects may also have been further amplified by adsorption of TGF-β3 to 
HA particles, which can act as carrier particles for controlled protein release342. This would allow for higher 
local concentrations of TGF-β3, leading in turn to enhanced proliferation and biosynthesis, similar to what 
has previously been observed with our TGF-β3-encapsulated nanofibers (see Chapter 5).  
 In contrast to the trends observed in cell proliferation and matrix synthesis, matrix mineralization 
potential, as evaluated by ALP activity, was initially lowest on 35% HA scaffolds in the untreated groups. 
Similar behavior, where ALP activity or expression is reduced in the presence of calcium phosphate, has 
also been reported for fibrochondrocytes (see Chapter 3) and chondrocytes244, but both our group (see 
Chapter 4) and others296,297 have shown that ALP activity of BMSCs is typically enhanced by culture on 
polymer-HA nanofibers. Interestingly, the addition of TGF-β3 enhanced mineralization potential on 35% HA 
scaffold groups, resulting in comparable ALP activity to the untreated control group. These findings suggest 
that TGF-β3 and HA potentially have opposing effects on hypertrophic differentiation and matrix 
mineralization. Moreover, previous work has demonstrated that TGF-β plays a role in both inhibition and 
induction of hypertrophy in chondrocytes110,291,343,344, which suggests that the specific timing of cell exposure 
to TGF-β3 and HA may need to be further optimized. 
 Nonetheless, the findings from this study suggest that co-administration of TGF-β3 and 
hydroxyapatite has the potential to enhance fibrocartilage regeneration by promoting cell proliferation and 
collagen and proteoglycan synthesis. Recently, a number of groups have demonstrated that localized co-
administration of calcium phosphate and TGF-β has the potential to improve tendon-to-bone healing in 
vivo141,345. In a rat model of rotator cuff repair, Kovacevic et al. showed that while an injectable calcium 
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phosphate matrix alone enhanced formation of fibrocartilage and new bone at the tendon-to-bone junction, 
the addition of TGF-β3 led to greater expression of type I collagen and significantly improved functional 
outcomes141. You et al. similarly showed that local delivery of TGF-β1 encapsulated in HA microspheres to 
the tendon-to-bone junction resulted in improved fibrocartilage formation, collagen organization, and 
mechanical strength following rotator cuff repair345. 
 
7.5. Conclusions 
 In summary, the findings from this study demonstrate that a polymer-HA nanofiber scaffold used in 
combination with TGF-β3 stimulation has the potential to guide SDSC-mediated mineralized fibrocartilage 
formation. In particular, scaffold mineral content and exogenous TGF-β3 stimulation were observed to have 
a positive synergistic effect on SDSC proliferation and relevant matrix synthesis. These results represent a 
critical step towards developing a solution for functional fibrocartilage interface regeneration. Moreover, 
these findings can be extended to other critical attachments throughout the body, including the 







Figure 7.1. SDSC viability and proliferation on HA scaffolds. SDSCs seeded on control (0% HA), 15% 
HA, and 35% HA scaffolds remained viable and proliferated over time, with significantly higher cell 
proliferation on HA scaffolds by day 7 (n=5; *p<0.05, between consecutive time points; #p<0.05 between 
scaffold groups; ^p<0.05 between treatment groups). Cell proliferation on HA scaffolds was further 
enhanced by exogenous addition of TGF-β3, with the highest overall cell number observed on 35% HA 
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Figure 7.2. SDSC collagen deposition on HA scaffolds. Total collagen synthesis was similar among 
groups up through day 14. The highest collagen synthesis on day 28 was observed on the 35% HA scaffold 
groups, with no difference between untreated and TGF-β3-treated groups (n=5; *p<0.05, between 
consecutive time points; #p<0.05 between scaffold groups; ^p<0.05 between treatment groups). 
Exogenous TGF-β3 treatment resulted in significantly higher collagen deposition on control scaffolds. 
Picrosirus red staining of day 28 samples showed that collagen matrix was primarily localized to the scaffold 
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Figure 7.3. SDSC proteoglycan deposition on HA scaffolds. GAG synthesis was enhanced on HA 
scaffolds compared to on control scaffolds in a dose-dependent manner (n=5; *p<0.05, between 
consecutive time points; #p<0.05 between scaffold groups; ^p<0.05 between treatment groups). 
Proteoglycan deposition on HA scaffolds was further enhanced by exogenous addition of TGF-β3, with the 
highest overall GAG deposition observed on 35% HA scaffolds cultured in the presence of TGF-β3. Alcian 
blue staining of day 28 samples showed that proteoglycans were primarily localized to the scaffold surface 
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Figure 7.4. SDSC matrix mineralization on HA scaffolds. Matrix mineralization potential, as assessed 
by alkaline phosphatase (ALP) activity, was initially similar on control and 15% HA scaffolds, and  was 
reduced on  35% HA scaffolds (n=5; *p<0.05, between consecutive time points; #p<0.05 between scaffold 
groups; ^p<0.05 between treatment groups). The addition of TGF-β3 reduced ALP activity on control 
scaffolds but enhanced matrix mineralization potential on 35% HA scaffolds. Von Kossa staining of day 28 
samples showed more prominent mineral nodules in both 35% HA scaffold groups compared to 
corresponding control and 15% HA scaffolds. Immunohistochemistry staining revealed the deposition of 
type X collagen (green=type X collagen; blue=cell nuclei) on all groups. 
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 The objective of this thesis was to develop a comprehensive tissue engineering approach for 
regeneration of the fibrocartilaginous ACL-to-bone interface. Inspired by the native development and 
maturation process of the ligament-to-bone insertion, it was hypothesized that controlled chemical and/or 
mechanical stimuli can guide stem cell-mediated regeneration of insertion fibrocartilage. Thus, the studies 
detailed in this thesis consisted of: 1) identification of key scaffold design parameters, 2) identification of an 
optimal cell source for fibrocartilage tissue engineering, and optimization of chemical and mechanical stimuli 
for both 3) non-mineralized and 4) mineralized fibrocartilage formation. Thus, studies were designed to 
address four specific aims. 
 In order to obtain design parameters for a biomimetic interface scaffold, as well as to establish 
benchmark criteria for subsequent evaluation of the system, Aim 1 focused on characterization of the 
mature native ACL-to-bone interface. The matrix composition and organization across the insertion were 
characterized using Fourier Transform infrared spectroscopy imaging (FTIRI), which allows for quantitative 
spatial mapping of physicochemical tissue properties39,40, and optical coherence tomography (OCT), which 
provides depth resolved, three-dimensional imaging of biological tissue41 (Chapter 2). It was shown that a 
well-aligned fiber structure is maintained over the course of postnatal development. Thus, the ex vivo 
behavior of native insertion fibrochondrocytes on nanofiber scaffolds that mimic the native extracellular 
matrix structure was also assessed to establish cell-level benchmarks for evaluation of stem cell-mediated 
fibrocartilage regeneration (Chapter 3).  
 The enthesis originates from a unique subset of mesenchymal progenitor cells42-44 that transiently 
expresses transforming growth factor (TGF)-β3 early during fetal development38. The fibrocartilaginous 
insertion develops postnatally in response to normal physiologic loading47-49 to form a well-organized 
transition between soft tissue and bone. Guided by the process by which the native enthesis develops, 
subsequent studies focused on optimization of various aspects of a tissue engineering system for stem cell-
mediated fibrocartilage formation. As fibrochondrocytes are mesenchymal in origin50, Aim 2 focused on 
first identifying an appropriate source of MSCs for fibrocartilage interface tissue engineering. Bone marrow- 
(BMSCs) and synovium-derived MSCs (SDSCs) are both clinically and anatomically relevant MSC 
populations with favorable chondrogenic potential51. BMSC and SDSC response to fibrochondrogenic 
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culture conditions, including exogenous TGF-β3 stimulation combined with an aligned nanofiber 
substrate52, as well as scaffold-provided HA for mineralized tissue formation, were systematically compared 
(Chapter 4).  
 Aim 3 focused on strategies for guiding MSC-mediated fibrocartilage formation. Specifically, a 
controlled-release nanofiber scaffold system that can provide localized delivery of TGF-β3 for chemical 
induction of fibrochondrogenesis was developed and evaluated (Chapter 5). Additionally, it was 
hypothesized that mechanical stimulation can also facilitate fibrochondrogenic differentiation of MSCs as it 
has long been known that physiologic loading plays a key role in postnatal remodeling and maturation of 
the native enthesis47-49. Thus, we developed a bioreactor capable of mimicking the complex loads sustained 
at the ligament-to-bone interface36  and evaluated its effects on MSC response (Chapter 6).  
 Finally, a functional scaffold for integrative ACL repair must support spatial tissue heterogeneity, 
including the establishment of both non-mineralized and mineralized tissue regions. Thus, Aim 4 explored 
the combined effects of TGF-β3 and HA on MSC-mediated formation of mineralized fibrocartilage (Chapter 
7).  
 In order to enable fibrocartilage regeneration for integrative and functional ACL reconstruction, the 
studies outlined in this thesis established fibrocartilage scaffold design and evaluation criteria though 
characterization of the native enthesis, and systematically explore and evaluate cell sources and chemical 
and mechanical stimuli for fibrocartilage tissue engineering. The major findings from each Aim are briefly 
highlighted below.  
 
8.1.1. ACL-to-Bone Interface Characterization 
 Aim 1 focused on characterization of the native ACL-to-bone interface in order to obtain design 
parameters for a biomimetic interface scaffold, as well as to establish benchmark criteria for subsequent 
evaluation of the system. In Chapter 2, matrix content, distribution, and organization across the adult ACL-
to-bone interface were quantitatively characterized. Dense collagenous matrix was found to span across 
all three regions of the interface, while proteoglycans were localized to the fibrocartilage regions. 
Additionally, an exponential increase in mineral content was observed between non-mineralized and 
mineralized fibrocartilage regions. Comparison to the neonatal interface revealed that the aligned collagen 
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matrix structure and distinctive mineral distribution pattern across the insertion are highly conserved over 
time and should therefore be pre-established as part of the scaffold design. An ideal scaffold for 
fibrocartilage interface regeneration should therefore consist of highly aligned nano-scale fibers and must 
be able to support the formation of both non-mineralized and mineralized fibrocartilage tissues. The 
exponential increase in mineral content across the insertion can be approximated as a step-wise change 
and can be recapitulated by a stratified design. Other matrix parameters, such as relative collagen and 
proteoglycan content, changed substantially over time, underscoring the importance of physiologic loading 
in enthesis maturation and suggesting that mechanical stimulation can also be harnessed to guide tissue 
regeneration. Moreover, the compositional and structural similarities between the mature femoral and tibial 
entheses suggest that a single scaffold design can be effectively used for regeneration of either or both 
insertions.  
 Chapter 3 focused on characterizing the ex vivo behavior of cells from insertion fibrocartilage, 
especially when cultured on biomimetic, aligned nanofiber scaffolds. As the native enthesis consists of both 
non-mineralized and mineralized regions, fibrochondrocyte response on scaffolds both with and without 
nano-HA was assessed. The findings from this study showed that aligned PCL-PLGA and PCL-PLGA/HA 
composite nanofiber scaffolds support insertion fibrochondrocyte proliferation and maintenance of their 
phenotype, as characterized by their continued synthesis of both types I and II collagen and proteoglycans, 
in in vitro culture. Additionally, these cells were shown to be responsive to changes in their extracellular 
environment, as evidenced by the differential response to scaffolds with and without hydroxyapatite. In 
addition to enhancing current understanding of the fibrochondrocytes found at soft tissue-to-bone interfaces 
and the role they play in matrix synthesis and maintenance, these findings also established benchmark 
guidelines for evaluation of interface tissue engineering efforts. Thus, based on these results, an ideal 
system for fibrocartilage regeneration should also support organized, cell-mediated deposition of both types 
I and II collagen as well as proteoglycans.  
 
8.1.2. Cell Source for Fibrocartilage interface Regeneration 
 The focus of Aim 2 was to identify an ideal cell source for fibrocartilage interface regeneration. Due 
to low cell yield, de-differentiation during ex vivo expansion, and donor site morbidity, mature primary cells 
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are often not a practical cell source for use in clinical applications. Thus, in Chapter 4, the response of 
MSCs to fibrochondrogenic culture conditions was systematically evaluated. Specifically, the behavior of 
bone marrow- and synovium-derived MSCs in monolayer culture, and on nanofiber scaffolds with and 
without HA or exogenous TGF-β3 were compared. Overall, SDSCs exhibited higher proliferation and 
baseline synthesis of cartilaginous matrix, as well as greater sensitivity to TGF-β3 stimulation compared to 
BMSCs. Moreover, the nanofibrous substrate and addition of TGF-β3 synergistically increased SDSC 
proliferation and relevant matrix synthesis. While BMSCs exhibited higher ALP activity overall, SDSCs 
demonstrated the potential for mineralization in the presence of osteogenic media, which suggests that 
these cells would be capable of synthesizing mineralized fibrocartilaginous tissue under optimized 
conditions. Additionally, the greater proliferative capacity of SDSCs makes these cells an advantageous 
choice for clinical applications. Based on the findings from this chapter, SDSCs were selected as the cell 
source for all subsequent studies in this thesis. 
 
8.1.3. Strategies for Non-Mineralized Fibrocartilage Regeneration 
Aim 3 focused on optimization of strategies for SDSC-mediated regeneration of the non-
mineralized region of fibrocartilage interface. The results from Chapter 4 demonstrate that a nanofibrous 
substrate combined with exogenous delivery of TGF-β3 can guide fibrochondrogenic differentiation of 
SDSCs. To adapt this strategy for clinical translation, Chapter 5 focused on the fabrication and optimization 
of a controlled-release nanofiber scaffold system that can provide localized delivery of TGF-β3 for SDSC-
mediated fibrocartilage interface regeneration. TGF-β3-releasing nanofiber scaffolds were fabricated by 
electrospinning and were shown to provide sustained growth factor delivery. Moreover, scaffold-mediated 
TGF-β3 delivery enhanced cell proliferation and synthesis of fibrocartilaginous matrix, which consisted of 
both type I and II collagen as well as proteoglycans, in a dose-dependent manner. Interestingly, robust 
fibrochondrogenic response was achieved in this study with a much lower concentration of TGF-β3 than 
what has previously been reported in studies that relied on exogenous administration of growth factor. By 
eliminating the need for exogenous or systemic administration of growth factor, and demonstrating that 
fibrochondrogenesis can be achieved with a much lower dose of TGF-β3, this scaffold design represents a 
critical step towards developing a clinical solution for fibrocartilage interface regeneration.  
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 As mechanical loading is known to also play a critical role in enthesis development, it was 
hypothesized that mechanical loading can serve as an alternative or complementary method for guiding 
SDSC-mediated insertion fibrocartilage regeneration. Thus, Chapter 6 focused on the design, optimization, 
and characterization of a custom bioreactor that mimics the complex loads sustained at the ligament-to-
bone interface. The bioreactor consisted of a pulley-like system with two cylindrical rods, around which a 
nanofiber scaffold loop was suspended. It was shown that tensile and compressive stresses can be 
simultaneously generated in the scaffold construct by application of simple cyclic linear motion. Moreover, 
matrix synthesis of SDSCs cultured in the bioreactor was modulated by the mechanical environment, where 
higher per-cell synthesis of collagen and proteoglycans was observed in the compressive regions compared 
to tensile regions. Moreover, the synthesis of types I and II collagen, which, in addition to proteoglycans 
are characteristic matrix components of fibrocartilage tissue, was observed on scaffolds subjected to 
mechanical loading in the absence of any additional growth factor co-stimulation. This study demonstrated 
the potential for complex, physiologic loading to drive fibrochondrogenic differentiation.  
 
8.1.4. Strategies for Mineralized Fibrocartilage Regeneration 
 As the native ACL-to-bone insertion consists of both non-mineralized and mineralized tissue 
regions, Aim 4 focused on optimization of culture conditions for guiding SDSC-mediated formation of 
mineralized fibrocartilage. Chapter 7 evaluated the combined effects of scaffold HA content and exogenous 
TGF-β3 on SDSC matrix synthesis. Scaffold mineral content and exogenous TGF-β3 stimulation were 
observed to have a positive synergistic effect on SDSC proliferation and relevant matrix synthesis, with the 
highest cell number, collagen deposition, and proteoglycan deposition observed on 35% HA scaffolds 
cultured in the presence of TGF-β3. 
 
8.2. Future Directions 
 The findings from this thesis delineate the importance of bioinspired chemical and physical stimuli 
in fibrochondrogenic differentiation, and how they can be optimized for stem cell-mediated interface 
regeneration. These studies yield valuable scaffold design criteria and establish in vitro culture parameters 
that can be applied to functional integration of soft connective tissue with bone at various critical 
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attachments throughout the musculoskeletal system, including the ligament and tendon-to-bone entheses, 
as well as for regeneration of other important fibrocartilaginous tissues. However, to realize the clinical 
translation of this system, several areas of further study and optimization are needed, and are described 
below.  
 
8.2.1. Integration of Non-Mineralized and Mineralized Phases 
 Based on the results from Aim 1, a scaffold for functional fibrocartilage interface regeneration must 
support spatial tissue heterogeneity and the formation and integration of both non-mineralized and 
mineralized tissue regions. While the findings from Aims 3 and 4 establish strategies for regeneration of 
both non-mineralized and mineralized fibrocartilage, functional integration of the two tissue phases remains 
to be optimized. One potential approach is to use masking techniques in order to fabricate stratified 
scaffolds with controlled spatial differences in composition along the fiber20,93. It is anticipated that a 
stepwise increase in mineral content between phases of a stratified scaffold design will approximate the 
exponential increase in mineral content across the interface regions76,176, and will support simultaneous 
regeneration of both phases of the fibrocartilaginous interface. Pre-engineering integration of the non-
mineralized to mineralized tissue regions ex vivo, will not only ensure the re-establishment of an organized 
soft tissue-to-bone transition, but can ultimately allow for faster and more robust graft integration via bone-
to-bone healing11. 
 
8.2.2. Integration with Ligament and Bone Regions 
 In addition to ensuring integration between the non-mineralized and mineralized fibrocartilage 
tissue regions, integration and interconnectivity with adjacent ligament and bone scaffold or tissue phases, 
as well as compatibility with current surgical repair methods are also associated requirements in interface 
scaffold design and fabrication. One strategy is to integrate the bioactive scaffold developed here into a 
complex, multi-phase synthetic total ACL graft that would replace the use of a conventional tendinous graft 
in ACL reconstruction93. Alternatively, the scaffold could be adapted for use as a graft collar94,95 that can be 





8.2.3. In Vivo Evaluation 
 In vivo evaluation of the scaffold system will be necessary for subsequent clinical translation. 
Several animal models have been developed for ACL reconstruction, including murine346, rat65,93,347,348, 
rabbit15, canine13, porcine349, ovine350, and caprine351 models. In particular, the rodent model of ACL 
reconstruction has been extensively studied65,93,347,348 and is a promising candidate for initial in vivo testing. 
While large animal models provide a more accurate representation of human anatomical size and 
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